Document
false--12-31Q120192019-03-310000059440falseLarge Accelerated Filerfalse0.380.400.100.102500000002500000001409146421408990651409146421408990652946500033590002430000000.0900.0800.0850.0850.0750.0800.1840.0520.4850.1500.5000.1500.4950.03150000005462800054202000111000000010000000P2YP12MP90D0P1Y0 0000059440 2019-01-01 2019-03-31 0000059440 2019-05-07 0000059440 2018-12-31 0000059440 2019-03-31 0000059440 2018-01-01 2018-03-31 0000059440 vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:TobaccoSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:TobaccoSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-03-31 0000059440 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0000059440 2017-12-31 0000059440 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-03-31 0000059440 2018-03-31 0000059440 us-gaap:CommonStockMember 2017-12-31 0000059440 us-gaap:RetainedEarningsMember 2018-03-31 0000059440 us-gaap:CommonStockMember 2018-03-31 0000059440 us-gaap:NoncontrollingInterestMember 2018-01-01 2018-03-31 0000059440 us-gaap:RetainedEarningsMember 2017-12-31 0000059440 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0000059440 us-gaap:NoncontrollingInterestMember 2017-12-31 0000059440 us-gaap:CommonStockMember 2018-01-01 2018-03-31 0000059440 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0000059440 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0000059440 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000059440 us-gaap:NoncontrollingInterestMember 2018-03-31 0000059440 us-gaap:CommonStockMember 2019-03-31 0000059440 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000059440 us-gaap:RetainedEarningsMember 2018-12-31 0000059440 us-gaap:CommonStockMember 2018-12-31 0000059440 us-gaap:NoncontrollingInterestMember 2018-12-31 0000059440 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000059440 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0000059440 us-gaap:NoncontrollingInterestMember 2019-03-31 0000059440 us-gaap:RetainedEarningsMember 2019-03-31 0000059440 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-03-31 0000059440 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0000059440 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0000059440 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000059440 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0000059440 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000059440 us-gaap:TrademarksMember 2018-12-31 0000059440 vgr:MasterSettlementAgreementIntangibleAssetMember 2019-03-31 0000059440 us-gaap:TrademarksMember 2019-03-31 0000059440 vgr:MasterSettlementAgreementIntangibleAssetMember 2018-12-31 0000059440 srt:MaximumMember 2018-12-31 0000059440 2018-09-27 0000059440 vgr:AccountingStandardsUpdate201802Member 2019-01-01 0000059440 srt:MaximumMember 2019-03-31 0000059440 srt:MinimumMember 2018-12-31 0000059440 srt:MinimumMember 2019-03-31 0000059440 us-gaap:RestrictedStockMember 2019-01-01 2019-03-31 0000059440 us-gaap:RestrictedStockMember 2018-01-01 2018-03-31 0000059440 us-gaap:ConvertibleDebtSecuritiesMember 2019-01-01 2019-03-31 0000059440 us-gaap:ConvertibleDebtSecuritiesMember 2018-01-01 2018-03-31 0000059440 vgr:TobaccoMember 2018-01-01 2018-03-31 0000059440 vgr:OtherBrandsMember vgr:TobaccoMember 2019-01-01 2019-03-31 0000059440 vgr:OtherBrandsMember vgr:TobaccoMember 2018-01-01 2018-03-31 0000059440 vgr:CoreDiscountBrandsPyramidGrandPrixLiggettSelectEveandEAGLE20sMember vgr:TobaccoMember 2019-01-01 2019-03-31 0000059440 vgr:TobaccoMember 2019-01-01 2019-03-31 0000059440 vgr:CoreDiscountBrandsPyramidGrandPrixLiggettSelectEveandEAGLE20sMember vgr:TobaccoMember 2018-01-01 2018-03-31 0000059440 2019-01-01 0000059440 vgr:OtherRealEstateRevenuesMember vgr:NortheastMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:CommissionandOtherBrokerageIncomeMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:DevelopmentMarketingMember vgr:NortheastMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:PropertyManagementIncomeMember vgr:SoutheastMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:WestMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:TitleFeesMember vgr:NortheastMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:DevelopmentMarketingMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:CommissionandOtherBrokerageIncomeMember vgr:NortheastMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:TotalDouglasEllimanRealityRevenueMember vgr:WestMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:PropertyManagementIncomeMember vgr:NortheastMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:OtherRealEstateRevenuesMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:NortheastMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:CommissionandOtherBrokerageIncomeMember vgr:SoutheastMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:PropertyManagementIncomeMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:OtherRealEstateRevenuesMember vgr:WestMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:CommissionandOtherBrokerageIncomeMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:TotalDouglasEllimanRealityRevenueMember vgr:NortheastMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:TotalDouglasEllimanRealityRevenueMember vgr:SoutheastMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:DevelopmentMarketingMember vgr:SoutheastMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:PropertyManagementIncomeMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:DevelopmentMarketingMember vgr:WestMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:CommissionandOtherBrokerageIncomeMember vgr:WestMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:TotalDouglasEllimanRealityRevenueMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:TitleFeesMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:TitleFeesMember vgr:SoutheastMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:SoutheastMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:TitleFeesMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:OtherRealEstateRevenuesMember vgr:SoutheastMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:DevelopmentMarketingMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:TitleFeesMember vgr:WestMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:PropertyManagementIncomeMember vgr:WestMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:OtherRealEstateRevenuesMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:TotalDouglasEllimanRealityRevenueMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 vgr:TitleFeesMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:OtherRealEstateRevenuesMember vgr:SoutheastMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:SoutheastMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:CommissionandOtherBrokerageIncomeMember vgr:SoutheastMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:OtherRealEstateRevenuesMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:TotalDouglasEllimanRealityRevenueMember vgr:WestMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:PropertyManagementIncomeMember vgr:NortheastMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:DevelopmentMarketingMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:PropertyManagementIncomeMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:NortheastMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:TitleFeesMember vgr:WestMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:DevelopmentMarketingMember vgr:NortheastMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:TitleFeesMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:CommissionandOtherBrokerageIncomeMember vgr:NortheastMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:DevelopmentMarketingMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:TotalDouglasEllimanRealityRevenueMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:PropertyManagementIncomeMember vgr:WestMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:DevelopmentMarketingMember vgr:WestMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:TitleFeesMember vgr:NortheastMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:OtherRealEstateRevenuesMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:TitleFeesMember vgr:SoutheastMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:OtherRealEstateRevenuesMember vgr:NortheastMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:TotalDouglasEllimanRealityRevenueMember vgr:NortheastMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:PropertyManagementIncomeMember vgr:SoutheastMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:CommissionandOtherBrokerageIncomeMember vgr:WestMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:TotalDouglasEllimanRealityRevenueMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:PropertyManagementIncomeMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:CommissionandOtherBrokerageIncomeMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:DevelopmentMarketingMember vgr:SoutheastMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:CommissionandOtherBrokerageIncomeMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:OtherRealEstateRevenuesMember vgr:WestMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:TotalDouglasEllimanRealityRevenueMember vgr:SoutheastMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 vgr:WestMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 us-gaap:TransferredOverTimeMember 2019-01-01 2019-03-31 0000059440 2023-04-01 2019-03-31 0000059440 us-gaap:EquipmentMember 2019-03-31 0000059440 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 0000059440 vgr:OneLeaseLessorAffiliateofSignificantInvestorMember 2019-01-01 2019-03-31 0000059440 vgr:OneLeaseLessorAffiliateofSignificantInvestorMember 2019-03-31 0000059440 srt:MaximumMember 2019-01-01 2019-03-31 0000059440 srt:MinimumMember 2019-01-01 2019-03-31 0000059440 us-gaap:InventoriesMember 2018-12-31 0000059440 vgr:FinishedGoodsMember 2018-12-31 0000059440 vgr:FinishedGoodsMember 2019-03-31 0000059440 vgr:WorkinProcessMember 2018-12-31 0000059440 vgr:LeafTobaccoMember 2018-12-31 0000059440 us-gaap:InventoriesMember 2019-03-31 0000059440 vgr:LiggettMember us-gaap:InventoriesMember 2019-01-01 2019-03-31 0000059440 vgr:OtherRawMaterialsMember 2019-03-31 0000059440 vgr:OtherRawMaterialsMember 2018-12-31 0000059440 vgr:WorkinProcessMember 2019-03-31 0000059440 vgr:LeafTobaccoMember 2019-03-31 0000059440 vgr:MarketableDebtSecuritiesMember 2019-03-31 0000059440 us-gaap:DebtSecuritiesMember 2019-03-31 0000059440 vgr:CorporateSecuritiesandU.S.GovernmentSecuritiesMember 2019-01-01 2019-03-31 0000059440 us-gaap:OtherLongTermInvestmentsMember 2019-01-01 2019-03-31 0000059440 vgr:CorporateSecuritiesandU.S.GovernmentSecuritiesMember 2018-01-01 2018-03-31 0000059440 us-gaap:DebtSecuritiesMember 2018-12-31 0000059440 us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2019-03-31 0000059440 us-gaap:CommercialMortgageBackedSecuritiesMember 2019-03-31 0000059440 us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2019-03-31 0000059440 vgr:ForeignFixedIncomeSecuritiesMember 2019-03-31 0000059440 us-gaap:CorporateDebtSecuritiesMember 2019-03-31 0000059440 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2019-03-31 0000059440 us-gaap:USTreasurySecuritiesMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel1Member vgr:MarketableEquitySecuritiesMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel1Member vgr:MarketableEquitySecuritiesMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel1Member us-gaap:FixedIncomeFundsMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel1Member us-gaap:FixedIncomeFundsMember 2018-12-31 0000059440 vgr:LadenburgThalmannFinancialServicesInc.Member 2018-12-31 0000059440 vgr:IndianCreekInvestorsLPMember 2018-12-31 0000059440 vgr:LadenburgThalmannFinancialServicesInc.Member 2019-03-31 0000059440 vgr:IndianCreekInvestorsLPMember 2019-03-31 0000059440 vgr:BoyarValueFundMember 2018-12-31 0000059440 vgr:BoyarValueFundMember 2019-03-31 0000059440 vgr:CastleBrandsMember 2018-12-31 0000059440 vgr:CastleBrandsMember 2019-03-31 0000059440 vgr:NewValleyLlcMember vgr:SagaponackMember 2019-03-31 0000059440 vgr:NewValleyLlcMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2019-03-31 0000059440 vgr:DouglasEllimanRealtyLlcMember 2018-01-01 2018-03-31 0000059440 vgr:NewValleyLlcMember vgr:A3526thAvenueLLCMember us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2019-03-31 0000059440 vgr:DouglasEllimanRealtyLlcMember 2019-01-01 2019-03-31 0000059440 srt:MultifamilyMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember 2019-01-01 2019-03-31 0000059440 vgr:NewValleyLlcMember 2019-01-01 2019-03-31 0000059440 vgr:NewValleyLlcMember vgr:A3526thAvenueLLCMember us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2019-02-28 0000059440 vgr:NewValleyLlcMember 2018-01-01 2018-03-31 0000059440 vgr:NewValleyLlcMember srt:MultifamilyMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember 2019-01-01 2019-03-31 0000059440 vgr:NewValleyLlcMember vgr:EscenaMember 2019-01-01 2019-03-31 0000059440 vgr:NewValleyLlcMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2018-12-31 0000059440 vgr:NewValleyLlcMember vgr:EscenaMember 2018-01-01 2018-03-31 0000059440 vgr:NewValleyLlcMember vgr:SagaponackMember 2015-04-01 2015-04-30 0000059440 vgr:NewValleyLlcMember srt:HotelMember 2018-01-01 2018-03-31 0000059440 vgr:NewValleyLlcMember srt:HotelMember 2019-01-01 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:HotelMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember 2019-01-01 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:OtherPropertyMember 2019-01-01 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:HotelMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember 2018-01-01 2018-03-31 0000059440 vgr:NewValleyLlcMember srt:MultifamilyMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember 2018-01-01 2018-03-31 0000059440 vgr:NewValleyLlcMember srt:OtherPropertyMember 2018-01-01 2018-03-31 0000059440 vgr:NewValleyLlcMember srt:MultifamilyMember 2018-01-01 2018-03-31 0000059440 vgr:NewValleyLlcMember srt:MultifamilyMember 2019-01-01 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:ApartmentBuildingMember vgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMember 2019-01-01 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:MultifamilyMember vgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMember 2019-01-01 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:RetailSiteMember vgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMember 2018-01-01 2018-03-31 0000059440 vgr:NewValleyLlcMember srt:ApartmentBuildingMember 2019-01-01 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:RetailSiteMember 2019-01-01 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:ApartmentBuildingMember 2018-01-01 2018-03-31 0000059440 vgr:NewValleyLlcMember srt:ApartmentBuildingMember vgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMember 2018-01-01 2018-03-31 0000059440 vgr:NewValleyLlcMember srt:RetailSiteMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember 2018-01-01 2018-03-31 0000059440 vgr:NewValleyLlcMember srt:RetailSiteMember vgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMember 2019-01-01 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:HotelMember us-gaap:NonUsMember 2018-01-01 2018-03-31 0000059440 vgr:NewValleyLlcMember srt:MultifamilyMember vgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMember 2018-01-01 2018-03-31 0000059440 vgr:NewValleyLlcMember srt:HotelMember us-gaap:NonUsMember 2019-01-01 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:RetailSiteMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember 2019-01-01 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:RetailSiteMember 2018-01-01 2018-03-31 0000059440 vgr:NewValleyLlcMember 2018-12-31 0000059440 vgr:NewValleyLlcMember vgr:SagaponackMember 2018-12-31 0000059440 vgr:NewValleyLlcMember 2019-03-31 0000059440 vgr:NewValleyLlcMember vgr:EscenaMember 2018-12-31 0000059440 vgr:NewValleyLlcMember vgr:EscenaMember 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:HotelMember 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:RetailSiteMember vgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMember 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:MultifamilyMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember 2018-12-31 0000059440 vgr:NewValleyLlcMember srt:HotelMember us-gaap:NonUsMember 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:MultifamilyMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:HotelMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember 2018-12-31 0000059440 vgr:NewValleyLlcMember srt:MultifamilyMember vgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMember 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:HotelMember us-gaap:NonUsMember 2018-12-31 0000059440 vgr:NewValleyLlcMember srt:OtherPropertyMember 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:RetailSiteMember vgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMember 2018-12-31 0000059440 vgr:NewValleyLlcMember srt:MultifamilyMember 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:RetailSiteMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember 2018-12-31 0000059440 vgr:NewValleyLlcMember srt:RetailSiteMember 2018-12-31 0000059440 vgr:NewValleyLlcMember srt:HotelMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:HotelMember 2018-12-31 0000059440 vgr:NewValleyLlcMember srt:MultifamilyMember 2018-12-31 0000059440 vgr:NewValleyLlcMember srt:MultifamilyMember vgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMember 2018-12-31 0000059440 vgr:NewValleyLlcMember srt:RetailSiteMember 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:OtherPropertyMember 2018-12-31 0000059440 vgr:NewValleyLlcMember srt:RetailSiteMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:OtherPropertyMember srt:MaximumMember 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:MultifamilyMember srt:MaximumMember vgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMember 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:HotelMember srt:MaximumMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:MultifamilyMember srt:MinimumMember vgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMember 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:MinimumMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:MaximumMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:HotelMember srt:MinimumMember vgr:NewYorkCityStandardMetropolitanStatisticalAreaMember 2019-03-31 0000059440 vgr:NewValleyLlcMember srt:OtherPropertyMember srt:MinimumMember 2019-03-31 0000059440 us-gaap:ConvertibleDebtMember 2019-03-31 0000059440 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:OtherDebtSecuritiesMember 2019-03-31 0000059440 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2019-03-31 0000059440 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2018-12-31 0000059440 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2018-12-31 0000059440 us-gaap:SeniorNotesMember 2019-03-31 0000059440 us-gaap:SeniorNotesMember 2018-12-31 0000059440 us-gaap:ConvertibleDebtMember 2018-12-31 0000059440 us-gaap:OtherDebtSecuritiesMember 2018-12-31 0000059440 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-03-31 0000059440 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-03-31 0000059440 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:OtherDebtSecuritiesMember 2018-12-31 0000059440 us-gaap:OtherDebtSecuritiesMember 2019-03-31 0000059440 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2018-12-31 0000059440 vgr:A5.5VariableInterestSeniorConvertibleDebenturesdue2020Member us-gaap:ConvertibleDebtMember 2018-12-31 0000059440 vgr:LiggettMember us-gaap:SecuredDebtMember 2019-03-31 0000059440 vgr:A7.5VariableInterestSeniorConvertibleNotesdue2019Member us-gaap:ConvertibleDebtMember 2018-12-31 0000059440 vgr:LiggettMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2018-12-31 0000059440 vgr:LiggettMember vgr:TermLoanUnderCreditFacilityMember us-gaap:LineOfCreditMember 2019-03-31 0000059440 vgr:LiggettMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2019-03-31 0000059440 vgr:LiggettMember vgr:TermLoanUnderCreditFacilityMember us-gaap:LineOfCreditMember 2018-12-31 0000059440 vgr:LiggettMember us-gaap:SecuredDebtMember 2018-12-31 0000059440 vgr:A7.5VariableInterestSeniorConvertibleNotesdue2019Member us-gaap:ConvertibleDebtMember 2019-03-31 0000059440 us-gaap:NotesPayableOtherPayablesMember 2018-12-31 0000059440 vgr:A10.5SeniorNotesdue2026Member us-gaap:ConvertibleDebtMember 2019-03-31 0000059440 vgr:A10.5SeniorNotesdue2026Member us-gaap:ConvertibleDebtMember 2018-12-31 0000059440 us-gaap:NotesPayableOtherPayablesMember 2019-03-31 0000059440 vgr:A6.125SeniorSecuredNotesdue2025Member us-gaap:SeniorNotesMember 2018-12-31 0000059440 vgr:A6.125SeniorSecuredNotesdue2025Member us-gaap:SeniorNotesMember 2019-03-31 0000059440 vgr:A5.5VariableInterestSeniorConvertibleDebenturesdue2020Member us-gaap:ConvertibleDebtMember 2019-03-31 0000059440 vgr:A10.5SeniorNotesdue2026Member us-gaap:SeniorNotesMember 2018-11-02 0000059440 vgr:LiggettMember us-gaap:LineOfCreditMember 2019-03-31 0000059440 vgr:A7.5VariableInterestSeniorConvertibleNotesdue2019Member us-gaap:ConvertibleDebtMember 2019-01-01 2019-01-31 0000059440 vgr:A10.5SeniorNotesdue2026Member us-gaap:SeniorNotesMember 2018-11-02 2018-11-02 0000059440 vgr:A10.5SeniorNotesdue2026Member us-gaap:SeniorNotesMember 2019-03-31 0000059440 vgr:DouglasEllimanRealtyLlcMember vgr:A10.5SeniorNotesdue2026Member us-gaap:SeniorNotesMember 2018-11-02 0000059440 vgr:A7.5VariableInterestSeniorConvertibleNotesdue2019Member us-gaap:ConvertibleDebtMember 2019-01-31 0000059440 vgr:LiggettMember vgr:IndividualActionsCasesMember stpr:OH 2019-03-31 0000059440 vgr:LiggettMember vgr:IndividualActionsCasesMember stpr:NY 2019-03-31 0000059440 vgr:LiggettMember vgr:IndividualActionsCasesMember stpr:LA 2019-03-31 0000059440 vgr:LiggettMember vgr:IndividualActionsCasesMember stpr:FL 2019-03-31 0000059440 vgr:LiggettMember vgr:IndividualActionsCasesMember stpr:IL 2019-03-31 0000059440 vgr:LiggettMember vgr:IndividualActionsCasesMember stpr:WV 2019-03-31 0000059440 vgr:IndividualActionsCasesMember 2019-03-31 0000059440 vgr:LiggettMember vgr:HealthCareCostRecoveryActions20112015NPMAdjustmentMember 2019-03-31 0000059440 vgr:LiggettMember vgr:HealthCareCostRecoveryActionsMember 1996-03-01 1998-03-31 0000059440 vgr:LiggettAndVectorTobaccoMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-03-31 0000059440 vgr:LiggettMember vgr:HealthCareCostRecoveryActionsMember stpr:FL 2010-01-01 2010-12-31 0000059440 vgr:TobaccoLitigationPersonalInjuryCasesMember stpr:WV 2013-10-01 2013-10-31 0000059440 vgr:VectorTobaccoMember vgr:HealthCareCostRecoveryActionsMember 2019-03-31 0000059440 vgr:TobaccoLitigationPersonalInjuryCasesMember stpr:WV 2013-05-01 2013-05-31 0000059440 vgr:LiggettAndVectorTobaccoMember vgr:HealthCareCostRecoveryActionsNPMAdjustmentMember us-gaap:CostOfSalesMember 2013-01-01 2017-12-31 0000059440 vgr:LiggettMember vgr:TobaccoLitigationPersonalInjuryCasesMember stpr:WV 2019-03-31 0000059440 vgr:EngleProgenyCasesMember 2019-03-31 0000059440 vgr:LiggettAndVectorTobaccoMember vgr:EngleProgenyCasesMember 2019-01-01 2019-03-31 0000059440 vgr:LiggettMember vgr:EngleProgenyCasesMember 2017-09-01 2017-09-30 0000059440 vgr:LiggettMember 1996-03-01 1998-03-31 0000059440 vgr:HealthCareCostRecoveryActionsMember 1996-03-01 1998-03-31 0000059440 vgr:LiggettMember vgr:HealthCareCostRecoveryActionsMember stpr:MS 2019-03-21 0000059440 vgr:LiggettMember vgr:HealthCareCostRecoveryActionsMember 2019-03-31 0000059440 vgr:LiggettMember vgr:EngleProgenyCasesMember 2019-03-31 0000059440 vgr:LiggettMember 2019-01-01 2019-03-31 0000059440 vgr:LiggettAndVectorTobaccoMember vgr:EngleProgenyCasesMember 2019-03-31 0000059440 vgr:LiggettAndVectorTobaccoMember vgr:HealthCareCostRecoveryActionsMember 2017-12-28 2017-12-28 0000059440 vgr:LiggettMember vgr:Santorov.R.J.ReynoldsMember us-gaap:SuretyBondMember 2018-12-31 0000059440 1996-11-21 1996-11-21 0000059440 vgr:LiggettMember vgr:EngleProgenyCasesMember 2016-12-01 2016-12-31 0000059440 vgr:LiggettMember vgr:EngleProgenyCasesMember 2013-10-01 2013-10-31 0000059440 vgr:LiggettMember 2018-01-01 2018-03-31 0000059440 vgr:HealthCareCostRecoveryActions2003NPMAdjustmentMember 2019-01-01 2019-03-31 0000059440 vgr:LiggettMember vgr:EngleProgenyCasesMember 2017-06-01 2017-06-30 0000059440 vgr:ParsonsVAcSIncMember 2019-03-31 0000059440 vgr:LiggettMember vgr:EngleProgenyCasesMember 2015-02-01 2015-02-28 0000059440 vgr:LiggettMember vgr:ClassActionsMember 2019-03-31 0000059440 vgr:LiggettAndVectorTobaccoMember vgr:HealthCareCostRecoveryActions20042010NPMAdjustmentMember 2019-03-31 0000059440 vgr:LiggettMember vgr:EngleProgenyCasesMember 2013-10-31 0000059440 vgr:HealthCareCostRecoveryActionsMember 2019-01-01 2019-03-31 0000059440 vgr:LiggettMember vgr:CrowCreekSiouxTribev.AmericanTobaccoCompanyMember 2019-03-31 0000059440 vgr:LiggettMember vgr:EngleProgenyCasesMember 2016-10-01 2016-12-31 0000059440 vgr:LiggettMember vgr:EngleProgenyCasesMember stpr:FL 2009-06-30 0000059440 vgr:LiggettMember vgr:HealthCareCostRecoveryActionsMember stpr:MS 2016-01-12 2016-01-12 0000059440 vgr:LiggettMember vgr:Santorov.R.J.ReynoldsMember 2019-01-01 2019-03-31 0000059440 vgr:TobaccoLitigationPersonalInjuryCasesMember stpr:WV 2001-12-31 0000059440 vgr:LiggettMember vgr:LukacsCampbellDouglasClayTulloWardRizzutoLambertandBuchananMember 2019-01-01 2019-03-31 0000059440 vgr:HealthCareCostRecoveryActions2003NPMAdjustmentMember 2019-03-31 0000059440 vgr:LiggettMember 2019-03-31 0000059440 vgr:LiggettMember vgr:TobaccoLitigationPersonalInjuryCasesMember stpr:WV 2017-04-30 0000059440 vgr:LiggettMember 1996-11-21 1996-11-21 0000059440 vgr:LiggettAndVectorTobaccoMember vgr:HealthCareCostRecoveryActionsMember 2019-03-31 0000059440 vgr:LiggettMember vgr:HealthCareCostRecoveryActionsMember stpr:MN 2003-01-01 2003-12-31 0000059440 vgr:LiggettAndVectorTobaccoMember srt:MaximumMember us-gaap:SuretyBondMember 2019-03-31 0000059440 vgr:LiggettMember vgr:IndividualActionsCasesMember stpr:MD 2019-03-31 0000059440 us-gaap:SettledLitigationMember 2018-01-01 2018-03-31 0000059440 us-gaap:PendingLitigationMember 2018-03-31 0000059440 us-gaap:SettledLitigationMember 2018-03-31 0000059440 us-gaap:PendingLitigationMember 2018-01-01 2018-03-31 0000059440 us-gaap:PendingLitigationMember 2017-12-31 0000059440 us-gaap:SettledLitigationMember 2017-12-31 0000059440 us-gaap:PendingLitigationMember 2019-01-01 2019-03-31 0000059440 us-gaap:SettledLitigationMember 2018-12-31 0000059440 us-gaap:SettledLitigationMember 2019-01-01 2019-03-31 0000059440 us-gaap:SettledLitigationMember 2019-03-31 0000059440 us-gaap:PendingLitigationMember 2018-12-31 0000059440 us-gaap:PendingLitigationMember 2019-03-31 0000059440 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-03-31 0000059440 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-01-01 2018-03-31 0000059440 us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-03-31 0000059440 us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-03-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel3Member vgr:MeasurementInputLeverageAdjustedEquityandVolatilityofPeerFirmsMember vgr:MonteCarloSimulationModelMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendPaymentMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputConversionPriceMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputSharePriceMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel3Member 2019-03-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember vgr:MonteCarloSimulationModelMember 2019-03-31 0000059440 vgr:RestrictedAssetsMember us-gaap:CommercialPaperMember us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0000059440 vgr:CurrentRestrictedAssetsMember us-gaap:CommercialPaperMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000059440 vgr:RestrictedAssetsMember us-gaap:CommercialPaperMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000059440 vgr:DouglasEllimanMember 2019-03-31 0000059440 vgr:CurrentRestrictedAssetsMember us-gaap:CommercialPaperMember us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel3Member vgr:MeasurementInputLeverageAdjustedEquityandVolatilityofPeerFirmsMember vgr:MonteCarloSimulationModelMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputSharePriceMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendPaymentMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel3Member 2018-12-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember vgr:MonteCarloSimulationModelMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputConversionPriceMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:ValuationTechniqueDiscountedCashFlowMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel2Member 2018-12-31 0000059440 us-gaap:SuretyBondMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel1Member 2018-12-31 0000059440 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeSecuritiesMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember vgr:ForeignFixedIncomeSecuritiesMember 2018-12-31 0000059440 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000059440 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel2Member vgr:MarketableEquitySecuritiesMember 2018-12-31 0000059440 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0000059440 us-gaap:CertificatesOfDepositMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000059440 us-gaap:SuretyBondMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:FixedIncomeFundsMember 2018-12-31 0000059440 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2018-12-31 0000059440 us-gaap:SuretyBondMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel2Member us-gaap:EquitySecuritiesMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel1Member us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialMortgageBackedSecuritiesMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember vgr:ForeignFixedIncomeSecuritiesMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember vgr:ForeignFixedIncomeSecuritiesMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialMortgageBackedSecuritiesMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0000059440 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000059440 us-gaap:CertificatesOfDepositMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2018-12-31 0000059440 us-gaap:CommercialPaperMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2018-12-31 0000059440 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000059440 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2018-12-31 0000059440 us-gaap:FairValueMeasurementsRecurringMember vgr:ForeignFixedIncomeSecuritiesMember 2018-12-31 0000059440 us-gaap:CertificatesOfDepositMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000059440 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeSecuritiesMember 2018-12-31 0000059440 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialMortgageBackedSecuritiesMember 2018-12-31 0000059440 us-gaap:CertificatesOfDepositMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000059440 vgr:MarketableEquitySecuritiesMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel2Member us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2018-12-31 0000059440 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2018-12-31 0000059440 us-gaap:EquitySecuritiesMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel2Member us-gaap:FixedIncomeFundsMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeSecuritiesMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0000059440 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel1Member us-gaap:EquitySecuritiesMember 2018-12-31 0000059440 us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000059440 us-gaap:SuretyBondMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000059440 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialMortgageBackedSecuritiesMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeSecuritiesMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000059440 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000059440 us-gaap:FixedIncomeFundsMember 2018-12-31 0000059440 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2018-12-31 0000059440 us-gaap:FairValueInputsLevel3Member vgr:MarketableEquitySecuritiesMember 2018-12-31 0000059440 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member 2019-03-31 0000059440 us-gaap:FairValueInputsLevel1Member 2019-03-31 0000059440 us-gaap:FairValueInputsLevel1Member vgr:ForeignFixedIncomeSecuritiesMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel2Member 2019-03-31 0000059440 us-gaap:CertificatesOfDepositMember us-gaap:FairValueInputsLevel3Member 2019-03-31 0000059440 us-gaap:FairValueInputsLevel2Member vgr:MarketableEquitySecuritiesMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel1Member us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2019-03-31 0000059440 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2019-03-31 0000059440 us-gaap:CertificatesOfDepositMember us-gaap:FairValueInputsLevel1Member 2019-03-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel2Member us-gaap:USTreasurySecuritiesMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel2Member us-gaap:FixedIncomeSecuritiesMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel1Member us-gaap:CommercialMortgageBackedSecuritiesMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:CommercialMortgageBackedSecuritiesMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel3Member vgr:MarketableEquitySecuritiesMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2019-03-31 0000059440 us-gaap:SuretyBondMember us-gaap:FairValueInputsLevel2Member 2019-03-31 0000059440 us-gaap:CertificatesOfDepositMember us-gaap:FairValueInputsLevel2Member 2019-03-31 0000059440 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2019-03-31 0000059440 us-gaap:FairValueInputsLevel2Member us-gaap:EquitySecuritiesMember 2019-03-31 0000059440 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel3Member 2019-03-31 0000059440 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasurySecuritiesMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel1Member us-gaap:FixedIncomeSecuritiesMember 2019-03-31 0000059440 vgr:MarketableEquitySecuritiesMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2019-03-31 0000059440 us-gaap:MoneyMarketFundsMember 2019-03-31 0000059440 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member 2019-03-31 0000059440 us-gaap:FixedIncomeSecuritiesMember 2019-03-31 0000059440 us-gaap:SuretyBondMember us-gaap:FairValueInputsLevel1Member 2019-03-31 0000059440 us-gaap:FairValueInputsLevel1Member us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel2Member us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2019-03-31 0000059440 us-gaap:CommercialPaperMember 2019-03-31 0000059440 us-gaap:EquitySecuritiesMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:USTreasurySecuritiesMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel2Member us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:FixedIncomeSecuritiesMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel2Member us-gaap:FixedIncomeFundsMember 2019-03-31 0000059440 us-gaap:CertificatesOfDepositMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2019-03-31 0000059440 us-gaap:SuretyBondMember us-gaap:FairValueInputsLevel3Member 2019-03-31 0000059440 us-gaap:FairValueInputsLevel3Member vgr:ForeignFixedIncomeSecuritiesMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel2Member us-gaap:CommercialMortgageBackedSecuritiesMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel2Member vgr:ForeignFixedIncomeSecuritiesMember 2019-03-31 0000059440 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel1Member 2019-03-31 0000059440 us-gaap:FixedIncomeFundsMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel1Member us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel1Member us-gaap:EquitySecuritiesMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel2Member us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2019-03-31 0000059440 us-gaap:SuretyBondMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:FixedIncomeFundsMember 2019-03-31 0000059440 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member 2019-03-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputCreditSpreadMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-03-31 0000059440 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputCreditSpreadMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2018-12-31 0000059440 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputCreditSpreadMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-03-31 0000059440 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputCreditSpreadMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-03-31 0000059440 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputCreditSpreadMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2018-12-31 0000059440 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputCreditSpreadMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2018-12-31 0000059440 us-gaap:OperatingSegmentsMember vgr:TobaccoSegmentMember 2018-01-01 2018-03-31 0000059440 us-gaap:OperatingSegmentsMember vgr:TobaccoSegmentMember 2019-01-01 2019-03-31 0000059440 us-gaap:OperatingSegmentsMember vgr:RealEstateSegmentMember 2019-01-01 2019-03-31 0000059440 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-03-31 0000059440 us-gaap:CorporateNonSegmentMember 2018-01-01 2018-03-31 0000059440 us-gaap:OperatingSegmentsMember vgr:RealEstateSegmentMember 2018-01-01 2018-03-31 0000059440 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2019-03-31 0000059440 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2019-03-31 0000059440 srt:ConsolidationEliminationsMember 2019-03-31 0000059440 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2019-03-31 0000059440 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2018-12-31 0000059440 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2018-12-31 0000059440 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2018-12-31 0000059440 srt:ConsolidationEliminationsMember 2018-12-31 0000059440 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2019-01-01 2019-03-31 0000059440 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2019-01-01 2019-03-31 0000059440 srt:ConsolidationEliminationsMember 2019-01-01 2019-03-31 0000059440 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2019-01-01 2019-03-31 0000059440 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2018-01-01 2018-03-31 0000059440 srt:ConsolidationEliminationsMember 2018-01-01 2018-03-31 0000059440 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2018-01-01 2018-03-31 0000059440 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2018-01-01 2018-03-31 0000059440 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2018-03-31 0000059440 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2017-12-31 0000059440 srt:ConsolidationEliminationsMember 2017-12-31 0000059440 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2018-03-31 0000059440 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2018-03-31 0000059440 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2017-12-31 0000059440 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2017-12-31 0000059440 srt:ConsolidationEliminationsMember 2018-03-31 vgr:venture iso4217:USD xbrli:pure xbrli:shares iso4217:USD xbrli:shares vgr:investment vgr:state vgr:defendant vgr:sponsorship vgr:case


 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For The Quarterly Period Ended March 31, 2019
 
VECTOR GROUP LTD.
(Exact name of registrant as specified in its charter)
Delaware
1-5759
65-0949535
(State or other jurisdiction of incorporation
Commission File Number
(I.R.S. Employer Identification No.)
incorporation or organization)
 
 
4400 Biscayne Boulevard
Miami, Florida 33137
305-579-8000
(Address, including zip code and telephone number, including area code,
of the principal executive offices)
 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
x Yes o No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
x Yes o No
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
x Large accelerated filer
o  Accelerated filer
o  Non-accelerated filer
o  Smaller reporting company
o  Emerging Growth Company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the Registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.
o Yes x No
Securities Registered Pursuant to 12(b) of the Act:
Title of each class:
Trading
Name of each exchange
 
Symbol(s)
on which registered:
Common stock, par value $0.10 per share
VGR
New York Stock Exchange
At May 7, 2019, Vector Group Ltd. had 140,959,065 shares of common stock outstanding.
 




VECTOR GROUP LTD.

FORM 10-Q

TABLE OF CONTENTS

 
Page
PART I. FINANCIAL INFORMATION
 
 
 
Item 1. Vector Group Ltd. Condensed Consolidated Financial Statements (Unaudited):
 
 
 
Condensed Consolidated Balance Sheets as of March 31, 2019 and December 31, 2018
 
 
Condensed Consolidated Statements of Operations for the three months ended March 31, 2019 and 2018
 
 
Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, 2019 and 2018
 
 
Condensed Consolidated Statements of Stockholders' Deficiency for the three months ended March 31, 2019 and 2018
 
 
Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2019 and 2018
 
 
Notes to Condensed Consolidated Financial Statements
 
 
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
 
 
Item 3. Quantitative and Qualitative Disclosures About Market Risk
 
 
Item 4. Controls and Procedures
 
 
PART II. OTHER INFORMATION
 
 
 
Item 1. Legal Proceedings
 
 
Item 1A. Risk Factors
 
 
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
 
 
Item 6. Exhibits
 
 
SIGNATURE


1

VECTOR GROUP LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in Thousands, Except Per Share Amounts)
Unaudited

 
March 31,
2019
 
December 31,
2018
ASSETS:
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
312,638

 
$
584,581

Investment securities at fair value
134,652

 
131,569

Accounts receivable - trade, net
36,440

 
34,246

Inventories
101,977

 
90,997

Restricted assets
5,412

 
4,477

Other current assets
36,242

 
26,351

Total current assets
627,361

 
872,221

Property, plant and equipment, net
85,641

 
86,736

Investments in real estate, net
26,777

 
26,220

Long-term investments (of which $54,202 and $54,628 were carried at fair value)
66,768

 
66,259

Investments in real estate ventures
138,393

 
141,105

Operating lease right of use assets
124,723

 

Restricted assets
6,316

 
6,306

Goodwill and other intangible assets, net
266,065

 
266,611

Prepaid pension costs
24,179

 
23,869

Other assets
62,933

 
60,177

Total assets
$
1,429,156

 
$
1,549,504

LIABILITIES AND STOCKHOLDERS' DEFICIENCY:
 
 
 
Current liabilities:
 
 
 
   Current portion of notes payable and long-term debt
$
41,080

 
$
256,134

   Current portion of fair value of derivatives embedded within convertible debt

 
6,635

 Current payments due under the Master Settlement Agreement
73,809

 
36,561

   Current portion of employee benefits
875

 
875

Income taxes payable, net
9,701

 
5,252

Litigation accruals
3,404

 
310

Current operating lease liability
20,414

 

Other current liabilities
153,334

 
179,153

Total current liabilities
302,617

 
484,920

Notes payable, long-term debt and other obligations, less current portion
1,387,945

 
1,386,697

Fair value of derivatives embedded within convertible debt
21,075

 
24,789

Non-current employee benefits
61,684

 
61,288

Deferred income taxes, net
39,823

 
37,411

Non-current operating lease liability
128,999

 

Payments due under the Master Settlement Agreement
16,383

 
16,383

Litigation accruals
19,027

 
21,794

Other liabilities
41,704

 
63,588

Total liabilities
2,019,257

 
2,096,870

Commitments and contingencies (Note 9)

 

Stockholders' deficiency:
 
 
 
Preferred stock, par value $1.00 per share, 10,000,000 shares authorized

 

Common stock, par value $0.10 per share, 250,000,000 shares authorized,140,899,065 and 140,914,642 shares issued and outstanding
14,090

 
14,092

Accumulated deficit
(580,581
)
 
(542,169
)
Accumulated other comprehensive loss
(24,098
)
 
(19,982
)
Total Vector Group Ltd. stockholders' deficiency
(590,589
)
 
(548,059
)
Non-controlling interest
488

 
693

Total stockholders' deficiency
(590,101
)
 
(547,366
)
Total liabilities and stockholders' deficiency
$
1,429,156

 
$
1,549,504


The accompanying notes are an integral part of the condensed consolidated financial statements.

2



VECTOR GROUP LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Dollars in Thousands, Except Per Share Amounts)
Unaudited

 
Three Months Ended
 
March 31,
 
2019
 
2018
Revenues:
 
 
 
   Tobacco*
$
256,756

 
$
267,116

   Real estate
164,168

 
161,850

       Total revenues
420,924

 
428,966

 
 
 
 
Expenses:
 
 
 
 Cost of sales:
 
 
 
   Tobacco*
177,303

 
184,962

   Real estate
108,717

 
109,313

       Total cost of sales
286,020

 
294,275

 
 
 
 
Operating, selling, administrative and general expenses
92,314

 
89,076

Litigation settlement and judgment income

 
(2,469
)
Operating income
42,590

 
48,084

 
 
 
 
Other income (expenses):
 
 
 
Interest expense
(37,520
)
 
(45,947
)
Change in fair value of derivatives embedded within convertible debt
10,349

 
10,567

Equity in losses from real estate ventures
(2,439
)
 
(6,560
)
Equity in earnings from investments
1,362

 
1,162

Net gains (losses) recognized on investment securities
4,773

 
(3,340
)
Other, net
2,667

 
1,646

Income before provision for income taxes
21,782

 
5,612

Income tax expense
6,749

 
1,948

 
 
 
 
Net income
15,033

 
3,664

 
 
 
 
Net (income) loss attributed to non-controlling interest
(80
)
 
3,547

 
 
 
 
Net income attributed to Vector Group Ltd.
$
14,953

 
$
7,211

 
 
 
 
Per basic common share:
 
 
 
 
 
 
 
Net income applicable to common shares attributed to Vector Group Ltd.
$
0.09

 
$
0.04

 
 
 
 
Per diluted common share:
 
 
 
 
 
 
 
Net income applicable to common shares attributed to Vector Group Ltd.
$
0.08

 
$
0.04

                                      

* Revenues and cost of sales include federal excise taxes of $104,633 and $112,801, respectively.


The accompanying notes are an integral part of the condensed consolidated financial statements.

3




VECTOR GROUP LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Dollars in Thousands)
Unaudited
 
Three Months Ended
 
March 31,
 
2019
 
2018
 
 
Net income
$
15,033

 
$
3,664

 
 
 
 
Net unrealized gains (losses) on investment securities available for sale:
 
 
 
Change in net unrealized gains (losses)
377

 
(692
)
Net unrealized (gains) losses reclassified into net income
(33
)
 
595

Net unrealized gains (losses) on investment securities available for sale
344

 
(97
)
 


 
 
Net change in pension-related amounts
 
 
 
Amortization of loss
457

 
442

Net change in pension-related amounts
457

 
442

 
 
 
 
Other comprehensive income
801

 
345

 
 
 
 
Income tax effect on:
 
 
 
Change in net unrealized gains (losses) on investment securities
(104
)
 
189

Net unrealized (gains) losses reclassified into net income on investment securities
9

 
(163
)
Pension-related amounts
(125
)
 
(121
)
Income tax provision on other comprehensive income
(220
)
 
(95
)
 
 
 
 
Other comprehensive income, net of tax
581

 
250

 
 
 
 
Comprehensive income
15,614

 
3,914

 
 
 
 
Comprehensive (income) loss attributed to non-controlling interest
(80
)
 
3,547

Comprehensive income attributed to Vector Group Ltd.
$
15,534

 
$
7,461


The accompanying notes are an integral part of the condensed consolidated financial statements.

4



VECTOR GROUP LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIENCY
(Dollars in Thousands, Except Share Amounts)
Unaudited

 
Vector Group Ltd. Stockholders' Deficiency
 
 
 
 
 
 
Additional Paid-In
 
 
 
Accumulated
Other Comprehensive
 
Non-controlling
 
 
 
Common Stock
 
 
Accumulated
 
 
 
 
 
Shares
 
Amount
 
Capital
 
Deficit
 
Loss
 
Interest
 
Total
Balance as of January 1, 2019
140,914,642

 
$
14,092

 
$

 
$
(542,169
)
 
$
(19,982
)
 
$
693

 
$
(547,366
)
Impact of adoption of new accounting standards

 

 

 
3,147

 
(4,697
)
 

 
(1,550
)
Net income

 

 

 
14,953

 

 
80

 
15,033

Total other comprehensive income

 

 

 

 
581

 

 
581

Distributions and dividends on common stock ($0.40 per share)

 

 
(2,264
)
 
(56,512
)
 

 

 
(58,776
)
Surrender of shares in connection with restricted stock vesting
(15,577
)
 
(2
)
 
(172
)
 

 

 

 
(174
)
Stock-based compensation

 

 
2,436

 

 

 

 
2,436

Distributions to non-controlling interest

 

 

 

 

 
(285
)
 
(285
)
Balance as of March 31, 2019
140,899,065

 
$
14,090

 
$

 
$
(580,581
)
 
$
(24,098
)
 
$
488

 
$
(590,101
)

 
Vector Group Ltd. Stockholders' Deficiency
 
 
 
 
 
 
Additional Paid-In
 
 
 
Accumulated
Other Comprehensive
 
Non-controlling
 
 
 
Common Stock
 
 
Accumulated
 
 
 
 
 
Shares
 
Amount
 
Capital
 
Deficit
 
Loss
 
Interest
 
Total
Balance as of January 1, 2018
134,365,424

 
$
13,437

 
$

 
$
(414,785
)
 
$
(12,571
)
 
$
82,159

 
$
(331,760
)
Impact of adoption of new accounting standards

 

 

 
1,094

 
(6,036
)
 
(7,915
)
 
(12,857
)
Net income

 

 

 
7,211

 

 
(3,547
)
 
3,664

Total other comprehensive income

 

 

 

 
250

 

 
250

Distributions and dividends on common stock ($0.38 per share)

 

 
(2,384
)
 
(53,516
)
 

 

 
(55,900
)
Effect of stock dividend*
6,718,271

 
672

 

 
(672
)
 

 

 

Stock-based compensation

 

 
2,384

 

 

 

 
2,384

Balance as of March 31, 2018
141,083,695

 
$
14,109

 
$

 
$
(460,668
)
 
$
(18,357
)
 
$
70,697

 
$
(394,219
)
                        
*    Represents the effect of the September 27, 2018 stock dividend on the first quarter 2018 common-stock activity.

The accompanying notes are an integral part of the condensed consolidated financial statements.

5



VECTOR GROUP LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in Thousands)
Unaudited

 
Three Months Ended
 
Three Months Ended
 
March 31,
2019
 
March 31,
2018
Net cash provided by operating activities
$
19,726

 
$
40,714

Cash flows from investing activities:
 
 
 
Sale of investment securities
7,759

 
2,357

Maturities of investment securities
11,308

 
8,112

Purchase of investment securities
(20,623
)
 
(4,364
)
Investments in real estate ventures
(871
)
 
(533
)
Distributions from investments in real estate ventures
1,134

 
219

Increase in cash surrender value of life insurance policies
(238
)
 
(36
)
Increase in restricted assets
(7
)
 
(4
)
Capital expenditures
(3,825
)
 
(3,987
)
Repayments of notes receivable

 
32

Purchase of subsidiaries
(668
)
 

Pay downs of investment securities
258

 
446

Investments in real estate, net
(641
)
 
(355
)
Net cash (used in) provided by investing activities
(6,414
)
 
1,887

Cash flows from financing activities:
 
 
 
Repayments of debt
(230,466
)
 
(490
)
Borrowings under revolver
94,400

 
55,170

Repayments on revolver
(87,420
)
 
(61,728
)
Dividends and distributions on common stock
(60,459
)
 
(57,187
)
Distributions to non-controlling interest
(285
)
 

Net cash used in financing activities
(284,230
)
 
(64,235
)
Net decrease in cash, cash equivalents and restricted cash
(270,918
)
 
(21,634
)
Cash, cash equivalents and restricted cash, beginning of period
591,729

 
310,937

Cash, cash equivalents and restricted cash, end of period
$
320,811

 
$
289,303


The accompanying notes are an integral part of the condensed consolidated financial statements.

6

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


1.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

(a)
Basis of Presentation:
The condensed consolidated financial statements of Vector Group Ltd. (the “Company” or “Vector”) include the accounts of Liggett Group LLC (“Liggett”), Vector Tobacco Inc. (“Vector Tobacco”), Liggett Vector Brands LLC (“Liggett Vector Brands”), New Valley LLC (“New Valley”) and other less significant subsidiaries. New Valley includes the accounts of Douglas Elliman Realty, LLC (“Douglas Elliman”) and other less significant subsidiaries. All significant intercompany balances and transactions have been eliminated.
Liggett and Vector Tobacco are engaged in the manufacture and sale of cigarettes in the United States. Liggett Vector Brands coordinates Liggett and Vector Tobacco’s sales and marketing efforts. Certain references to “Liggett” refer to the Company’s tobacco operations, including the business of Liggett and Vector Tobacco, unless otherwise specified. New Valley is engaged in the real estate business.
The unaudited, interim condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and, in management’s opinion, contain all adjustments, consisting only of normal recurring items, necessary for a fair statement of the results for the periods presented. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 filed with the Securities and Exchange Commission (“SEC”). The consolidated results of operations for interim periods should not be regarded as necessarily indicative of the results that may be expected for the entire year.
(b)
Distributions and Dividends on Common Stock:

The Company records distributions on its common stock as dividends in its condensed consolidated statement of stockholders’ deficiency to the extent of retained earnings. Any amounts exceeding retained earnings are recorded as a reduction to additional paid-in capital to the extent paid-in-capital is available and then to accumulated deficit. The Company’s stock dividends are recorded as stock splits and given retroactive effect to earnings per share for all periods presented.

(c)
Earnings Per Share (“EPS”):

Information concerning the Company’s common stock has been adjusted to give retroactive effect to the 5% stock dividend distributed to Company stockholders on September 27, 2018. All per share amounts and references to share amounts have been updated to reflect the retrospective effect of the stock dividend.

Net income for purposes of determining basic EPS was as follows:

 
Three Months Ended
 
March 31,
 
2019
 
2018
Net income attributed to Vector Group Ltd.
$
14,953

 
$
7,211

Income attributed to participating securities
(2,003
)
 
(1,772
)
Net income applicable to common shares attributed to Vector Group Ltd.
$
12,950

 
$
5,439




7

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


Net income for purposes of determining diluted EPS was as follows:

 
Three Months Ended
 
March 31,
 
2019
 
2018
Net income attributed to Vector Group Ltd.
$
14,953

 
$
7,211

Income attributable to 7.5% Variable Interest Senior Convertible Notes
(1,246
)
 

Income attributed to participating securities
(2,003
)
 
(1,772
)
Net income applicable to common shares attributed to Vector Group Ltd.
$
11,704

 
$
5,439



 
Basic and diluted EPS were calculated using the following common shares:

 
Three Months Ended
 
March 31,
 
2019
 
2018
Weighted-average shares for basic EPS
139,493,555

 
139,288,460

Plus incremental shares related to convertible debt
2,776,775

 

Plus incremental shares related to stock options and non-vested restricted stock
14,670

 
338,591

Weighted-average shares for diluted EPS
142,285,000

 
139,627,051



The following non-vested restricted stock and shares issuable upon the conversion of convertible debt were outstanding during the three months ended March 31, 2019 and 2018, but were not included in the computation of diluted EPS because the impact of the per share expense associated with the restricted stock were greater than the average market price of the common shares during the respective periods and the common shares issuable under the convertible debt were anti-dilutive to EPS.

 
Three Months Ended
 
March 31,
 
2019
 
2018
  Weighted-average shares of non-vested restricted stock
1,340,781

 

  Weighted-average expense per share
$
18.82

 
$

  Weighted-average number of shares issuable upon conversion of debt
10,901,963

 
28,819,626

  Weighted-average conversion price
$
21.28

 
$
16.96





8

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


(d)
Fair Value of Derivatives Embedded within Convertible Debt:

The Company has estimated the fair value of the embedded derivatives based principally on the results of a valuation model. A readily determinable fair value of the embedded derivatives is not available. The estimated fair value of the derivatives embedded within the convertible debt is based principally on the present value of future dividend payments expected to be received by the convertible debt holders over the term of the debt. The discount rate applied to the future cash flows is estimated based on a spread in the yield of the Company’s debt when compared to risk-free securities with the same duration. The valuation model assumes future dividend payments by the Company and utilizes interest rates and credit spreads for secured to unsecured debt, unsecured to subordinated debt and subordinated debt to preferred stock to determine the fair value of the derivatives embedded within the convertible debt. The valuation also considers other items, including current and future dividends and the volatility of Vector’s stock price. At March 31, 2019, the range of estimated fair values of the Company’s embedded derivatives was between $21,022 and $21,125. The Company recorded the fair value of its embedded derivatives at the approximate midpoint of the range at $21,075 as of March 31, 2019. At December 31, 2018, the range of estimated fair values of the Company’s embedded derivatives was between $31,371 and $31,519. The Company recorded the fair value of its embedded derivatives at the midpoint of the range at $31,424 as of December 31, 2018. The estimated fair value of the Company’s embedded derivatives could change significantly based on future market conditions. (See Note 8.)

(e)
Investments in Real Estate Ventures:
In accounting for its investments in real estate ventures, the Company identified its participation in Variable Interest Entities (“VIE”), which are defined as (a) entities in which the equity investment at risk is not sufficient to finance its activities without additional subordinated financial support; (b) as a group, the equity investors at risk lack (1) the power to direct the activities of a legal entity that most significantly impact the entity’s economic performance, (2) the obligation to absorb the expected losses of the entity, or (3) the right to receive the expected residual returns of the entity; or (c) as a group, the equity investors have voting rights that are not proportionate to their economic interests and the entity’s activities involve or are conducted on behalf of an investor with a disproportionately small voting interest.
The Company’s interest in VIEs is primarily in the form of equity ownership. The Company examines specific criteria and uses judgment when determining if the Company is the primary beneficiary of a VIE. Factors considered include risk and reward sharing, experience and financial condition of other partner(s), voting rights, involvement in day-to-day capital and operating decisions, representation on a VIE’s executive committee, existence of unilateral kick-out rights exclusive of protective rights or voting rights and level of economic disproportionality between the Company and its other partner(s).
Accounting guidance requires the consolidation of VIEs in which the Company is the primary beneficiary. The guidance requires consolidation of VIEs that an enterprise has a controlling financial interest. A controlling financial interest will have both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance and (b) the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE.
The Company’s maximum exposure to loss in its investments in unconsolidated VIEs is limited to its investment in the VIE, any unfunded capital commitments to the VIE, and, in some cases, guarantees in connection with debt on the specific project. The Company’s maximum exposure to loss in its investment in consolidated VIEs is limited to its investment, which is the carrying value of the investment net of the non-controlling interest. Creditors of the consolidated VIEs have no recourse to the general credit of the primary beneficiary.


9

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


(f)
Other, Net:

Other, net consisted of:
 
Three Months Ended
 
March 31,
 
2019
 
2018
Interest and dividend income
$
3,208

 
$
1,922

Net periodic benefit cost other than the service costs
(541
)
 
(253
)
Other expense

 
(23
)
Other, net
$
2,667

 
$
1,646



(g)
Other Current Liabilities:
Other current liabilities consisted of:
 
March 31, 2019
 
December 31, 2018
Accounts payable
$
11,704

 
$
13,144

Accrued promotional expenses
30,909

 
37,940

Accrued excise and payroll taxes payable, net
12,710

 
14,612

Accrued interest
27,571

 
38,673

Commissions payable
18,199

 
12,975

Accrued salary and benefits
13,352

 
30,228

Contract liabilities
7,824

 

Allowance for sales returns
7,318

 
6,935

Other current liabilities
23,747

 
24,646

Total other current liabilities
$
153,334

 
$
179,153



(h)
Goodwill and Other Intangible Assets, Net:
The components of “Goodwill and other intangible assets, net” were as follows:
 
March 31,
2019
 
December 31,
2018
Goodwill
$
78,008

 
$
77,568

 
 
 
 
Indefinite life intangibles:
 
 
 
Intangible asset associated with benefit under the MSA
107,511

 
107,511

Trademark - Douglas Elliman
80,000

 
80,000

 
 
 
 
Intangibles with a finite life, net
546

 
1,532

 
 
 
 
  Total goodwill and other intangible assets, net
$
266,065

 
$
266,611





10

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


(i)
Reconciliation of Cash, Cash Equivalents and Restricted Cash:

The components of “Cash, cash equivalents and restricted cash” in the Statement of Cash Flows were as follows:
 
March 31,
2019
 
December 31,
2018
Cash and cash equivalents
$
312,638

 
$
584,581

Restricted cash and cash equivalents included in current restricted assets
3,719

 
2,697

Restricted cash and cash equivalents included in non-current restricted assets
4,454

 
4,451

  Total cash, cash equivalents, and restricted cash shown in the statement of cash flows
$
320,811

 
$
591,729



Amounts included in current restricted assets and non-current restricted assets represent cash and cash equivalents required to be deposited into escrow for bonds required to appeal adverse product liability judgments, amounts required for letters of credit related to office leases, and certain deposit requirements for banking arrangements. The restrictions related to the appellate bonds will remain in place until the appeal process has been completed. The restrictions related to the letters of credit will remain in place for the duration of the respective lease. The restrictions related to the banking arrangements will remain in place for the duration of the arrangement.
 
(j)    New Accounting Pronouncements:

Accounting Standards Updates (“ASU”) adopted in 2019:
In July 2018, the FASB issued ASU No. 2018-09, Codification Improvements (“ASU 2018-09”). This standard does not prescribe any new accounting guidance, but instead makes minor improvements and clarifications of several different FASB Accounting Standards Codification areas based on comments and suggestions made by various stakeholders. Certain updates were applicable immediately while others were effective for the Company’s fiscal year beginning January 1, 2019. Adoption of this update did not have a material impact on the Company’s condensed consolidated financial statements.
In February 2018, the FASB issued ASU No. 2018-02, Income Statement – Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (“ASU 2018-02”), which allows for stranded tax effects in accumulated other comprehensive income resulting from the Tax Act to be reclassified to retained earnings. The Company adopted ASU 2018-02 effective January 1, 2019. The reclassification from the adoption of this standard resulted in a decrease of $4,697 to accumulated deficit and an increase of $4,697 to accumulated other comprehensive loss.
In February 2016, the FASB issued ASU 2016-02, Leases (“ASU 2016-02”), which provides guidance for accounting for leases. ASU 2016-02 requires lessees to classify leases as either finance or operating leases and to record a right-of-use asset and a lease liability for all leases with a term greater than 12 months regardless of the lease classification. The lease classification will determine whether the lease expense is recognized based on an effective interest rate method or on a straight-line basis over the term of the lease. Accounting for lessors remains largely unchanged from current U.S. GAAP. In July 2018, the FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases and ASU 2018-11 “Leases (Topic 842): Targeted Improvements” (ASU 2018-11). ASU 2018-10 clarifies certain areas within ASU 2016-02. Prior to ASU 2018-11, a modified retrospective transition was required for financing or operating leases existing at or entered into after the beginning of the earliest comparative period presented in the financial statements. ASU 2018-11 allows entities an additional transition method to the existing requirements whereby an entity could adopt the provisions of ASU 2016-02 by recognizing a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption without adjustment to the financial statements for periods prior to adoption. ASU 2018-11 also allows a practical expedient that permits lessors to not separate non-lease components from the associated lease component if certain conditions are present. In December 2018, the FASB also issued ASU 2018-20, Leases (Topic 842): Narrow-Scope Improvements for Lessors, which requires lessors to exclude lessor costs paid directly to a third party by lessees from lease revenues and expenses, provides an election for lessors to exclude sales taxes and other similar taxes collected from lessees from consideration in the contract, and clarifies lessors accounting for variable payments related to lease and nonlease components. ASU 2016-02, ASU 2018-10, ASU 2018-11 and ASU 2018-20 was effective for the Company’s fiscal year beginning January 1, 2019 and subsequent interim periods.

11

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


On January 1, 2019, the Company adopted ASU No. 2016-02- Leases (Topic 842) applying the modified retrospective method and the option presented under ASU 2018-11 to transition only active leases as of January 1, 2019 with a cumulative effect adjustment as of that date. See Note 3 - Leases, for additional accounting policy and transition disclosures.

ASUs to be adopted in future periods:
In October 2018, the FASB issued ASU No. 2018-17, Consolidation (Topic 810): Targeted Improvements to Related Party Guidance for Variable Interest Entities. The guidance requires indirect interests held through related parties under common control arrangements be considered on a proportional basis for determining whether fees paid to decision makers and service providers are variable interests. The guidance is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. The Company is currently evaluating the impact of the new guidance on our condensed consolidated financial statements.
In October 2018, the FASB issued ASU No. 2018-16, Inclusion of the Secured Overnight Financing Rate (“SOFR”) Overnight Index Swap (“OIS”) Rate as a Benchmark Interest Rate for Hedge Accounting Purposes (“ASU 2018-16”), which amends ASC 815, Derivatives and Hedging. This ASU adds the OIS rate based on SOFR to the list of permissible benchmark rates for hedge accounting purposes. The amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Adoption of ASU 2018-16 will be on a prospective basis for qualifying new or redesignated hedging relationships entered into on or after the date of adoption. The Company is currently assessing the impact the adoption of ASU 2018-16 will have on the Company’s condensed consolidated financial statements.
In August 2018, the FASB issued ASU 2018-15, Intangibles - Goodwill and Other Internal Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract. The amendments in this update align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. ASU 2018-15 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted. The Company is currently assessing the impact the adoption of ASU 2018-15 will have on the Company’s condensed consolidated financial statements.
In August 2018, the FASB issued ASU No. 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans (“ASU 2018-14”). ASU 2018-14 eliminates the requirement to disclose the amounts in accumulated other comprehensive income expected to be recognized as part of net periodic benefit cost over the next year. The ASU also removes the disclosure requirements for the effects of a one-percentage-point change on the assumed health care costs and the effect of this change in rates on service cost, interest cost and the benefit obligation for postretirement health care benefits. ASU 2018-14 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. Early adoption is permitted. The adoption of ASU 2018-14 will impact financial statement disclosure with no impact on operating results.
In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which is designed to improve the effectiveness of disclosures by removing, modifying and adding disclosures related to fair value measurements. The ASU eliminates disclosures such as the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy. The ASU also adds new disclosure requirements for Level 3 measurements. ASU No. 2018-13 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The adoption of ASU 2018-13 will impact financial statement disclosure with no impact on operating results.

2.
REVENUE RECOGNITION


Revenue Recognition Accounting Pronouncement Adoption

On January 1, 2018, the Company adopted Topic 606 applying the modified retrospective method. The following practical expedients and optional disclosure exemptions available under Topic 606 have been applied:
1.
The Company applied the optional exemption in paragraph 606-10-50-14 of Topic 606, and has not disclosed the amount of the transaction price allocated to the remaining performance obligations for the Real Estate property management business because the contracts to provide property management services are typically annual contracts.

12

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


2.
The Company applied the optional exemption in paragraph 606-10-50-14A of Topic 606, and has not disclosed the amount of the transaction price allocated to the remaining performance obligations for the Real Estate development marketing business because the transaction prices in these contracts are comprised entirely of variable consideration based on the ultimate selling price of each unit in the subject property.

Revenue Recognition Policies
Revenue is measured based on a consideration specified in a contract with a customer less any sales incentives. Revenue is recognized when (a) an enforceable contract with a customer exists, that has commercial substance, and collection of substantially all consideration for services is probable; and (b) the performance obligations to the customer are satisfied either over time or at a point in time.
Tobacco sales: Revenue from cigarette sales, which include federal excise taxes billed to customers, are recognized upon shipment of cigarettes when control has passed to the customer. Average collection terms for Tobacco sales range between three and twelve days from the time that the cigarettes are shipped to the customer. The Company records a liability for goods estimated to be returned in other current liabilities and the associated receivable for anticipated federal excise tax refunds in other current assets on the condensed consolidated balance sheet. The liability for returned goods is based principally on sales volumes and historical return rates. The estimated costs of sales incentives, including customer incentives and trade promotion activities, are based principally on historical experience and are accounted for as reductions in Tobacco revenue. Expected payments for sales incentives are included in other current liabilities on the Company’s condensed consolidated balance sheet. The Company accounts for shipping and handling costs as fulfillment costs as part of cost of sales.
Real estate sales: Real estate commissions and other payments earned by the Company’s real estate brokerage businesses are recognized as revenue when the real estate sale is completed or lease agreement is executed, which is the point in time that the performance obligation is satisfied. Any commission and other payments received in advance are deferred until the satisfaction of the performance obligation. Corresponding agent commission expenses, including any advance commission or other direct expense payments, are deferred and recognized as cost of sales concurrently with related revenues.
The Company’s Real Estate revenue contracts with customers do not have multiple material performance obligations to customers under Topic 606, except for contracts in the Company’s development marketing business. Contracts in the development marketing business provide the Company with the exclusive right to sell units in a subject property for a commission fee per unit sold calculated as a percentage of the sales price of each unit. Accordingly, a performance obligation exists for each unit in the development marketing property under contract, and a portion of the total contract transaction price is allocated to and recognized at the time each unit is sold.
The total contract transaction price is allocated to each unit in the subject property and recognized when the performance obligation, i.e. the sale of each unit, is satisfied. Accordingly, the transaction price allocated to the remaining performance obligations for the development marketing business represents variable consideration allocated entirely to wholly unsatisfied performance obligations.
Under development marketing service arrangements, dedicated staff are required for a subject property and these costs are typically reimbursed from the customer through advance payments that are recoupable from future commission earnings. Advance payments received and associated direct costs paid are deferred, allocated to each unit in the subject property, and recognized at the time of the completed sale of each unit.
Development marketing service arrangements also include direct fulfillment costs incurred in advance of the satisfaction of the performance obligation. The Company capitalizes costs incurred in fulfilling a contract with a customer if the fulfillment costs 1) relate directly to an existing contract or anticipated contract, 2) generate or enhance resources that will be used to satisfy performance obligations in the future, and 3) are expected to be recovered. These costs are amortized over the estimated customer relationship period which is the contract term. The Company uses an amortization method that is consistent with the pattern of transfer of goods or services to its customers by allocating these costs to each unit in the subject property and expensing these costs as each unit sold is closed over the contract.
Commission revenue is recognized at the time the performance obligation is met for commercial leasing contracts, which is when the lease agreement is executed, as there are no further performance obligations, including any amounts of future payments under extended payment terms.

13

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


Property management revenue arrangements consist of providing operational and administrative services to manage a subject property. Fees for these services are typically billed and collected monthly. Property management service fees are recognized as revenue over time using the output method as the performance obligations under the customer arrangement are satisfied each month.
Title insurance commission fee revenue is earned when the sale of the title insurance policy is completed, which corresponds to the point in time when the underlying real estate sale is completed, which is when the performance obligation is satisfied.

Disaggregation of Revenue
In the following table, revenue is disaggregated by major product line for the Tobacco segment:
 
 
Three Months Ended
 
 
March 31,
 
 
2019
 
2018
Tobacco Segment Revenues:
 
 
 
 
Core Discount Brands - PYRAMID, GRAND PRIX, LIGGETT SELECT, EVE and EAGLE 20’s
 
$
233,106

 
$
241,531

Other Brands
 
23,650

 
25,585

Total tobacco revenues
 
$
256,756

 
$
267,116


In the following table, revenue is disaggregated by major services line and primary geographical market for the Real Estate segment:

 
 
Three Months Ended March 31, 2019
 
 
New York City
 
Northeast
 
Southeast
 
West
 
Total
Real Estate Segment Revenues:
 
 
 
 
 
 
 
 
 
 
Commission brokerage income
 
$
65,679

 
$
31,111

 
$
22,971

 
$
18,529

 
$
138,290

Development marketing
 
11,386

 

 
2,630

 
7

 
14,023

Property management revenue
 
8,167

 
184

 

 

 
8,351

Title fees
 

 
1,233

 

 

 
1,233

Total Douglas Elliman Realty revenue
 
85,232

 
32,528

 
25,601

 
18,536

 
161,897

Other real estate revenues
 

 

 

 
2,271

 
2,271

  Total real estate revenues
 
$
85,232

 
$
32,528

 
$
25,601

 
$
20,807

 
$
164,168



14

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


 
 
Three Months Ended March 31, 2018
 
 
New York City
 
Northeast
 
Southeast
 
West
 
Total
Real Estate Segment Revenues:
 
 
 
 
 
 
 
 
 
 
Commission brokerage income
 
$
60,408

 
$
32,678

 
$
24,398

 
$
21,412

 
$
138,896

Development marketing
 
10,610

 
123

 
293

 
194

 
11,220

Property management revenue
 
8,138

 
200

 

 

 
8,338

Title fees
 

 
989

 

 

 
989

Total Douglas Elliman Realty revenue
 
79,156

 
33,990

 
24,691

 
21,606

 
159,443

Other real estate revenues
 

 

 

 
2,407

 
2,407

  Total real estate revenues
 
$
79,156

 
$
33,990

 
$
24,691

 
$
24,013

 
$
161,850



 
Contract Balances
The following table provides information about contracts assets and contract liabilities from development marketing and commercial leasing contracts with customers:

 
 
 
 
 
March 31, 2019
 
January 1, 2019
Receivables, which are included in accounts receivable - trade, net
$
3,175

 
$
2,050

Contract assets, net, which are included in other current assets
9,329

 
9,264

Payables, which are included in other current liabilities
1,921

 
1,082

Contract liabilities, which are included in other current liabilities
7,824

 
7,071

Contract assets, net, which are included in other assets
18,024

 
15,794

Contract liabilities, which are included in other liabilities
32,376

 
30,445



Receivables and payables relate to commission receivables and commissions payable from the Real Estate commercial leasing contracts for which the performance obligation has been satisfied, have extended payment terms and are expected to be received and paid in the next twelve months. Receivables decreased $1,125 for the three-month period ended March 31, 2019 primarily due to revenue accrued as performance obligations are satisfied of $1,551, offset by cash collections. Correspondingly, payables increased $839 primarily due to additional expense accruals as performance obligations are satisfied of $1,119, offset by cash payments.
Contract assets increased by $2,295 during the three months ended March 31, 2019 due to $3,794 of payments made for direct fulfillment costs incurred in advance of the satisfaction of the performance obligations for Real Estate development marketing contracts, offset by costs recognized for units closed during the quarter.
Contract liabilities relate to payments received in advance of the performance obligations being satisfied under the contract for the Real Estate development marketing and are recognized as revenue at the points in time when the Company performs under the contract. Performance obligations related to the Real Estate development marketing contracts are considered satisfied when each unit is closed. Development marketing projects tend to span 4 to 6 years from the time the Company enters into the contract with the developer to the time that all of the sales of the units in a subject property are closed. The timing for sales closings are dependent upon several external factors outside the Company’s control, including but not limited to, economic factors, seller and buyer actions, construction timing and other real estate market factors. Accordingly, all contract liabilities and contract costs associated with development marketing are considered long-term until closing dates for unit sales are scheduled. As of March 31, 2019, the Company estimates approximately $7,824 of contract liabilities will be recognized as revenue within the next twelve months.
Contract liabilities increased by $2,684 during the three months ended March 31, 2019 due to $5,219 of advance payments received from customer prior to the satisfaction of performance obligations for Real Estate development marketing contracts,

15

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


offset by revenue recognized for units sold during the quarter. The Company recognized revenue of $1,514 and $951 for the three months ended March 31, 2019 and 2018, respectively, that were included in the contract liabilities balances at January 1, 2019 and January 1, 2018, respectively.
Topic 606 requires an entity to disclose the revenue recognized in the reporting period from performance obligations satisfied (or partially satisfied) in previous periods (for example, due to changes in transaction price). There was no revenue recognized relating to performance obligations satisfied or partially satisfied in prior periods for the three months ended March 31, 2019 and 2018, respectively.

3.
LEASES

Leasing Accounting Pronouncement Adoption

On January 1, 2019, the Company adopted ASU No. 2016-02- Leases (Topic 842) applying the modified retrospective method and the option presented under ASU 2018-11 to transition only active leases as of January 1, 2019 with a cumulative effect adjustment as of that date. All comparative periods prior to January 1, 2019 retain the financial reporting and disclosure requirements of ASC 840. The Company elected the package of practical expedients permitted under the transition guidance within the new standard. The package of three expedients includes: 1) the ability to carry forward the historical lease classification, 2) the elimination of the requirement to reassess whether existing or expired agreements contain leases, and 3) the elimination of the requirement to reassess initial direct costs. The Company also elected the practical expedient related to short-term leases without purchase options reasonably certain to exercise, allowing it to exclude leases with terms of less than twelve (12) months from capitalization for all asset classes. The Company did not elect the hindsight practical expedient when determining the lease terms. The adoption of the new standard resulted in the recording of right-of-use (“ROU”) assets and lease liabilities of $128,890 and $153,676, respectively, as of January 1, 2019. The difference between the ROU assets and lease liabilities reflects the reclassification of historical deferred rent balances of approximately $22,881, and tenant improvement receivable of $355 as adjustments to the ROU asset balances, and an adjustment that increased accumulated deficit by $1,550 to recognize the impairment in ROU assets for asset groups previously identified as being impaired. The standard did not materially impact the Company’s consolidated net earnings and had no impact on cash flows. The new standard had no material impact on liquidity and had no impact on the Company’s debt-covenant compliance under its current debt agreements.

Leasing Policies
The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease ROU assets and lease liabilities on the Company’s balance sheets. Finance leases are included in investments in real estate, net, property, plant and equipment and current and long-term portions of notes payable and long-term debt on the Company’s balance sheets.
ROU assets represent the Company’s right to use an underlying asset for the duration of the lease term. Lease liabilities represent the Company’s obligation to make lease payments as determined by the lease agreement. Lease liabilities are recorded at commencement for the net present value of future lease payments over the lease term. The discount rate used is generally the Company’s estimated incremental borrowing rate unless the lessor’s implicit rate is readily determinable. Discount rates are calculated periodically to estimate the rate the Company would pay to borrow the funds necessary to obtain an asset of similar value, over a similar term, with a similar security. ROU assets are recorded and recognized at commencement for the lease liability amount, initial direct costs incurred and is reduced for lease incentives received. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Operating lease expense is recognized on a straight-line basis over the lease term. Finance lease cost is recognized on a straight line basis over the shorter of the useful life of the asset and the lease term.
The Company has lease agreements with lease and non-lease components; the Company has elected the accounting policy to combine lease and non-lease components for all underlying asset classes.

16

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


Leases
The Company has operating and finance leases for corporate and sales offices, and certain vehicles and equipment. The leases have remaining lease terms of one year to 15 years, some of which include options to extend for up to 5 years, and some of which include options to terminate the leases within one year. However, the Company in general is not reasonably certain to exercise options to renew or terminate, and therefore renewal and termination options are not considered in the lease term or the ROU asset and lease liability balances. The Company’s lease population includes purchase options on equipment leases that are included in the lease payments when reasonably certain to be exercised. The Company’s lease population does not include any residual value guarantees. The Company’s lease population does not contain any material restrictive covenants.
The Company has leases with variable payments, most commonly in the form of Common Area Maintenance (“CAM”) and tax charges which are based on actual costs incurred. These variable payments were excluded from the ROU asset and lease liability balances since they are not fixed or in-substance fixed payments. Variable payments are expensed as incurred.
The components of lease expense were as follows:

 
Three Months Ended
 
March 31,
 
2019
Operating lease cost
$
8,875

Short-term lease cost
234

Variable lease cost
792

 
 
Finance lease cost:
 
Amortization of right-of-use assets
56

Interest on lease liabilities
3

Total lease cost
$
9,960


Supplemental cash flow information related to leases was as follows:
 
Three Months Ended
 
March 31,
 
2019
Cash paid for amounts included in measurement of lease liabilities:
 
Operating cash flows from operating leases
$
9,001

Operating cash flows from finance leases
3

Financing cash flows from finance leases
54

 
 
Right-of-use assets obtained in exchange for lease obligations:
 
Operating leases
356

Finance leases






17

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


Supplemental balance sheet information related to leases was as follows:
 
March 31,
 
 
2019
 
Operating leases:
 
 
Operating lease right-of-use assets
$
124,723

 
 
 
 
Current operating lease liability
$
20,414

 
Non-current operating lease liability
128,999

 
Total operating lease liabilities
$
149,413

 
 
 
 
Finance leases:
 
 
Investments in real estate, net
$
178

(1) 
 
 
 
Property, plant and equipment, at cost
$
183

 
Accumulated amortization
(149
)
 
Property and equipment, net
$
34

 
 
 
 
Current portion of notes payable and long-term debt
$
181

 
Notes payable, long-term debt and other obligations, less current portion
27

 
Total finance lease liabilities
$
208

 
 
 
 
Weighted average remaining lease term:
 
 
Operating leases
8.51

 
Finance leases
1.10

 
 
 
 
Weighted average discount rate:
 
 
Operating leases
11.21
%
 
Finance leases
4.97
%
 
(1)  
Included in Investments in real estate, net on the condensed consolidated balance sheet are financing lease equipment, at cost of $729 and accumulated amortization of $551 as of March 31, 2019.


18

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


As of March 31, 2019, maturities of lease liabilities were as follows:
 
Operating Leases
 
Finance
 Leases
Year Ending December 31:
 

 
 

Remainder of 2019
$
27,019

 
$
158

2020
30,852

 
54

2021
28,260

 
1

2022
25,390

 

2023
23,753

 

2024
18,674

 
 
Thereafter
85,807

 

Total lease payments
239,755

 
213

 Less imputed interest
(90,342
)
 
(5
)
Total
$
149,413

 
$
208



Under ASC 840, Leases, future minimum lease payments under noncancelable operating leases as of December 31, 2018 were as follows:

 
Lease
Commitments
 
Sublease
Rentals
 
Net
Year Ending December 31:
 

 
 

 
 

2019
$
35,973

 
$
69

 
$
35,904

2020
29,917

 

 
29,917

2021
27,592

 

 
27,592

2022
25,185

 

 
25,185

2023
23,589

 

 
23,589

Thereafter
104,126

 

 
104,126

Total
$
246,382

 
$
69

 
$
246,313


The Company has one lease for office space wherein the lessor is an affiliate of a significant shareholder of the Company. This lease represents $1,521 of the ROU asset balances and $1,577 of lease liability balances as of March 31, 2019. The rent expense for this lease was approximated $115 for the three months ended March 31, 2019.
As of March 31, 2019, the Company had an additional operating lease for office space, that has not yet commenced, of $657 in undiscounted lease payments. The operating lease will commence in the second quarter of 2019 with lease terms of 10 years.


19

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


4.
INVENTORIES

Inventories consisted of:
 
March 31,
2019
 
December 31,
2018
Leaf tobacco
$
50,266

 
$
42,917

Other raw materials
3,119

 
3,750

Work-in-process
2,266

 
1,931

Finished goods
67,864

 
63,937

Inventories at current cost
123,515

 
112,535

LIFO adjustments
(21,538
)
 
(21,538
)
 
$
101,977

 
$
90,997



All of the Company’s inventories at March 31, 2019 and December 31, 2018 are reported under the LIFO method. The $21,538 LIFO adjustment as of March 31, 2019 decreases the current cost of inventories by $14,932 for Leaf tobacco, $219 for Other raw materials, $25 for Work-in-process and $6,362 for Finished goods. The $21,538 LIFO adjustment as of December 31, 2018 decreased the current cost of inventories by $14,932 for Leaf tobacco, $219 for Other raw materials, $25 for Work-in-process and $6,362 for Finished goods.

Liggett enters into purchase commitments with third-party providers for leaf tobacco. The future quantities of leaf tobacco and prices are established at the date of the commitments. At March 31, 2019, Liggett had tobacco purchase commitments of approximately $3,858. Liggett has a single source supply agreement for reduced ignition propensity cigarette paper through 2019.

Each period, the Company capitalizes in inventory the portion of its MSA liability that relates to cigarettes shipped to public warehouses but not sold. The amount of capitalized MSA cost in “Finished goods” inventory was $16,892 and $16,001 at March 31, 2019 and December 31, 2018, respectively. Federal excise tax in inventory was $26,555 and $26,419 at March 31, 2019 and December 31, 2018, respectively.


5.
INVESTMENT SECURITIES AT FAIR VALUE

Investment securities at fair value consisted of the following:
 
March 31, 2019
 
December 31, 2018
Debt securities available for sale
$
88,605

 
$
84,367

Equity securities at fair value
46,047

 
47,202

Total investment securities at fair value
$
134,652

 
$
131,569



Net gains (losses) recognized on investment securities were as follows:
 
Three Months Ended
 
March 31,
 
2019
 
2018
Net gains (losses) recognized on equity securities
$
4,740

 
$
(2,745
)
Net gains (losses) recognized on debt securities available for sale
36

 
(9
)
Impairments on debt securities available for sale
(3
)
 
(586
)
Net gains (losses) recognized on investment securities
$
4,773

 
$
(3,340
)


20

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


 
Sales of investment securities totaled $7,759 and $2,357 and proceeds from early redemptions by issuers totaled $11,566 and $8,558 for the three months ended March 31, 2019 and 2018, respectively, mainly from the sales and redemptions of Corporate securities and U.S. Government securities.
    
(a) Debt Securities Available for Sale
The components of debt securities available for sale at March 31, 2019 were as follows:

 
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Fair
Value
Marketable debt securities
$
88,093

 
$
512

 
$

 
$
88,605

Total debt securities available for sale
$
88,093

 
$
512

 
$

 
$
88,605




The table below summarizes the maturity dates of debt securities available for sale at March 31, 2019.

Investment Type:
Fair Value
 
Under 1 Year
 
1 Year up to 5 Years
 
More than 5 Years
U.S. Government securities
$
24,275

 
$
12,662

 
$
11,613

 
$

Corporate securities
43,110

 
10,694

 
32,416

 

U.S. mortgage-backed securities
4,132

 
489

 
3,643

 

Commercial mortgage-backed securities
397

 
33

 
364

 

Commercial paper
13,180

 
13,180

 

 

Index-linked U.S. bonds
2,354

 
2,354

 

 

Foreign fixed-income securities
1,157

 
652

 
505

 

Total debt securities available for sale by maturity dates
$
88,605

 
$
40,064

 
$
48,541

 
$



The components of debt securities available for sale at December 31, 2018 were as follows:

 
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Fair
Value
Marketable debt securities
$
84,199

 
$
168

 
$

 
$
84,367

Total debt securities available for sale
$
84,199

 
$
168

 
$

 
$
84,367



There were no available-for-sale debt securities with continuous unrealized losses for less than 12 months and 12 months or greater at March 31, 2019 and December 31, 2018, respectively.


21

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


Gross realized gains and losses on debt securities available for sale were as follows:

 
Three Months Ended
 
March 31,
 
2019
 
2018
Gross realized gains on sales
$
38

 
$

Gross realized losses on sales
(2
)
 
(9
)
Net gains (losses) recognized on debt securities available for sale
$
36

 
$
(9
)
 
 
 
 
Gross realized losses on other-than-temporary impairments
$
(3
)
 
$
(586
)
 

 



Although management generally does not have the intent to sell any specific securities at the end of the period, in the ordinary course of managing the Company’s investment securities portfolio, management may sell securities prior to their maturities for a variety of reasons, including diversification, credit quality, yield and liquidity requirements.

(b) Equity Securities at Fair Value
Equity securities at fair value consisted of the following:
 
March 31, 2019
 
December 31, 2018
Marketable equity securities
$
24,387

 
$
26,010

Mutual funds invested in fixed income securities
21,660

 
21,192

Total equity securities at fair value
$
46,047

 
$
47,202


The following is a summary of unrealized and realized net gains and losses recognized in net income on equity securities at fair value during the three months ended March 31, 2019 and 2018, respectively:

 
Three Months Ended
 
March 31,
 
2019
 
2018
Net gains (losses) recognized on equity securities (1)
$
4,740

 
$
(2,745
)
Less: Net gains recognized on equity securities sold (2)
132

 
130

Net unrealized gains (losses) recognized on equity securities still held at the reporting date
$
4,608

 
$
(2,875
)
 
 
 
 
(1) 
Includes $3,559 and $1,731 of net gains recognized on equity securities at fair value that qualify for the net asset value (“NAV”) practical expedient during the three months ended March 31, 2019 and 2018, respectively. These equity securities are included in the “Long-term investments” line item on the condensed consolidated balance sheet and are further discussed in Note 6.
(2) 
Includes $434 of gains recognized on sales of equity securities at fair value that qualify for the NAV practical expedient during the three months ended March 31, 2019. These equity securities are included in the “Long-term investments” line item on the condensed consolidated balance sheet and are further discussed in Note 6.

The Company’s marketable equity securities and mutual funds invested in fixed-income securities are classified as Level 1 under the fair value hierarchy disclosed in Note 12. Their fair values are based on quoted prices for identical assets in active markets or inputs that are based upon quoted prices for similar instruments in active markets.
    


22

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited



(c) Equity Securities Without Readily Determinable Fair Values That Do Not Qualify for the NAV Practical Expedient

Equity securities without readily determinable fair values that do not qualify for the NAV practical expedient consisted of an investment in the common stock of a reinsurance company at March 31, 2019 and December 31, 2018, respectively. The total carrying value of this investment was $5,000 and was included in “Other assets” on the condensed consolidated balance sheet at March 31, 2019 and December 31, 2018, respectively. No impairment or other adjustments related to observable price changes in orderly transactions for identical or similar investments were identified for the three months ended March 31, 2019 and 2018, respectively.

6.
LONG-TERM INVESTMENTS

Long-term investments consisted of the following:
 
March 31, 2019
 
December 31, 2018
Equity securities at fair value that qualify for the NAV practical expedient
$
54,202

 
$
54,628

Equity-method investments
12,566

 
11,631

 
$
66,768

 
$
66,259



(a) Equity Securities at Fair Value That Qualify for the NAV Practical Expedient

The estimated fair value of the Company’s equity securities at fair value that qualify for the NAV practical expedient was provided by the partnerships based on the indicated market values of the underlying assets or investment portfolio. The investments in these investment partnerships are illiquid and the ultimate realization of these investments is subject to the performance of the underlying partnership and its management by the general partners. In accordance with Subtopic 820-10, these investments are not classified under the fair value hierarchy disclosed in Note 12 because they are investments measured at fair value using the NAV practical expedient.
The Company redeemed 25% of one of its investments that qualify for the NAV practical expedient during March 2019. The Company recorded $3,984 of in-transit redemptions from the proceeds at March 31, 2019.

(b) Equity-Method Investments:

Equity-method investments consisted of the following:
 
March 31,
2019
 
December 31, 2018
Indian Creek Investors LP (“Indian Creek”)
$
1,353

 
$
1,167

Boyar Value Fund (“Boyar”)
9,041

 
8,384

Ladenburg Thalmann Financial Services Inc. (“LTS”)
2,172

 
2,080

Castle Brands, Inc. (“Castle”)

 

 
$
12,566

 
$
11,631




At March 31, 2019, the Company’s ownership percentages in Indian Creek, Boyar, LTS and Castle were 12.58%, 34.38%, 10.20% and 7.64%, respectively. The Company accounted for its Indian Creek and Boyar interests as equity-method investments because the Company’s ownership percentage meets the threshold for equity-method accounting. The Company accounted for its LTS and Castle interests as equity-method investments because the Company has the ability to exercise significant influence over their operating and financial policies.

23

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


The fair value of the investment in Boyar, based on the quoted market price as of March 31, 2019, was $9,041, equal to its carrying value. At March 31, 2019, the aggregate fair values of the LTS and Castle investments, based on the quoted market price, were $42,991 and $9,027, respectively.
The Company received cash distributions of $427 and $414 from the Company’s equity-method investments for the three months ended March 31, 2019 and 2018, respectively. The Company recognized equity in earnings from equity-method investments of $1,362 and $1,162 for the three months ended March 31, 2019 and 2018, respectively. The Company has suspended its recognition of equity in losses from Castle to the extent such losses exceed its basis.
If it is determined that an other-than-temporary decline in fair value exists in equity-method investments, the Company records an impairment charge with respect to such investment in its condensed consolidated statements of operations. The Company will continue to perform additional assessments to determine the impact, if any, on the Company’s condensed consolidated financial statements. Thus, future impairment charges may occur.
The equity-method investments are carried on the condensed consolidated balance sheet at cost under the equity method of accounting. The fair values disclosed above for Boyar, LTS and Castle would be classified as Level 1 under the fair value hierarchy disclosed in Note 12 if such assets were recorded on the condensed consolidated balance sheet at fair value. The fair values are based on quoted prices for identical assets in active markets or inputs that are based upon quoted prices for similar instruments in active markets.
The estimated fair value of the Company’s investment in Indian Creek represents the NAV per share and was provided by the partnership based on the indicated market value of the underlying assets or investment portfolio. The investment is illiquid and its ultimate realization is subject to the performance of the underlying partnership and its management by the general partners. In accordance with Subtopic 820-10, this investment would not be classified under the fair value hierarchy disclosed in Note 12 if the asset was recorded on the condensed consolidated balance sheet at fair value because it is measured at fair value using the NAV practical expedient.

7.
NEW VALLEY LLC

Investments in real estate ventures:

New Valley holds equity investments in various real estate projects domestically and internationally. The majority of New Valley’s investment in real estate ventures were located in the New York City Standard Metropolitan Statistical Area (“SMSA”). New Valley aggregates the disclosure of its investments in real estate ventures by property type and operating characteristics.

The components of “Investments in real estate ventures” were as follows:
 
Range of Ownership (1)
 
March 31, 2019
 
December 31, 2018
Condominium and Mixed Use Development:
 
 
 
 
 
            New York City SMSA
3.1% - 49.5%
 
$
63,570

 
$
65,007

            All other U.S. areas
15.0% - 48.5%
 
31,858

 
31,392

 
 
 
95,428

 
96,399

Hotels:
 
 
 
 
 
            New York City SMSA
5.2% - 18.4%
 
14,462

 
15,782

            International
49.0%
 
1,848

 
2,334

 
 
 
16,310

 
18,116

Commercial:
 
 
 
 
 
            New York City SMSA
49.0%
 
1,739

 
1,867

            All other U.S. areas
1.6%
 
7,345

 
7,053

 
 
 
9,084

 
8,920

 
 
 
 
 
 
Other:
15.0% - 50.0%
 
17,571

 
17,670

Investments in real estate ventures
 
 
$
138,393

 
$
141,105


24

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


______________________
(1) The Range of Ownership reflects New Valley’s estimated current ownership percentage. New Valley’s actual ownership percentage as well as the percentage of earnings and cash distributions may ultimately differ as a result of a number of factors including potential dilution, financing or admission of additional partners.

Contributions:

The components of New Valley’s contributions to its investments in real estate ventures were as follows:
 
Three Months Ended March 31,
 
2019
 
2018
Condominium and Mixed Use Development:
 
 
 
            New York City SMSA
$
500

 
$
533

 
500

 
533

Hotels:
 
 
 
            New York City SMSA
172

 

 
172

 

 
 
 
 
Other:
199

 

Total contributions
$
871

 
$
533



New Valley contributed its proportionate share of additional capital along with contributions by the other investment partners during the three months ended March 31, 2019 and March 31, 2018. New Valley’s direct investment percentage for these ventures did not significantly change. 

Distributions:

The components of distributions received by New Valley from its investments in real estate ventures were as follows:
 
Three Months Ended March 31,
 
2019
 
2018
Condominium and Mixed Use Development:
 
 
 
            New York City SMSA
$
571

 
$
2,868

 
571

 
2,868

Apartment Buildings:
 
 
 
            All other U.S. areas

 
201

 

 
201

Hotels:
 
 
 
            New York City SMSA
784

 

 
784

 

Commercial:
 
 
 
            New York City SMSA
6

 

            All other U.S. areas
58

 
215

 
64

 
215

 
 
 
 
Other
1,098

 
18

Total distributions
$
2,517

 
$
3,302



Of the distributions received by New Valley from its investment in real estate ventures, $1,383 and $3,083 were from distributions of earnings for the three months ended March 31, 2019 and March 31, 2018, respectively, and $1,134 and $219 were a return of capital for the three months ended March 31, 2019 and March 31, 2018, respectively. Distributions from earnings are

25

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


included in cash from operations in the Condensed Consolidating Statements of Cash Flows, while distributions that are returns of capital are included in cash flows from investing activities in the Condensed Consolidating Statements of Cash Flows.

Equity in Earnings (Losses) from Real Estate Ventures:

New Valley recognized equity in earnings (losses) from real estate ventures as follows:
 
Three Months Ended March 31,
 
2019
 
2018
Condominium and Mixed Use Development:
 
 
 
            New York City SMSA
$
(2,106
)
 
$
(3,462
)
            All other U.S. areas
(108
)
 
(505
)
 
(2,214
)
 
(3,967
)
Apartment Buildings:
 
 
 
            All other U.S. areas

 
(1,580
)
 

 
(1,580
)
Hotels:
 
 
 
            New York City SMSA
(708
)
 
(814
)
            International
(486
)
 
(425
)
 
(1,194
)
 
(1,239
)
Commercial:
 
 
 
            New York City SMSA
(121
)
 
(267
)
            All other U.S. areas
292

 
230

 
171

 
(37
)
 
 
 
 
Other:
798

 
263

Equity in losses from real estate ventures
$
(2,439
)
 
$
(6,560
)


As part of the Company’s ongoing assessment of the carrying values of its investments in real estate ventures, the Company determined that the fair value of a New York City SMSA Condominium and Mixed Use Development venture was less than its carrying value as of March 31, 2018. The Company determined that the impairment was other than temporary. The Company recorded an impairment charge as a component of equity in losses from real estate ventures of $7,474 of which $6,354 was attributed to the Company for the three months ended March 31, 2018.
Investment in Real Estate Ventures Entered into during 2019:

In February 2019, New Valley invested $500 for an approximate 37% interest in 352 6th, LLC. The joint venture plans to develop a condominium complex. The venture is a variable interest entity; however, New Valley is not the primary beneficiary. New Valley accounts for this investment under the equity method of accounting. New Valley's maximum exposure to loss as a result of its investment in 352 6th, LLC was $506 at March 31, 2019.
VIE Consideration:

The Company has determined that New Valley is the primary beneficiary of two real estate ventures because it controls the activities that most significantly impact economic performance of each of the two real estate ventures. Consequently, New Valley consolidates these variable interest entities (“VIEs”).

The carrying amount of the consolidated assets of the VIEs was $976 and $1,387 as of March 31, 2019 and December 31, 2018, respectively. Those assets are owned by the VIEs, not the Company. Neither of the two consolidated VIEs had recourse liabilities as of March 31, 2019 and December 31, 2018. A VIE’s assets can only be used to settle obligations of that VIE. The VIEs are not guarantors of the Company’s senior notes and other debts payable.


26

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


For the remaining investments in real estate ventures, New Valley determined that the entities were variable interest entities but New Valley was not the primary beneficiary. Therefore, New Valley’s investment in such real estate ventures has been accounted for under the equity method of accounting.

Maximum Exposure to Loss:

New Valley’s maximum exposure to loss from its investments in real estate ventures consisted of the net carrying value of the venture adjusted for any future capital commitments and/or guarantee arrangements. The maximum exposure to loss was as follows:
 
March 31, 2019
Condominium and Mixed Use Development:
 
            New York City SMSA
$
68,492

            All other U.S. areas
44,358

 
112,850

Hotels:
 
            New York City SMSA
14,462

            International
1,848

 
16,310

Commercial:
 
            New York City SMSA
1,739

            All other U.S. areas
7,345

 
9,084

 
 
Other:
32,350

Total maximum exposure to loss
$
170,594



New Valley capitalized $1,315 of interest costs into the carrying value of its ventures whose projects were currently under development for the three months ended March 31, 2019. New Valley capitalized $2,209 of interest costs into the carrying value of its venture whose projects were currently under development for the three months ended March 31, 2018.

Douglas Elliman has been engaged by the developers as the sole broker or the co-broker for several of the real estate ventures that New Valley owns an interest. Douglas Elliman earned gross commissions of approximately $3,118 and $3,759 from these projects for the three months ended March 31, 2019 and March 31, 2018, respectively.

Combined Financial Statements for Unconsolidated Subsidiaries:
The following summarized financial data for certain unconsolidated subsidiaries that meet certain thresholds pursuant to SEC Regulation S-X Rule 210.10-01(b) includes information for the 215 Chrystie Street investment. New Valley has elected a one-month lag reporting period for the investment.

Hotels:
 
Three Months Ended March 31,
 
2019
 
2018
Income Statement
 
 
 
Revenue
$
13,421

 
$
82,947

Cost of sales

 
53,851

Other expenses
19,395

 
20,692

(Loss) income from continuing operations
$
(5,974
)
 
$
8,404




27

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


Investments in Real Estate, net:

The components of “Investments in real estate, net” were as follows:
 
March 31,
2019
 
December 31,
2018
Escena, net
$
10,086

 
$
10,170

Sagaponack
16,691

 
16,050

            Investments in real estate, net
$
26,777

 
$
26,220



Escena.  The assets of “Escena, net” were as follows:
 
March 31,
2019
 
December 31,
2018
Land and land improvements
$
8,910

 
$
8,910

Building and building improvements
1,900

 
1,900

Other
2,197

 
2,162

 
13,007

 
12,972

Less accumulated depreciation
(2,921
)
 
(2,802
)
 
$
10,086

 
$
10,170



New Valley recorded operating income of $686 and $800 for the three months ended March 31, 2019 and 2018, respectively, from Escena.

Investment in Sagaponack. In April 2015, New Valley invested $12,502 in a residential real estate project located in Sagaponack, NY. The project is wholly owned and the balances of the project are included in the condensed consolidated financial statements of the Company. As of March 31, 2019, the assets of Sagaponack consisted of land and land improvements of $16,691.


28

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


8.
NOTES PAYABLE, LONG-TERM DEBT AND OTHER OBLIGATIONS

Notes payable, long-term debt and other obligations consisted of:

 
March 31,
2019
 
December 31,
2018
Vector:
 
 
 
6.125% Senior Secured Notes due 2025
$
850,000

 
$
850,000

10.5% Senior Notes due 2026
325,000

 
325,000

7.5% Variable Interest Senior Convertible Notes due 2019, net of unamortized discount of $0 and $3,359*

 
226,641

5.5% Variable Interest Senior Convertible Debentures due 2020, net of unamortized discount of $24,300 and $29,465*
207,700

 
202,535

Liggett:
 
 
 
Revolving credit facility
35,435

 
28,381

Term loan under credit facility
2,335

 
2,409

Equipment loans
667

 
1,039

Other
30,346

 
30,440

Notes payable, long-term debt and other obligations
1,451,483

 
1,666,445

Less:
 
 
 
Debt issuance costs
(22,458
)
 
(23,614
)
Total notes payable, long-term debt and other obligations
1,429,025

 
1,642,831

Less:
 
 
 
Current maturities
(41,080
)
 
(256,134
)
Amount due after one year
$
1,387,945

 
$
1,386,697

______________________
* The fair value of the derivatives embedded within the 7.5% Variable Interest Senior Convertible Notes ($0 at March 31, 2019 and $6,635 at December 31, 2018, respectively) and the 5.5% Variable Interest Senior Convertible Debentures ($21,075 at March 31, 2019 and $24,789 at December 31, 2018, respectively), is separately classified as a derivative liability in the condensed consolidated balance sheets.

6.125% Senior Secured Notes due 2025 — Vector:
As of March 31, 2019, the Company was in compliance with all debt covenants related to its 6.125% Senior Secured Notes due 2025.
10.5% Senior Notes due 2026 — Vector:
On November 2, 2018, the Company completed the sale of $325,000 of its 10.5% Senior Notes due 2026 (“10.5% Senior Notes”) in a private offering that is exempt from registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), to qualified institutional buyers in accordance with Rule 144A of the Securities Act. There are no registration rights associated with the notes, and the Company does not intend to offer notes registered under the Securities Act in exchange for the 10.5% Senior Notes or file a registration statement with respect to the 10.5% Senior Notes. The aggregate net proceeds from the sale of the 10.5% Senior Notes were approximately $315,000 after deducting underwriting discounts, commissions, fees and offering expenses.
The Company will pay cash interest at a rate of 10.5% per year, payable semi-annually on May 1 and November 1 of each year, beginning on May 1, 2019. Interest will accrue from November 2, 2018. The 10.5% Senior Notes mature on November 1, 2026. Interest on overdue principal and interest, if any, will accrue at a rate that is 1% higher than the then applicable interest rate on the 10.5% Senior Notes. The Company will make each interest payment to the holders of record on the immediately preceding April 15 and October 15. The Company may redeem some or all of the 10.5% Senior Notes at any time prior to November 1, 2021 at a make-whole redemption price. On or after November 1, 2021, the Company may redeem some or all of the 10.5% Senior Notes at redemption prices set forth in the indenture, plus accrued and unpaid interest, if any, to the redemption date. In addition, any time prior to November 1, 2021, the Company may redeem up to 40% of the aggregate outstanding amount of the 10.5% Senior Notes with the net proceeds of certain equity offerings at 110.5% of the aggregate principal amount of the 10.5% Senior

29

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


Notes, plus accrued and unpaid interest, if any, to the redemption date, if at least 60% of the aggregate principal amount of the 10.5% Senior Notes originally issued remains outstanding after such redemption, and the redemption occurs within 90 of the closing of such equity offering. In the event of a change of control, as defined in the indenture, each holder of the 10.5% Senior Notes will have the right to require the Company to make an offer to repurchase some or all of its 10.5% Senior Notes at a repurchase price equal to 101% of the aggregate principal amount of the 10.5% Senior Notes plus accrued and unpaid interest to the date of purchase. If the Company sells certain assets and does not apply the proceeds as required pursuant to the indenture, it must offer to repurchase the 10.5% Senior Notes at the prices listed in the indenture.
The 10.5% Senior Notes are guaranteed subject to certain customary automatic release provisions on a joint and several basis by all of the wholly owned domestic subsidiaries of the Company that are engaged in the conduct of the Company’s cigarette businesses, and by DER Holdings LLC, through which the Company indirectly owns a 100.00% interest in Douglas Elliman. The 10.5% Senior Notes are the Company’s general senior unsecured obligations, and are pari passu in right of payment with all of the Company’s existing and future senior indebtedness and senior in right of payment to all of our future subordinated indebtedness. The 10.5% Senior Notes are effectively subordinated in right of payment to all of our existing and future indebtedness that is secured by assets of the Company or assets of the Guarantors, to the extent of the value of the assets securing such indebtedness. The 10.5% Senior Notes are structurally subordinated to all of the liabilities and preferred stock of any of our subsidiaries that do not guarantee the notes. Each guarantee of the 10.5% Senior Notes are the general obligation of the Guarantor and are pari passu in right of payment with all other senior indebtedness of such Guarantor, including the indebtedness of Liggett Group and Maple under their Credit Agreement with Wells Fargo. Each guarantee of the 10.5% Senior Notes are senior in right of payment to all future subordinated indebtedness of the Guarantor, if any.
The indenture contains covenants that limit the Company and each Guarantor’s ability to, among other things: (i) incur additional indebtedness; (ii) pay dividends or make other distributions, including dividends, repurchases or redemptions of its equity interests; (iii) prepay, redeem or repurchase its subordinated indebtedness; (iv) make investments; (v) sell assets; (vi) incur certain liens; (vii) enter into agreements restricting its subsidiaries’ ability to pay dividends; (viii) enter into transactions with affiliates; and (ix) consolidate, merge or sell all or substantially all of its assets. These covenants are subject to a number of important exceptions and qualifications, as described in the indenture.
As of March 31, 2019, the Company was in compliance with all debt covenants related to its 10.5% Senior Notes due 2026.
7.5% Variable Interest Senior Convertible Notes due 2019 — Vector:
In January 2019, the Company paid $230,000 of principal and $8,102 of accrued interest as full payment of its 7.5% Convertible Notes that matured on January 15, 2019.
Revolving Credit Facility and Term Loan Under Credit Facility — Liggett:
As of March 31, 2019, a total of $37,770 was outstanding under the revolving and term loan portions of the credit facility. The total outstanding balance under the revolving and term loan portions of the credit facility was classified as current debt as of March 31, 2019. Availability, as determined under the facility, was approximately $20,500 based on eligible collateral at March 31, 2019. As of March 31, 2019, the Company’s applicable subsidiaries were in compliance with all debt covenants under this revolving and term loan facility.
Non-Cash Interest Expense — Vector:
 
Three Months Ended
 
March 31,
 
2019
 
2018
Amortization of debt discount, net
$
8,528

 
$
18,193

Amortization of debt issuance costs
1,185

 
2,681


$
9,713

 
$
20,874




30

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited



Fair Value of Notes Payable and Long-Term Debt:

 
March 31, 2019
 
December 31, 2018
 
Carrying
 
Fair
 
Carrying
 
Fair
 
Value
 
Value
 
Value
 
Value
Senior Notes
$
1,175,000

 
$
1,060,943

 
$
1,175,000

 
$
1,034,500

Variable Interest Senior Convertible Debt
207,700

 
235,190

 
429,176

 
468,704

Liggett and other
68,783

 
68,773

 
62,269

 
62,255

Notes payable and long-term debt
$
1,451,483

(1)
$
1,364,906

 
$
1,666,445

(1)
$
1,565,459


______________________
(1) The carrying value does not include the carrying value of the embedded derivative. See Note 12.

Notes payable and long-term debt are carried on the condensed consolidated balance sheet at amortized cost. The fair value determinations disclosed above are classified as Level 2 under the fair value hierarchy disclosed in Note 12 if such liabilities were recorded on the condensed consolidated balance sheet at fair value. The estimated fair value of the Company’s notes payable and long-term debt has been determined by the Company using available market information and appropriate valuation methodologies including the evaluation of the Company’s credit risk as described in the Company’s Form 10-K. The Company used a derived price based upon quoted market prices and trade activity as of March 31, 2019 to determine the fair value of its publicly-traded notes and debentures. The carrying value of the revolving credit facility and term loan is equal to the fair value. The fair value of the equipment loans and other obligations was determined by calculating the present value of the required future cash flows. However, considerable judgment is required to develop the estimates of fair value and, accordingly, the estimate presented herein is not necessarily indicative of the amount that could be realized in a current market exchange.


9.
CONTINGENCIES

Tobacco-Related Litigation:
Overview. Since 1954, Liggett and other United States cigarette manufacturers have been named as defendants in numerous direct, third-party and purported class actions predicated on the theory that cigarette manufacturers should be liable for damages alleged to have been caused by cigarette smoking or by exposure to secondary smoke from cigarettes. The cases have generally fallen into the following categories: (i) smoking and health cases alleging personal injury brought on behalf of individual plaintiffs (“Individual Actions”); (ii) lawsuits by individuals requesting the benefit of the Engle ruling (“Engle progeny cases”); (iii) smoking and health cases primarily alleging personal injury or seeking court-supervised programs for ongoing medical monitoring, as well as cases alleging that use of the terms “lights” and/or “ultra lights” constitutes a deceptive and unfair trade practice, common law fraud or violation of federal law, purporting to be brought on behalf of a class of individual plaintiffs (“Class Actions”); and (iv) health care cost recovery actions brought by various foreign and domestic governmental plaintiffs and non-governmental plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and/or disgorgement of profits (“Health Care Cost Recovery Actions”). The future financial impact of the risks and expenses of litigation are not quantifiable. For the three months ended March 31, 2019 and 2018, Liggett incurred tobacco product liability legal expenses and costs totaling $1,463 and $1,508, respectively. The tobacco product liability legal expenses and costs are included in the operating, selling, administrative and general expenses and litigation settlement and judgment expense line items in the Condensed Consolidated Statements of Operations. Legal defense costs are expensed as incurred.
Litigation is subject to uncertainty and it is possible that there could be adverse developments in pending cases. With the commencement of new cases, the defense costs and the risks relating to the unpredictability of litigation increase. Management reviews on a quarterly basis with counsel all pending litigation and evaluates the probability of a loss being incurred and whether an estimate can be made of the possible loss or range of loss that could result from an unfavorable outcome. An unfavorable outcome or settlement of pending tobacco-related litigation could encourage the commencement of additional litigation. Damages awarded in tobacco-related litigation can be significant.

31

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


Bonds. Although Liggett has been able to obtain required bonds or relief from bonding requirements in order to prevent plaintiffs from seeking to collect judgments while adverse verdicts are on appeal, there remains a risk that such relief may not be obtainable in all cases. This risk has been reduced given that a majority of states now limit the dollar amount of bonds or require no bond at all. As of March 31, 2019, to obtain a stay of the judgment pending the appeal of the Santoro case, Liggett had secured $535 in bonds.
In June 2009, Florida amended its existing bond cap statute by adding a $200,000 bond cap that applies to all Engle progeny cases in the aggregate and establishes individual bond caps for individual Engle progeny cases in amounts that vary depending on the number of judgments in effect at a given time. The maximum amount of any such bond for an appeal in the Florida state courts will be no greater than $5,000. In several cases, plaintiffs challenged the constitutionality of the bond cap statute, but to date the courts have upheld the constitutionality of the statute. It is possible that the Company’s consolidated financial position, results of operations, and cash flows could be materially adversely affected by an unfavorable outcome of such challenges.
Accounting Policy. The Company and its subsidiaries record provisions in their consolidated financial statements for pending litigation when they determine that an unfavorable outcome is probable and the amount of loss can be reasonably estimated. At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, except as discussed in this Note 9: (i) management has concluded that it is not probable that a loss has been incurred in any of the pending tobacco-related cases; or (ii) management is unable to reasonably estimate the possible loss or range of loss that could result from an unfavorable outcome of any of the pending tobacco-related cases and, therefore, management has not provided any amounts in the consolidated financial statements for unfavorable outcomes, if any.
Although Liggett has generally been successful in managing the litigation filed against it, litigation is subject to uncertainty and significant challenges remain, including with respect to the remaining Engle progeny cases. There can be no assurances that Liggett’s past litigation experience will be representative of future results. Judgments have been entered against Liggett in the past, in Individual Actions and Engle progeny cases, and several of those judgments were affirmed on appeal and satisfied by Liggett. It is possible that the consolidated financial position, results of operations and cash flows of the Company could be materially adversely affected by an unfavorable outcome or settlement of any of the remaining smoking-related litigation. Liggett believes, and has been so advised by counsel, that it has valid defenses to the litigation pending against it, as well as valid bases for appeal of adverse verdicts. All such cases are and will continue to be vigorously defended. Liggett has entered into settlement discussions in individual cases or groups of cases where Liggett has determined it was in its best interest to do so, and it may continue to do so in the future. As cases proceed through the appellate process, the Company will consider accruals on a case-by-case basis if an unfavorable outcome becomes probable and the amount can be reasonably estimated.
Individual Actions
As of March 31, 2019, there were 33 Individual Actions pending against Liggett, where one or more individual plaintiffs allege injury resulting from cigarette smoking, addiction to cigarette smoking or exposure to secondary smoke and seek compensatory and, in some cases, punitive damages. These cases do not include the remaining Engle progeny cases or the individual cases pending in West Virginia state court as part of a consolidated action. The following table lists the number of Individual Actions by state:
State
 
Number
of Cases
Florida
 
22
Illinois
 
4
New York
 
2
Louisiana
 
2
West Virginia
 
2
Ohio
 
1

The plaintiffs’ allegations of liability in cases in which individuals seek recovery for injuries allegedly caused by cigarette smoking are based on various theories of recovery, including negligence, gross negligence, breach of special duty, strict liability, fraud, concealment, misrepresentation, design defect, failure to warn, breach of express and implied warranties, conspiracy, aiding and abetting, concert of action, unjust enrichment, common law public nuisance, property damage, invasion of privacy, mental anguish, emotional distress, disability, shock, indemnity, violations of deceptive trade practice laws, the federal Racketeer Influenced and Corrupt Organizations Act (“RICO”), state RICO statutes and antitrust statutes. In many of these cases, in addition

32

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


to compensatory damages, plaintiffs also seek other forms of relief including treble/multiple damages, medical monitoring, disgorgement of profits and punitive damages. Although alleged damages often are not determinable from a complaint, and the law governing the pleading and calculation of damages varies from state to state and jurisdiction to jurisdiction, compensatory and punitive damages have been specifically pleaded in a number of cases, sometimes in amounts ranging into the hundreds of millions and even billions of dollars.
Defenses raised in Individual Actions include lack of proximate cause, assumption of the risk, comparative fault and/or contributory negligence, lack of design defect, statute of limitations, equitable defenses such as “unclean hands” and lack of benefit, failure to state a claim and federal preemption.
Engle Progeny Cases
In May 1994, the Engle case was filed as a class action against Liggett and others in Miami-Dade County, Florida. The class consisted of all Florida residents who, by November 21, 1996, “have suffered, presently suffer or have died from diseases and medical conditions caused by their addiction to cigarette smoking.” A trial was held and the jury returned a verdict adverse to the defendants (approximately $145,000,000 in punitive damages, including $790,000 against Liggett). Following an appeal to the Third District Court of Appeal, the Florida Supreme Court in July 2006 decertified the class on a prospective basis and affirmed the appellate court’s reversal of the punitive damages award. Former class members had until January 2008 to file individual lawsuits. As a result, Liggett and the Company, and other cigarette manufacturers, were sued in thousands of Engle progeny cases in both federal and state courts in Florida. Although the Company was not named as a defendant in the Engle case, it was named as a defendant in substantially all of the Engle progeny cases where Liggett was named as a defendant.
Cautionary Statement About Engle Progeny Cases. Since 2009, judgments have been entered against Liggett and other cigarette manufacturers in Engle progeny cases. A number of the judgments have been affirmed on appeal and satisfied by the defendants. Many have been overturned on appeal. As of March 31, 2019, 25 Engle progeny cases where Liggett was a defendant at trial resulted in verdicts.
There have been 16 verdicts returned in favor of the plaintiffs and nine in favor of Liggett. In five of the cases, punitive damages were awarded against Liggett. In certain cases, the judgments were entered jointly and severally with other defendants and Liggett may face the risk that one or more co-defendants decline or otherwise fail to participate in the bonding required for an appeal or to pay their proportionate or jury-allocated share of a judgment. As a result, under certain circumstances, Liggett may have to pay more than its proportionate share of any bonding or judgment related amounts. Except as discussed in this Note 9, management is unable to estimate the possible loss or range of loss from the remaining Engle progeny cases as there are currently multiple defendants in each case and, in most cases, discovery has not occurred or is limited. As a result, the Company lacks information about whether plaintiffs are in fact Engle class members, the relevant smoking history, the nature of the alleged injury and the availability of various defenses, among other things. Further, plaintiffs typically do not specify the amount of their demand for damages. As cases proceed through the appellate process, the Company will consider accruals on a case-by-case basis if an unfavorable outcome becomes probable and the amount can be reasonably estimated.
Engle Progeny Settlements.
In October 2013, the Company and Liggett entered into a settlement with approximately 4,900 Engle progeny plaintiffs and their counsel. Pursuant to the terms of the settlement, Liggett agreed to pay a total of approximately $110,000, with $61,600 paid in an initial lump sum and the balance of $48,000 to be paid in installments over 14 years starting in February 2015. In exchange, the claims of these plaintiffs were dismissed with prejudice against the Company and Liggett. The Company’s future payments will be approximately $3,400 per annum through 2028, with a cost of living increase beginning in 2021.
In December 2016, the Company and Liggett entered into an agreement with 124 Engle progeny plaintiffs and their counsel. Pursuant to the terms of this settlement, Liggett agreed to pay $17,650, $14,000 of which was paid in December 2016 with the balance paid in December 2017. As a result of this settlement, the Company recorded a charge of $17,650 in the fourth quarter of 2016.
In June 2017, Liggett entered into an agreement to settle nine cases (eight Engle progeny cases and one Individual Action) for $1,400 and in September 2017 Liggett entered into an agreement to settle 20 Engle progeny cases for $4,100. As of March 31, 2019, Liggett (and in certain cases the Company) had, on an individual basis, settled an additional 185 Engle progeny cases for approximately $7,600 in the aggregate.
Notwithstanding the comprehensive nature of the Engle Progeny Settlements, approximately 70 plaintiffs’ claims remain pending in state court. Therefore, the Company and Liggett may still be subject to periodic adverse judgments which could have a material adverse effect on the Company’s consolidated financial position, results of operations and cash flows.

33

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited



Judgments Paid in Engle Progeny Cases.
As of March 31, 2019, Liggett had paid in the aggregate $39,773, including interest and attorneys’ fees, to satisfy the judgments in the following Engle progeny cases: Lukacs, Campbell, Douglas, Clay, Tullo, Ward, Rizzuto, Lambert and Buchanan. An adverse verdict against Liggett for $160 in Santoro is currently on appeal.
Maryland Cases
Liggett was a defendant in 16 multi-defendant personal injury cases in Maryland alleging claims arising from asbestos and tobacco exposure (“synergy cases”). In July 2016, the Court of Appeals (Maryland’s highest court) ruled that joinder of tobacco and asbestos cases may be possible in certain circumstances, but plaintiffs must demonstrate at the trial court level how such cases may be joined while providing appropriate safeguards to prevent embarrassment, delay, expense or prejudice to defendants and “the extent to which, if at all, the special procedures applicable to asbestos cases should extend to tobacco companies.” The Court of Appeals remanded these issues to be determined at the trial court level. In June 2017, the trial court issued an order dismissing all synergy cases against the tobacco defendants, including Liggett, without prejudice. Plaintiffs may seek appellate review or file new cases against the tobacco companies.
Liggett Only Cases  
There is currently one case pending where Liggett is the sole defendant: Cowart, a Florida Individual Action where there has been no recent activity. It is possible that cases where Liggett is the only defendant could increase as a result of the remaining Engle progeny cases and newly filed Individual Cases.
Class Actions
As of March 31, 2019, three actions were pending for which either a class had been certified or plaintiffs were seeking class certification where Liggett is a named defendant. Other cigarette manufacturers are also named in these actions.
Plaintiffs’ allegations of liability in class action cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, nuisance, breach of express and implied warranties, breach of special duty, conspiracy, concert of action, violation of deceptive trade practice laws and consumer protection statutes and claims under the federal and state anti-racketeering statutes. Plaintiffs in the class actions seek various forms of relief, including compensatory and punitive damages, treble/multiple damages and other statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and equitable relief.
Defenses raised in these cases include, among others, lack of proximate cause, individual issues predominate, assumption of the risk, comparative fault and/or contributory negligence, statute of limitations and federal preemption.
In November 1997, in Young v. American Tobacco Co., a purported personal injury class action was commenced on behalf of plaintiff and all similarly situated residents in Louisiana who, though not themselves cigarette smokers, allege they were exposed to secondhand smoke from cigarettes that were manufactured by the defendants, including Liggett, and suffered injury as a result of that exposure. The plaintiffs seek to recover an unspecified amount of compensatory and punitive damages. No class certification hearing has been held. The stay order entered on March 16, 2016 stays the case pending completion of the smoking cessation program ordered by the court in Scott v. The American Tobacco Co.
In February 1998, in Parsons v. AC & S Inc., a purported class action was commenced on behalf of all West Virginia residents who allegedly have claims arising from their exposure to cigarette smoke and asbestos fibers. The operative complaint seeks to recover unspecified compensatory and punitive damages on behalf of the putative class. The case is stayed as a result of the December 2000 bankruptcy of three of the defendants.
Although not technically a class action, in In Re: Tobacco Litigation (Personal Injury Cases), a West Virginia state court consolidated approximately 750 individual smoker actions that were pending prior to 2001 for trial of certain “common” issues. Liggett was severed from trial of the consolidated action. In May 2013, the jury rejected all but one of the plaintiffs’ claims against the non-Liggett defendants, finding in favor of plaintiffs on the claim that ventilated filter cigarettes between 1964 and July 1, 1969 should have included instructions on how to use them. The court entered judgment in October 2013, dismissing all claims against the non-Liggett defendants except the ventilated filter claim on behalf of 30 plaintiffs. Subsequently, these claims were settled by the non-Liggett defendants.
In May 2016, the trial court ruled that the case could proceed against Liggett, notwithstanding the outcome of the first phase of the trial against the non-Liggett defendants. In December 2017, the court ordered plaintiffs’ counsel to confirm all

34

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


remaining plaintiffs with claims against Liggett. The court further agreed that it would entertain a renewed motion by Liggett regarding the impact of the final judgment in favor of co-defendants on the claims against Liggett and whether those claims are barred by the doctrine of collateral estoppel. In 2017 Liggett moved to dismiss a number of plaintiffs’ claims on various grounds.  The court granted the motions as to approximately 25 plaintiffs and reserved ruling as to other claims until additional discovery is provided by plaintiffs.  The Phase I Common Issues trial is set starting August 12, 2019. It is currently estimated that Liggett could be a defendant in approximately 55 individual cases.
Health Care Cost Recovery Actions
As of March 31, 2019, one Health Care Cost Recovery Action was pending against Liggett, Crow Creek Sioux Tribe v. American Tobacco Company, a South Dakota case filed in 1997, where the plaintiff seeks to recover damages from Liggett and other cigarette manufacturers based on various theories of recovery as a result of alleged sales of tobacco products to minors. The case is dormant.
The claims asserted in health care cost recovery actions vary, but can include the equitable claim of indemnity, common law claims of negligence, strict liability, breach of express and implied warranty, breach of special duty, fraud, negligent misrepresentation, conspiracy, public nuisance, claims under state and federal statutes governing consumer fraud, antitrust, deceptive trade practices and false advertising, and claims under RICO. Although no specific damage amounts are typically pleaded, it is possible that requested damages might be in the billions of dollars. In these cases, plaintiffs typically assert equitable claims that the tobacco industry was “unjustly enriched” by their payment of health care costs allegedly attributable to smoking and seek reimbursement of those costs. Relief sought by some, but not all, plaintiffs include punitive damages, multiple damages and other statutory damages and penalties, injunctions prohibiting alleged marketing and sales to minors, disclosure of research, disgorgement of profits, funding of anti-smoking programs, additional disclosure of nicotine yields, and payment of attorney and expert witness fees.
Department of Justice Lawsuit
In September 1999, the United States government commenced litigation against Liggett and other cigarette manufacturers in the United States District Court for the District of Columbia. The action sought to recover, among other things, an unspecified amount of health care costs paid and to be paid by the federal government for smoking-related illnesses allegedly caused by the fraudulent and tortious conduct of defendants. In August 2006, the trial court entered a Final Judgment against each of the cigarette manufacturing defendants, except Liggett. The judgment was affirmed on appeal. As a result, the cigarette manufacturing defendants, other than Liggett, are now subject to the trial court’s Final Judgment which ordered, among other things, the issuance of “corrective statements” in various media regarding the adverse health effects of smoking, the addictiveness of smoking and nicotine, the lack of any significant health benefit from smoking “low tar” or “lights” cigarettes, defendants’ manipulation of cigarette design to ensure optimum nicotine delivery and the adverse health effects of exposure to environmental tobacco smoke.
Upcoming Trials
As of March 31, 2019, there were three Individual Actions and two Engle Progeny cases scheduled for trial through March 31, 2020, where Liggett (and/or the Company) is a named defendant. Trial dates are subject to change and additional cases could be set for trial during this time.
MSA and Other State Settlement Agreements
In March 1996, March 1997 and March 1998, Liggett entered into settlements of smoking-related litigation with 45 states and territories. The settlements released Liggett from all smoking-related claims made by those states and territories, including claims for health care cost reimbursement and claims concerning sales of cigarettes to minors.
In November 1998, Philip Morris, R.J. Reynolds and two other companies (the “Original Participating Manufacturers” or “OPMs”) and Liggett and Vector Tobacco (together with any other tobacco product manufacturer that becomes a signatory, the “Subsequent Participating Manufacturers” or “SPMs”) (the OPMs and SPMs are hereinafter referred to jointly as “PMs”) entered into the Master Settlement Agreement (the “MSA”) with 46 states, the District of Columbia, Puerto Rico, Guam, the United States Virgin Islands, American Samoa and the Northern Mariana Islands (collectively, the “Settling States”) to settle the asserted and unasserted health care cost recovery and certain other claims of the Settling States. The MSA received final judicial approval in each Settling State.

35

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


As a result of the MSA, the Settling States released Liggett and Vector Tobacco from:
all claims of the Settling States and their respective political subdivisions and other recipients of state health care funds, relating to: (i) past conduct arising out of the use, sale, distribution, manufacture, development, advertising and marketing of tobacco products; (ii) the health effects of, the exposure to, or research, statements or warnings about, tobacco products; and
all monetary claims of the Settling States and their respective subdivisions and other recipients of state health care funds relating to future conduct arising out of the use of, or exposure to, tobacco products that have been manufactured in the ordinary course of business.
The MSA restricts tobacco product advertising and marketing within the Settling States and otherwise restricts the activities of PMs. Among other things, the MSA prohibits the targeting of youth in the advertising, promotion or marketing of tobacco products; bans the use of cartoon characters in all tobacco advertising and promotion; limits each PM to one tobacco brand name sponsorship during any 12-month period; bans all outdoor advertising, with certain limited exceptions; prohibits payments for tobacco product placement in various media; bans gift offers based on the purchase of tobacco products without sufficient proof that the intended recipient is an adult; prohibits PMs from licensing third parties to advertise tobacco brand names in any manner prohibited under the MSA; and prohibits PMs from using as a tobacco product brand name any nationally recognized non-tobacco brand or trade name or the names of sports teams, entertainment groups or individual celebrities.
The MSA also requires PMs to affirm corporate principles to comply with the MSA and to reduce underage use of tobacco products and imposes restrictions on lobbying activities conducted on behalf of PMs. In addition, the MSA provides for the appointment of an independent auditor to calculate and determine the amounts of payments owed pursuant to the MSA.
Under the payment provisions of the MSA, PMs are required to make annual payments of $9,000,000 (subject to applicable adjustments, offsets and reductions including a “Non-Participating Manufacturers Adjustment” or “NPM Adjustment”). These annual payments are allocated based on unit volume of domestic cigarette shipments. The payment obligations under the MSA are the several, and not joint, obligation of each PM and are not the responsibility of any parent or affiliate of a PM.
Liggett has no payment obligations under the MSA except to the extent its market share exceeds a market share exemption of approximately 1.65% of total cigarettes sold in the United States. Vector Tobacco has no payment obligations under the MSA except to the extent its market share exceeds a market share exemption of approximately 0.28% of total cigarettes sold in the United States. Liggett and Vector Tobacco’s domestic shipments accounted for 4.0% of the total cigarettes sold in the United States in 2018. If Liggett’s or Vector Tobacco’s market share exceeds their respective market share exemption in a given year, then on April 15 of the following year, Liggett and/or Vector Tobacco, as the case may be, must pay on each excess unit an amount equal (on a per-unit basis) to that due from the OPMs for that year. On December 28, 2018, Liggett and Vector Tobacco pre-paid $132,500 of their approximate $166,000 2018 MSA obligation, the balance of which was paid in April 2019, subject to applicable disputes or adjustments.
Certain MSA Disputes
NPM Adjustment.  Liggett and Vector Tobacco contend that they are entitled to an NPM Adjustment for each year from 2003 - 2018. The NPM Adjustment is a potential adjustment to annual MSA payments, available when PMs suffer a market share loss to NPMs for a particular year and an economic consulting firm selected pursuant to the MSA determines (or the parties agree) that the MSA was a “significant factor contributing to” that loss. A Settling State that has “diligently enforced” its qualifying escrow statute in the year in question may be able to avoid its allocable share of the NPM Adjustment. For 2003 - 2018, Liggett and Vector Tobacco, as applicable, disputed that they owed the Settling States the NPM Adjustments as calculated by the independent auditor. As permitted by the MSA, Liggett and Vector Tobacco either paid subject to dispute, withheld payment, or paid into a disputed payment account, the amounts associated with these NPM Adjustments.
In June 2010, after the PMs prevailed in 48 of 49 motions to compel arbitration, the parties commenced the arbitration for the 2003 NPM Adjustment. That arbitration concluded in September 2013. It was followed by various challenges filed in state courts by states that did not prevail in the arbitration. Those challenges resulted in reductions, but not elimination of, the amounts awarded. The arbitration for the 2004 NPM Adjustment started in 2016, and hearings in that arbitration are underway. A separate proceeding in state court is underway for one state that appealed an order compelling arbitration (New Mexico).
The PMs have now settled most of the disputed NPM Adjustment years with 37 states representing approximately 75% of the MSA share. In January 2019, Montana sent a demand letter to the PMs seeking the return of amounts withheld or paid into the disputed payments escrow account (plus interest) for the NPM Adjustment years 2005 - 2016. Any amounts purportedly due

36

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


from Liggett to Montana are immaterial. The 2004 arbitration and separate court proceedings continue for states with which the PMs have not settled.
As a result of the settlements and arbitration award described above, Liggett and Vector Tobacco reduced cost of sales in the aggregate by $32,840 for years 2013 - 2018. Liggett and Vector Tobacco may be entitled to further adjustments. As of March 31, 2019, Liggett and Vector Tobacco had accrued approximately $13,400 related to the disputed amounts withheld from the non-settling states for 2004 - 2010, which may be subject to payment, with interest, if Liggett and Vector Tobacco lose the disputes for those years. As of March 31, 2019, there remains approximately $27,300 in the disputed payments account relating to Liggett and Vector Tobacco’s 2011 - 2017 NPM Adjustment disputes with the non-settling states.
Other State Settlements.  The MSA replaced Liggett’s prior settlements with all states and territories except for Florida, Mississippi, Texas and Minnesota. Each of these four states, prior to the effective date of the MSA, negotiated and executed settlement agreements with each of the other major tobacco companies, separate from those settlements reached previously with Liggett. Except as described below, Liggett’s agreements with these states remain in full force and effect. These states’ settlement agreements with Liggett contained most favored nation provisions which could reduce Liggett’s payment obligations based on subsequent settlements or resolutions by those states with certain other tobacco companies. Beginning in 1999, Liggett determined that, based on settlements or resolutions with United States Tobacco Company, Liggett’s payment obligations to those four states were eliminated. With respect to all non-economic obligations under the previous settlements, Liggett believes it is entitled to the most favorable provisions as between the MSA and each state’s respective settlement with the other major tobacco companies. Therefore, Liggett’s non-economic obligations to all states and territories are now defined by the MSA.
In 2003, as a result of a dispute with Minnesota regarding its settlement agreement, Liggett agreed to pay $100 a year in any year cigarettes manufactured by Liggett are sold in that state. Further, the Attorneys General for Florida, Mississippi and Texas advised Liggett that they believed Liggett had failed to make payments under the respective settlement agreements with those states. In 2010, Liggett settled with Florida and agreed to pay $1,200 and to make further annual payments of $250 for a period of 21 years, starting in March 2011, with the payments from year 12 forward being subject to an inflation adjustment.
In January 2016, the Attorney General for Mississippi filed a motion in Chancery Court in Jackson County, Mississippi to enforce the March 1996 settlement agreement alleging that Liggett owes Mississippi at least $27,000 in damages (including interest), and $20,000 in punitive damages and attorneys’ fees. In April 2017, the Chancery Court ruled that the settlement agreement should be enforced and referred the matter to a Special Master for further proceedings to determine the amount of damages, if any, to be awarded. In May 2017, Liggett filed a Petition for Interlocutory Appeal to the Mississippi Supreme Court, which was denied. Liggett filed a demand for arbitration regarding two specific issues and moved in Chancery Court to compel arbitration and stay the proceedings pending before the Special Master.  In June 2018, the Chancery Court granted Liggett’s motion to compel arbitration and stayed the proceedings before the Special Master pending completion of the arbitration. On March 21, 2019, the arbitration panel issued its decision on the two specific issues before it: (i) the panel ruled in favor of Liggett, finding that the $294,000 of proceeds from Eve Holdings’ 1999 brand sale should not be included in Liggett’s pre-tax income, which would reduce the amount of compensatory damages, if any, that would be due to Mississippi; and (ii) ruled in favor of Mississippi on the remaining issue, finding that compensatory damages to Mississippi, if any, would be based on 0.5% of Liggett’s annual pre-tax income for the term of the settlement agreement.  The matter will now proceed to the next phase of the proceeding before the designated Special Master to address damages, if any.  Liggett continues to believe that the April 2017 Chancery Court order is in error because the most favored nations provision in the settlement agreement eliminated all of Liggett’s payment obligations to Mississippi, and Liggett intends to appeal that order, as may be necessary, after the Special Master phase of the case concludes.
Liggett may be required to make additional payments to Mississippi and Texas which could have a material adverse effect on the Company’s consolidated financial position, results of operations and cash flows.
Cautionary Statement  
Management is not able to reasonably predict the outcome of the litigation pending or threatened against Liggett or the Company. Litigation is subject to many uncertainties. Liggett has been found liable in multiple Engle progeny cases and Individual Actions, several of which were affirmed on appeal and satisfied by Liggett. It is possible that other cases could be decided unfavorably against Liggett and that Liggett will be unsuccessful on appeal. Liggett may attempt to settle particular cases if it believes it is in its best interest to do so.
Management cannot predict the cash requirements related to any future defense costs, settlements or judgments, including cash required to bond any appeals, and there is a risk that those requirements will not be able to be met. An unfavorable outcome of a pending smoking-related case could encourage the commencement of additional litigation. Except as discussed in this Note

37

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


9, management is unable to estimate the loss or range of loss that could result from an unfavorable outcome of the cases pending against Liggett or the costs of defending such cases and as a result has not provided any amounts in its consolidated financial statements for unfavorable outcomes.
The tobacco industry is subject to a wide range of laws and regulations regarding the marketing, sale, taxation and use of tobacco products imposed by local, state and federal governments. There have been a number of restrictive regulatory actions, adverse legislative and political decisions and other unfavorable developments concerning cigarette smoking and the tobacco industry. These developments may negatively affect the perception of potential triers of fact with respect to the tobacco industry, possibly to the detriment of certain pending litigation, and may prompt the commencement of additional litigation or legislation.
It is possible that the Company’s consolidated financial position, results of operations and cash flows could be materially adversely affected by an unfavorable outcome in any of the smoking-related litigation.
The activity in the Company’s accruals for the MSA and tobacco litigation for the three months ended March 31, 2019 was as follows:
 
Current Liabilities
 
Non-Current Liabilities
 
Payments due under Master Settlement Agreement
 
Litigation Accruals
 
Total
 
Payments due under Master Settlement Agreement
 
Litigation Accruals
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
Balance as of January 1, 2019
$
36,561

 
$
310

 
$
36,871

 
$
16,383

 
$
21,794

 
$
38,177

Expenses
36,358

 

 
36,358

 

 

 

Change in MSA obligations capitalized as inventory
890

 

 
890

 

 

 

Payments

 
(250
)
 
(250
)
 

 

 

Reclassification to/(from) non-current liabilities

 
3,338

 
3,338

 

 
(3,338
)
 
(3,338
)
Interest on withholding

 
6

 
6

 

 
571

 
571

Balance as of March 31, 2019
$
73,809

 
$
3,404

 
$
77,213

 
$
16,383

 
$
19,027

 
$
35,410

The activity in the Company’s accruals for the MSA and tobacco litigation for the three months ended March 31, 2018 were as follows:
 
Current Liabilities
 
Non-Current Liabilities
 
Payments due under Master Settlement Agreement
 
Litigation Accruals
 
Total
 
Payments due under Master Settlement Agreement
 
Litigation Accruals
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
Balance as of January 1, 2018
$
12,385

 
$
260

 
$
12,645

 
$
21,479

 
$
19,840

 
$
41,319

Expenses
38,142

 

 
38,142

 

 

 

NPM Settlement adjustment
(595
)
 

 
(595
)
 
(2,895
)
 

 
(2,895
)
Change in MSA obligations capitalized as inventory
147

 

 
147

 

 

 

Payments

 
(250
)
 
(250
)
 

 

 

Reclassification to/(from) non-current liabilities
32

 
218

 
250

 
(32
)
 
(218
)
 
(250
)
Interest on withholding

 
12

 
12

 

 
514

 
514

Balance as of March 31, 2018
$
50,111

 
$
240

 
$
50,351

 
$
18,552

 
$
20,136

 
$
38,688




38

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


Other Matters:
Liggett’s and Vector Tobacco’s management are unaware of any material environmental conditions affecting their existing facilities. Liggett’s and Vector Tobacco’s management believe that current operations are conducted in material compliance with all environmental laws and regulations and other laws and regulations governing cigarette manufacturers. Compliance with federal, state and local provisions regulating the discharge of materials into the environment, or otherwise relating to the protection of the environment, has not had a material effect on the capital expenditures, results of operations or competitive position of Liggett or Vector Tobacco.
Liggett and the Company have received three separate demands for indemnification from Altria Client Services, on behalf of Philip Morris, relating to lawsuits alleging smokers’ use of L&M cigarettes. The indemnification demands are purportedly issued in connection with Eve Holdings’ 1999 sale of certain brands to Philip Morris.
Liggett Vector Brands entered into an agreement with a subsidiary of the Convenience Distribution Association to support a program to permit certain tobacco distributors to secure, on reasonable terms, tax stamp bonds required by state and local governments for the distribution of cigarettes. Under the agreement, Liggett Vector Brands has agreed to pay a portion of losses incurred by the surety under the bond program, with a maximum loss exposure of $500. The Company believes the fair value of Liggett Vector Brands’ obligation under the agreement was immaterial at March 31, 2019.
In addition to the foregoing, Douglas Elliman and certain of its subsidiaries are subject to numerous proceedings, lawsuits and claims in connection with their ordinary business activities. Many of these matters are covered by insurance or, in some cases, the company is indemnified by third parties.
Management is of the opinion that the liabilities, if any, resulting from other proceedings, lawsuits and claims pending against the Company and its consolidated subsidiaries, unrelated to tobacco product liability, should not materially affect the Company’s consolidated financial position, results of operations or cash flows.

10.
EMPLOYEE BENEFIT PLANS

The following table summarizes key information related to the Company’s pension plans and other postretirement benefits:

 
Pension Benefits
 
Other Postretirement Benefits
 
Three Months Ended
 
Three Months Ended
 
March 31,
 
March 31,
 
2019
 
2018
 
2019
 
2018
Service cost — benefits earned during the period
$
133

 
$
147

 
$

 
$
1

Interest cost on projected benefit obligation
1,215

 
1,122

 
87

 
82

Expected return on assets
(1,219
)
 
(1,393
)
 

 

Amortization of prior service cost

 

 
1

 

Amortization of net loss (gain)
501

 
452

 
(44
)
 
(10
)
Net expense
$
630

 
$
328

 
$
44

 
$
73



The service cost component of net periodic benefit expense (income) is recorded in Operating, selling, administrative and general expenses in the condensed consolidated statements of income while the other components are recorded in Other, net.


39

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


11.
INCOME TAXES

The Company’s effective income tax rate is based on expected income, statutory rates, valuation allowances against deferred tax assets, and any tax planning opportunities available to the Company. For interim financial reporting, the Company estimates the annual effective income tax rate based on full year projections and applies the annual effective income tax rate against year-to-date pretax income (loss) to record income tax expense, adjusted for discrete items, if any. The Company refines annual estimates as new information becomes available. The Company’s tax rate does not bear a relationship to statutory tax rates due to permanent differences, a valuation allowance being established for interest expense that is not deductible, and state taxes.
The Company’s income tax expense consisted of the following:

 
Three Months Ended
 
March 31,
 
2019
 
2018
Income before provision for income taxes
$
21,782

 
$
5,612

Income tax expense using estimated annual effective income tax rate
6,863

 
2,056

Impact of discrete items, net
(114
)
 
(108
)
Income tax expense
$
6,749

 
$
1,948



The discrete items for the three months ended March 31, 2019 and 2018 is related to an income tax deduction for stock-based compensation.


40

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


12.
INVESTMENTS AND FAIR VALUE MEASUREMENTS

The Company’s financial assets and liabilities subject to fair value measurements were as follows:

 
 
Fair Value Measurements as of March 31, 2019
 
 
Description
 
Total
 
Quoted Prices in Active Markets for Identical Assets
(Level 1)
 

Significant Other Observable Inputs
(Level 2)
 


Significant Unobservable Inputs
(Level 3)
 
Total Gains (Losses)
Assets:
 
 
 
 
 
 
 
 
 
 
Money market funds (1)
 
$
222,559

 
$
222,559

 
$

 
$

 
 
 
 
 
 
 
 
 
 
 
 
 
Commercial paper (1)
 
39,100

 

 
39,100

 

 
 
 
 
 
 
 
 
 
 
 
 
 
Certificates of deposit (2)
 
2,171

 

 
2,171

 

 
 
 
 
 
 
 
 
 
 
 
 
 
Money market funds securing legal bonds (2)
 
535

 
535

 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
Investment securities at fair value
 
 
 
 
 
 
 
 
 
 
   Equity securities at fair value
 
 
 
 
 
 
 
 
 
 
   Marketable equity securities
 
24,387

 
24,387

 

 

 
 
   Mutual funds invested in fixed-income securities
 
21,660

 
21,660

 

 

 
 
         Total equity securities at fair value
 
46,047

 
46,047

 

 

 
 
    Debt securities available for sale
 
 
 
 
 
 
 
 
 
 
U.S. government securities
 
24,275

 

 
24,275

 

 
 
Corporate securities
 
43,110

 

 
43,110

 

 
 
U.S. government and federal agency
 
4,132

 

 
4,132

 

 
 
Commercial mortgage-backed securities
 
397

 

 
397

 

 
 
Commercial paper
 
13,180

 

 
13,180

 

 
 
Index-linked U.S. bonds
 
2,354

 

 
2,354

 

 
 
Foreign fixed-income securities
 
1,157

 

 
1,157

 

 
 
Total debt securities available for sale
 
88,605

 

 
88,605

 

 
 
 
 
 
 
 
 
 
 
 
 
 
Total investment securities at fair value
 
134,652

 
46,047

 
88,605

 

 
 
 
 
 
 
 
 
 
 
 
 
 
Long-term investments
 
 
 
 
 
 
 
 
 
 
Equity securities at fair value that qualify for the NAV practical expedient (3)
 
54,202

 

 

 

 
 
Total
 
$
453,219

 
$
269,141

 
$
129,876

 
$

 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
 
Fair value of contingent liability
 
$
6,258

 
$

 
$

 
$
6,258

 
 
Fair value of derivatives embedded within convertible debt
 
21,075

 

 

 
21,075

 
 
Total
 
$
27,333

 
$

 
$

 
$
27,333

 
 

(1)
Amounts included in Cash and cash equivalents on the condensed consolidated balance sheet, except for $3,719 that is included in current restricted assets and $3,910 that is included in non-current restricted assets.
(2)
Amounts included in current restricted assets and non-current restricted assets on the condensed consolidated balance sheet.
(3)
In accordance with Subtopic 820-10, investments that are measured at fair value using the NAV practical expedient are not classified in the fair value hierarchy.


41

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


 
 
Fair Value Measurements as of December 31, 2018
 
 
Description
 
Total
 
Quoted Prices in Active Markets for Identical Assets
(Level 1)
 

Significant Other Observable Inputs
(Level 2)
 


Significant Unobservable Inputs
(Level 3)
 
Total Gains (Losses)
Assets:
 
 
 
 
 
 
 
 
 
 
Money market funds (1)
 
$
448,560

 
$
448,560

 
$

 
$

 
 
 
 
 
 
 
 
 
 
 
 
 
Commercial paper (1)
 
46,062

 

 
46,062

 

 
 
 
 
 
 
 
 
 
 
 
 
 
Certificates of deposit (2)
 
2,251

 

 
2,251

 

 
 
 
 
 
 
 
 
 
 
 
 
 
Money market funds securing legal bonds (2)
 
535

 
535

 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
Investment securities at fair value
 
 
 
 
 
 
 
 
 
 
   Equity securities at fair value
 
 
 
 
 
 
 
 
 
 
   Marketable equity securities
 
26,010

 
26,010

 

 

 
 
   Mutual funds invested in fixed-income securities
 
21,192

 
21,192

 

 

 
 
         Total equity securities at fair value
 
47,202

 
47,202

 

 

 
 
    Debt securities available for sale
 
 
 
 
 
 
 
 
 
 
U.S. government securities
 
28,514

 

 
28,514

 

 
 
Corporate securities
 
41,733

 

 
41,733

 

 
 
U.S. government and federal agency
 
4,369

 

 
4,369

 

 
 
Commercial mortgage-backed securities
 
401

 

 
401

 

 
 
Commercial paper
 
5,870

 

 
5,870

 

 
 
Index-linked U.S. bonds
 
2,330

 

 
2,330

 

 
 
Foreign fixed-income securities
 
1,150

 

 
1,150

 

 
 
Total debt securities available for sale
 
84,367

 

 
84,367

 

 
 
 
 
 
 
 
 
 
 
 
 
 
Total investment securities at fair value
 
131,569

 
47,202

 
84,367

 

 
 
 
 
 
 
 
 
 
 
 
 
 
Long-term investments
 
 
 
 
 
 
 
 
 
 
Equity securities at fair value that qualify for the NAV practical expedient (3)
 
54,628

 

 

 

 
 
Total
 
$
683,605

 
$
496,297

 
$
132,680

 
$

 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
 
Fair value of contingent liability
 
$
6,304

 
$

 
$

 
$
6,304

 
 
Fair value of derivatives embedded within convertible debt
 
31,424

 

 

 
31,424

 
 
Total
 
$
37,728

 
$

 
$

 
$
37,728

 
 

(1)
Amounts included in Cash and cash equivalents on the condensed consolidated balance sheet, except for $2,570 that is included in current restricted assets and $3,910 that is included in non-current restricted assets.
(2)
Amounts included in current restricted assets and non-current restricted assets on the condensed consolidated balance sheet.
(3)
In accordance with Subtopic 820-10, investments that are measured at fair value using the NAV practical expedient are not classified in the fair value hierarchy.

The fair value of the Level 2 certificates of deposit is based on the discounted value of contractual cash flows. The discount rate is the rate offered by the financial institution. The fair value of investment securities at fair value included in Level 1 is based on quoted market prices from various stock exchanges. The Level 2 investment securities at fair value are based on quoted market

42

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


prices of securities that are thinly traded, quoted prices for identical or similar assets in markets that are not active or inputs other than quoted prices such as interest rates and yield curves.
The long-term investments are based on NAV per share provided by the partnerships based on the indicated market value of the underlying assets or investment portfolio. In accordance with Subtopic 820-10, these investments are not classified under the fair value hierarchy disclosed above because they are measured at fair value using the NAV practical expedient.
The fair value of derivatives embedded within convertible debt was derived using a valuation model. These derivatives have been classified as Level 3. The valuation model assumes future dividend payments by the Company and utilizes interest rates and credit spreads based upon the implied credit spread of the 5.5% Convertible Notes due 2020 to determine the fair value of the derivatives embedded within the convertible debt. The changes in fair value of derivatives embedded within convertible debt are presented on the condensed consolidated statements of operations.
The fair value of the Level 3 contingent liability was derived using a Monte Carlo valuation model. As part of the acquisition of the 29.41% non-controlling interest in Douglas Elliman, New Valley entered into a four-year payout agreement that requires it to pay the sellers a portion of the fair value in excess of the purchase price of Douglas Elliman should a sale of a controlling interest in Douglas Elliman occur.
The contingent liability is recorded within “Other liabilities” in the condensed consolidated balance sheet, and any change in fair value will be recorded in “Other, net” within the condensed consolidated statements of operations. The value of the contingent liability is calculated using the outstanding payable owed to the sellers and the estimated fair value of Douglas Elliman. The liability is contingent upon the sale of a controlling interest in Douglas Elliman by the Company prior to October 1, 2022.
The unobservable inputs related to the valuations of the Level 3 assets and liabilities were as follows at March 31, 2019:
 
 
Quantitative Information about Level 3 Fair Value Measurements
 
 
Fair Value at
 
 
 
 
 
 
 
 
March 31,
2019
 
Valuation Technique
 
Unobservable Input
 
Range (Actual)
 
 
 
 
 
 
 
 
 
Fair value of derivatives embedded within convertible debt
 
$
21,075

 
Discounted cash flow
 
Assumed annual stock dividend
 
5
%
 
 
 
 
 
 
Assumed annual cash dividend
 
$
1.60

 
 
 
 
 
 
Stock price
 
$
10.79

 
 
 
 
 
 
Convertible trading price (as a percentage of par value)
 
101.38
%
 
 
 
 
 
 
Volatility
 
25.48
%
 
 
 
 
 
 
Risk-free rate
 
Term structure of US Treasury Securities
 
 
 
 
 
 
Implied credit spread
 
7.5% - 8.5% (8.0%)

 
 
 
 
 
 
 
 
 
Fair value of contingent liability
 
$
6,258

 
Monte Carlo simulation model
 
Estimated fair value of the Douglas Elliman reporting unit
 
$
320,000

 
 
 
 
 
 
Risk-free rate for a 4-year term
 
2.19
%
 
 
 
 
 
 
Leverage-adjusted equity volatility of peer firms
 
30.42
%

43

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited



The unobservable inputs related to the valuations of the Level 3 assets and liabilities were as follows at December 31, 2018:
 
 
Quantitative Information about Level 3 Fair Value Measurements
 
 
Fair Value at
 
 
 
 
 
 
 
 
December 31,
2018
 
Valuation Technique
 
Unobservable Input
 
Range (Actual)
 
 
 
 
 
 
 
 
 
Fair value of derivatives embedded within convertible debt
 
$
31,424

 
Discounted cash flow
 
Assumed annual stock dividend
 
5
%
 
 
 
 
 
 
Assumed annual cash dividend
 
$
1.60

 
 
 
 
 
 
Stock price
 
$
9.73

 
 
 
 
 
 
Convertible trading price (as a percentage of par value)
 
100.31
%
 
 
 
 
 
 
Volatility
 
20.39
%
 
 
 
 
 
 
Risk-free rate
 
Term structure of US Treasury Securities
 
 
 
 
 
 
Implied credit spread
 
8.0% - 9.0% (8.5%)

 
 
 
 
 
 
 
 
 
Fair value of contingent liability
 
$
6,304

 
Monte Carlo simulation model
 
Estimated fair value of the Douglas Elliman reporting unit
 
$
320,000

 
 
 
 
 
 
Risk-free rate for a 4-year term
 
2.45
%
 
 
 
 
 
 
Leverage-adjusted equity volatility of peer firms
 
30.22
%


In addition to assets and liabilities that are recorded at fair value on a recurring basis, the Company is required to record assets and liabilities at fair value on a nonrecurring basis. Generally, assets and liabilities are recorded at fair value on a nonrecurring basis as a result of impairment charges. The Company had no nonrecurring nonfinancial assets subject to fair value measurements as of March 31, 2019 and 2018, respectively.

13.
SEGMENT INFORMATION

The Company’s business segments for the three months ended March 31, 2019 and 2018 were Tobacco and Real Estate. The Tobacco segment consisted of the manufacture and sale of conventional cigarettes. The Real Estate segment included the Company’s investment in New Valley LLC, which includes Douglas Elliman, Escena, Sagaponack and investments in real estate ventures. The accounting policies of the segments are the same as those described in the summary of significant accounting policies.


44

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


Financial information for the Company’s operations before taxes and non-controlling interests for the three months ended March 31, 2019 and 2018 were as follows:

 
 
 
Real
 
Corporate
 
 
 
Tobacco
 
Estate
 
and Other
 
Total
Three months ended March 31, 2019
 
 
 
 
 
 
 
Revenues
$
256,756

 
$
164,168

 
$

 
$
420,924

Operating income (loss)
60,144

 
(10,409
)
 
(7,145
)
 
42,590

Equity in losses from real estate ventures

 
(2,439
)
 

 
(2,439
)
Depreciation and amortization
1,957

 
2,501

 
250

 
4,708

Capital expenditures
1,638

 
2,187

 

 
3,825

 


 
 
 
 
 
 
Three months ended March 31, 2018
 
 
 
 
 
 
 
Revenues
$
267,116

 
$
161,850

 
$

 
$
428,966

Operating income (loss)
63,411

(1)
(8,760
)
(2)
(6,567
)
 
48,084

Equity in losses from real estate ventures

 
(6,560
)
 

 
(6,560
)
Depreciation and amortization
2,037

 
2,289

 
261

 
4,587

Capital expenditures
911

 
3,071

 
5

 
3,987


(1) 
Operating income includes $3,490 of income from a settlement of a long-standing dispute related to the Master Settlement Agreement.
(2) 
Operating income includes $2,469 of litigation settlement and judgment income.
     





45

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited



14. CONDENSED CONSOLIDATING FINANCIAL INFORMATION

The condensed consolidating financial information is based upon the following subsidiaries being subsidiary guarantors of unsecured debt securities that may be issued by the Company: VGR Holding LLC; Liggett Group LLC; Liggett Vector Brands LLC; Vector Research LLC; Vector Tobacco Inc.; Liggett & Myers Holdings Inc.; 100 Maple LLC; V.T. Aviation LLC; VGR Aviation LLC; Eve Holdings LLC; Zoom E-Cigs LLC; and DER Holdings LLC. Each of the subsidiary guarantors is 100% owned, directly or indirectly, by the Company, and all guarantees are full and unconditional and joint and several. The Company’s investments in its consolidated subsidiaries are presented under the equity method of accounting.
The Company and the guarantors have filed a shelf registration statement for the offering of debt securities on a delayed or continuous basis and the Company is including this condensed consolidating financial information in connection therewith. Any such debt securities may be issued by the Company and guaranteed by the guarantors, but any such debt securities would not be guaranteed by any of the Company’s other subsidiaries, including those subsidiaries other than DER Holdings LLC that are engaged in the real estate businesses conducted through its subsidiary New Valley.
Presented herein are Condensed Consolidating Balance Sheets as of March 31, 2019 and 2018, the related Condensed Consolidating Statements of Operations for the three months ended March 31, 2019 and 2018, and the related Condensed Consolidating Statements of Cash Flows for the three months ended March 31, 2019 and 2018 of Vector Group Ltd. (Parent/Issuer), the guarantor subsidiaries (Subsidiary Guarantors) and the subsidiaries that are not guarantors (Subsidiary Non-Guarantors).





















46

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


CONDENSED CONSOLIDATING BALANCE SHEETS
 
 
 
March 31, 2019
 
 
 
 
 
 
 
Subsidiary
 
 
 
Consolidated
 
Parent/
 
Subsidiary
 
Non-
 
Consolidating
 
Vector Group
 
Issuer
 
Guarantors
 
Guarantors
 
Adjustments
 
Ltd.
ASSETS:
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
203,828

 
$
47,903

 
$
60,907

 
$

 
$
312,638

Investment securities at fair value
134,652

 

 

 

 
134,652

Accounts receivable - trade, net

 
15,034

 
21,406

 

 
36,440

Intercompany receivables
39,561

 

 

 
(39,561
)
 

Inventories

 
101,977

 

 

 
101,977

Income taxes receivable, net

 

 
5,036

 
(5,036
)
 

Restricted assets

 
1,124

 
4,288

 

 
5,412

Other current assets
4,923

 
7,400

 
23,919

 

 
36,242

Total current assets
382,964

 
173,438

 
115,556

 
(44,597
)
 
627,361

Property, plant and equipment, net
453

 
37,695

 
47,493

 

 
85,641

Investments in real estate, net

 

 
26,777

 

 
26,777

Long-term investments (of which $54,202 were carried at fair value)
66,768

 

 

 

 
66,768

Investments in real estate ventures

 

 
138,393

 

 
138,393

Operating lease right of use assets
7,882

 
5,684

 
111,157

 

 
124,723

Investments in consolidated subsidiaries
412,964

 
230,191

 

 
(643,155
)
 

Restricted assets
1,502

 
904

 
3,910

 

 
6,316

Goodwill and other intangible assets, net

 
107,511

 
158,554

 

 
266,065

Prepaid pension costs

 
24,179

 

 

 
24,179

Other assets
13,083

 
13,624

 
36,226

 

 
62,933

Total assets
$
885,616

 
$
593,226

 
$
638,066

 
$
(687,752
)
 
$
1,429,156

LIABILITIES AND STOCKHOLDERS' DEFICIENCY:
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Current portion of notes payable and long-term debt
$

 
$
40,798

 
$
2,782

 
$
(2,500
)
 
$
41,080

Current portion of employee benefits

 
875

 

 

 
875

Intercompany payables

 
84

 
39,477

 
(39,561
)
 

Income taxes payable, net
11,524

 
3,213

 

 
(5,036
)
 
9,701

Litigation accruals and current payments due under the Master Settlement Agreement

 
77,213

 

 

 
77,213

Current operating lease liability
991

 
1,817

 
17,606

 

 
20,414

Other current liabilities
39,649

 
58,995

 
54,914

 
(224
)
 
153,334

Total current liabilities
52,164

 
182,995

 
114,779

 
(47,321
)
 
302,617

Notes payable, long-term debt and other obligations, less current portion
1,360,242

 
27,639

 
27,564

 
(27,500
)
 
1,387,945

Fair value of derivatives embedded within convertible debt
21,075

 

 

 

 
21,075

Non-current employee benefits
46,118

 
15,566

 

 

 
61,684

Deferred income taxes, net
(11,596
)
 
18,307

 
33,112

 

 
39,823

Non-current operating lease liability
7,808

 
4,346

 
116,845

 

 
128,999

Other liabilities, primarily litigation accruals and payments due under the Master Settlement Agreement
394

 
35,413

 
41,307

 

 
77,114

Total liabilities
1,476,205

 
284,266

 
333,607

 
(74,821
)
 
2,019,257

Commitments and contingencies


 


 


 


 


Stockholders' (deficiency) equity attributed to Vector Group Ltd.
(590,589
)
 
308,960

 
303,971

 
(612,931
)
 
(590,589
)
Non-controlling interest

 

 
488

 

 
488

Total stockholders' (deficiency) equity
(590,589
)
 
308,960

 
304,459

 
(612,931
)
 
(590,101
)
Total liabilities and stockholders' deficiency
$
885,616

 
$
593,226

 
$
638,066

 
$
(687,752
)
 
$
1,429,156




47

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


CONDENSED CONSOLIDATING BALANCE SHEETS
 
 
 
December 31, 2018
 
 
 
 
 
 
 
Subsidiary
 
 
 
Consolidated
 
Parent/
 
Subsidiary
 
Non-
 
Consolidating
 
Vector Group
 
Issuer
 
Guarantors
 
Guarantors
 
Adjustments
 
Ltd.
ASSETS:
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
474,880

 
$
23,308

 
$
86,393

 
$

 
$
584,581

Investment securities at fair value
131,569

 

 

 

 
131,569

Accounts receivable - trade, net

 
15,440

 
18,806

 

 
34,246

Intercompany receivables
38,391

 

 

 
(38,391
)
 

Inventories

 
90,997

 

 

 
90,997

Income taxes receivable, net

 

 
1,268

 
(1,268
)
 

Restricted assets

 
1,124

 
3,353

 

 
4,477

Other current assets
1,500

 
6,475

 
18,376

 

 
26,351

Total current assets
646,340

 
137,344

 
128,196

 
(39,659
)
 
872,221

Property, plant and equipment, net
506

 
38,562

 
47,668

 

 
86,736

Investments in real estate, net

 

 
26,220

 

 
26,220

Long-term investments (of which $54,628 were carried at fair value)
66,259

 

 

 

 
66,259

Investments in real estate ventures

 

 
141,105

 

 
141,105

Investments in consolidated subsidiaries
431,288

 
252,113

 

 
(683,401
)
 

Restricted assets
1,495

 
901

 
3,910

 

 
6,306

Goodwill and other intangible assets, net

 
107,511

 
159,100

 

 
266,611

Prepaid pension costs

 
23,869

 

 

 
23,869

Other assets
13,121

 
13,384

 
33,672

 

 
60,177

Total assets
$
1,159,009

 
$
573,684

 
$
539,871

 
$
(723,060
)
 
$
1,549,504

LIABILITIES AND STOCKHOLDERS' DEFICIENCY:
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Current portion of notes payable and long-term debt
$
226,343

 
$
29,480

 
$
311

 
$

 
$
256,134

Current portion of fair value of derivatives embedded within convertible debt
6,635

 

 

 

 
6,635

Current portion of employee benefits

 
875

 

 

 
875

Intercompany payables

 
479

 
37,912

 
(38,391
)
 

Income taxes payable, net
5,257

 
1,263

 

 
(1,268
)
 
5,252

Litigation accruals and current payments due under the Master Settlement Agreement

 
36,871

 

 

 
36,871

Other current liabilities
55,915

 
72,094

 
51,144

 

 
179,153

Total current liabilities
294,150

 
141,062

 
89,367

 
(39,659
)
 
484,920

Notes payable, long-term debt and other obligations, less current portion
1,354,219

 
2,349

 
30,129

 

 
1,386,697

Fair value of derivatives embedded within convertible debt
24,789

 

 

 

 
24,789

Non-current employee benefits
45,615

 
15,673

 

 

 
61,288

Deferred income taxes, net
(13,084
)
 
17,732

 
32,763

 

 
37,411

Other liabilities, primarily litigation accruals and payments due under the Master Settlement Agreement
1,379

 
38,179

 
62,207

 

 
101,765

Total liabilities
1,707,068

 
214,995

 
214,466

 
(39,659
)
 
2,096,870

Commitments and contingencies


 


 


 


 


Stockholders' (deficiency) equity attributed to Vector Group Ltd.
(548,059
)
 
358,689

 
324,712

 
(683,401
)
 
(548,059
)
Non-controlling interest

 

 
693

 

 
693

Total stockholders' (deficiency) equity
(548,059
)
 
358,689

 
325,405

 
(683,401
)
 
(547,366
)
Total liabilities and stockholders' deficiency
$
1,159,009

 
$
573,684

 
$
539,871

 
$
(723,060
)
 
$
1,549,504




48

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS


 
 
 
Three Months Ended March 31, 2019
 
 
 
 
 
 
 
Subsidiary
 
 
 
Consolidated
 
  Parent/  
 
Subsidiary
 
Non-
 
Consolidating
 
Vector Group
 
  Issuer  
 
Guarantors
 
Guarantors
 
Adjustments
 
        Ltd.        
Revenues
$

 
$
256,875

 
$
164,168

 
$
(119
)
 
$
420,924

Expenses:
 
 
 
 
 
 
 
 
 
Cost of sales

 
177,303

 
108,717

 

 
286,020

Operating, selling, administrative and general expenses
9,831

 
16,691

 
65,911

 
(119
)
 
92,314

Management fee expense

 
2,993

 

 
(2,993
)
 

Operating (loss) income
(9,831
)
 
59,888

 
(10,460
)
 
2,993

 
42,590

Other income (expenses):
 
 
 
 
 
 
 
 
 
Interest expense
(36,548
)
 
(967
)
 
(229
)
 
224

 
(37,520
)
Change in fair value of derivatives embedded within convertible debt
10,349

 

 

 

 
10,349

Equity in losses from real estate ventures

 

 
(2,439
)
 

 
(2,439
)
Equity in earnings from investments
1,362

 

 

 

 
1,362

Equity in earnings in consolidated subsidiaries
35,265

 
(10,414
)
 

 
(24,851
)
 

Net gain recognized on investment securities
4,773

 

 

 

 
4,773

Management fee income
2,993

 

 

 
(2,993
)
 

Other, net
1,810

 
153

 
704

 

 
2,667

Income (loss) before provision for income taxes
10,173

 
48,660

 
(12,424
)
 
(24,627
)
 
21,782

Income tax benefit (expense)
4,780

 
(14,948
)
 
3,419

 

 
(6,749
)
Net income (loss)
14,953

 
33,712

 
(9,005
)
 
(24,627
)
 
15,033

Net income attributed to non-controlling interest

 

 
(80
)
 

 
(80
)
Net income (loss) attributed to Vector Group Ltd.
$
14,953

 
$
33,712

 
$
(9,085
)
 
$
(24,627
)
 
$
14,953

Comprehensive income attributed to non-controlling interest
$

 
$

 
$
(80
)
 
$

 
$
(80
)
Comprehensive income (loss) attributed to Vector Group Ltd.
$
15,534

 
$
33,947

 
$
(9,085
)
 
$
(24,862
)
 
$
15,534




49

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS


 
 
 
Three Months Ended March 31, 2018
 
 
 
 
 
 
 
Subsidiary
 
 
 
Consolidated
 
  Parent/  
 
Subsidiary
 
Non-
 
Consolidating
 
Vector Group
 
  Issuer  
 
Guarantors
 
Guarantors
 
Adjustments
 
        Ltd.        
Revenues
$

 
$
267,235

 
$
161,850

 
$
(119
)
 
$
428,966

Expenses:
 
 
 
 
 
 
 
 
 
Cost of sales

 
184,962

 
109,313

 

 
294,275

Operating, selling, administrative and general expenses
9,096

 
16,275

 
63,824

 
(119
)
 
89,076

Litigation settlement and judgment income

 

 
(2,469
)
 

 
(2,469
)
Management fee expense

 
2,877

 

 
(2,877
)
 

Operating (loss) income
(9,096
)
 
63,121

 
(8,818
)
 
2,877

 
48,084

Other income (expenses):
 
 
 
 
 
 
 
 
 
Interest expense
(45,231
)
 
(667
)
 
(49
)
 

 
(45,947
)
Change in fair value of derivatives embedded within convertible debt
10,567

 

 

 

 
10,567

Equity in losses from real estate ventures

 

 
(6,560
)
 

 
(6,560
)
Net gains (losses) recognized on investment securities
1,066

 
(4,406
)
 

 

 
(3,340
)
Equity in earnings from investments
1,162

 

 

 

 
1,162

Equity in earnings in consolidated subsidiaries
34,421

 
(5,716
)
 

 
(28,705
)
 

Management fee income
2,877

 

 

 
(2,877
)
 

Other, net
527

 
777

 
342

 

 
1,646

(Loss) income before provision for income taxes
(3,707
)
 
53,109

 
(15,085
)
 
(28,705
)
 
5,612

Income tax benefit (expense)
10,918

 
(15,860
)
 
2,994

 

 
(1,948
)
Net income (loss)
7,211

 
37,249

 
(12,091
)
 
(28,705
)
 
3,664

Net loss attributed to non-controlling interest

 

 
3,547

 

 
3,547

Net income (loss) attributed to Vector Group Ltd.
$
7,211

 
$
37,249

 
$
(8,544
)
 
$
(28,705
)
 
$
7,211

Comprehensive loss attributed to non-controlling interest
$

 
$

 
$
3,547

 
$

 
$
3,547

Comprehensive income (loss) attributed to Vector Group Ltd.
$
7,461

 
$
37,387

 
$
(8,544
)
 
$
(28,843
)
 
$
7,461




50

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

 
 
 
Three Months Ended March 31, 2019
 
 
 
 
 
 
 
Subsidiary
 
 
 
Consolidated
 
  Parent/  
 
Subsidiary
 
Non-
 
Consolidating
 
Vector Group
 
Issuer   
 
Guarantors
 
Guarantors
 
Adjustments
 
Ltd.
Net cash provided by (used in) operating activities
$
22,468

 
$
72,093

 
$
(10,746
)
 
$
(64,089
)
 
$
19,726

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
Sale of investment securities
7,759

 

 

 

 
7,759

Maturities of investment securities
11,308

 

 

 

 
11,308

Purchase of investment securities
(20,623
)
 

 

 

 
(20,623
)
Investments in real estate ventures

 

 
(871
)
 

 
(871
)
Purchase of subsidiaries

 

 
(668
)
 

 
(668
)
Distributions from investments in real estate ventures

 

 
1,134

 

 
1,134

Increase in cash surrender value of life insurance policies
38

 
(276
)
 

 

 
(238
)
Increase in restricted assets
(7
)
 

 

 

 
(7
)
Investments in subsidiaries
(1,794
)
 

 

 
1,794

 

Capital expenditures

 
(1,638
)
 
(2,187
)
 

 
(3,825
)
Pay downs of investment securities
258

 

 

 

 
258

Investments in real estate, net

 

 
(641
)
 

 
(641
)
Net cash used in investing activities
(3,061
)
 
(1,914
)
 
(3,233
)
 
1,794

 
(6,414
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
Repayments of debt
(230,000
)
 
(372
)
 
(94
)
 

 
(230,466
)
Borrowings under revolver

 
94,400

 

 

 
94,400

Repayments on revolver

 
(87,420
)
 

 

 
(87,420
)
Capital contributions received

 
400

 
1,394

 
(1,794
)
 

Intercompany dividends paid

 
(52,589
)
 
(11,500
)
 
64,089

 

Dividends and distributions on common stock
(60,459
)
 

 

 

 
(60,459
)
Distributions to non-controlling interest

 

 
(285
)
 

 
(285
)
Net cash used in financing activities
(290,459
)
 
(45,581
)
 
(10,485
)
 
62,295

 
(284,230
)
Net (decrease) increase in cash, cash equivalents and restricted cash
(271,052
)
 
24,598

 
(24,464
)
 

 
(270,918
)
Cash, cash equivalents and restricted cash, beginning of period
474,880

 
23,849

 
93,000

 

 
591,729

Cash, cash equivalents and restricted cash, end of period
$
203,828

 
$
48,447

 
$
68,536

 
$

 
$
320,811




51

VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in Thousands, Except Per Share Amounts)
Unaudited


CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

 
 
 
Three Months Ended March 31, 2018
 
 
 
 
 
 
 
Subsidiary
 
 
 
Consolidated
 
  Parent/  
 
Subsidiary
 
Non-
 
Consolidating
 
Vector Group
 
Issuer   
 
Guarantors
 
Guarantors
 
Adjustments
 
Ltd.        
Net cash provided by (used in) operating activities
$
18,670

 
$
74,867

 
$
(9,669
)
 
$
(43,154
)
 
$
40,714

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
Sale of investment securities
2,357

 

 

 

 
2,357

Maturities of investment securities
8,112

 

 

 

 
8,112

Purchase of investment securities
(4,364
)
 

 

 

 
(4,364
)
Investments in real estate ventures

 

 
(533
)
 

 
(533
)
Investments in real estate, net

 

 
(355
)
 

 
(355
)
Distributions from investments in real estate ventures

 

 
219

 

 
219

Increase in cash surrender value of life insurance policies
11

 
(47
)
 

 

 
(36
)
Increase in restricted assets
(4
)
 

 

 

 
(4
)
Repayments of notes receivable
20,000

 

 
32

 
(20,000
)
 
32

Pay downs of investment securities
446

 

 

 

 
446

Investments in subsidiaries
(605
)
 

 

 
605

 

Capital expenditures
(5
)
 
(911
)
 
(3,071
)
 

 
(3,987
)
Net cash provided by (used in) investing activities
25,948

 
(958
)
 
(3,708
)
 
(19,395
)
 
1,887

Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
Repayments of debt

 
(20,422
)
 
(68
)
 
20,000

 
(490
)
Borrowings under revolver

 
55,170

 

 

 
55,170

Repayments on revolver

 
(61,728
)
 

 

 
(61,728
)
Capital contributions received

 
350

 
255

 
(605
)
 

Intercompany dividends paid

 
(40,119
)
 
(3,035
)
 
43,154

 

Dividends and distributions on common stock
(57,187
)
 

 

 

 
(57,187
)
Net cash used in financing activities
(57,187
)
 
(66,749
)
 
(2,848
)
 
62,549

 
(64,235
)
Net (decrease) increase in cash, cash equivalents and restricted cash
(12,569
)
 
7,160

 
(16,225
)
 

 
(21,634
)
Cash, cash equivalents and restricted cash, beginning of period
194,719

 
20,175

 
96,043

 

 
310,937

Cash, cash equivalents and restricted cash, end of period
$
182,150

 
$
27,335

 
$
79,818

 
$

 
$
289,303




52



ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION    AND RESULTS OF OPERATIONS

(Dollars in Thousands, Except Per Share Amounts)


Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is designed to provide a reader of Vector Group Ltd.’s financial statements with a narrative from our management’s perspective. Our MD&A is divided into the following sections:
Overview and Recent Developments
Results of Operations
Summary of Real Estate Investments
Liquidity and Capital Resources

Please read this discussion along with our MD&A and audited financial statements as of and for the year ended December 31, 2018 and Notes thereto, included in our 2018 Annual Report on Form 10-K, and our Condensed Consolidated Financial Statements and related Notes as of and for the quarterly period ended March 31, 2019 and 2018.

Overview
We are a holding company and are engaged principally in two business segments:
Tobacco: the manufacture and sale of cigarettes in the United States through our Liggett Group LLC (“Liggett”) and Vector Tobacco Inc. (“Vector Tobacco”) subsidiaries, and
Real Estate: the real estate business through our New Valley LLC (“New Valley”) subsidiary, which owns Douglas Elliman Realty, LLC (“Douglas Elliman”) and is seeking to acquire or invest in additional real estate properties or projects. Douglas Elliman operates the largest residential brokerage company in the New York metropolitan area and also conducts residential real estate brokerage operations in South Florida, Southern California, Connecticut, Massachusetts and Aspen, Colorado. On December 31, 2018, New Valley increased its ownership of Douglas Elliman from 70.59% to 100%.
    

Recent Developments

Maturity of 7.5% Variable Interest Senior Convertible Notes due 2019. In January 2019, we paid $230,000 of principal and $8,102 of accrued interest as full payment of our 7.5% Convertible Notes that matured on January 15, 2019.

    
Recent Developments in Litigation

Mississippi Dispute. In January 2016, the Attorney General for Mississippi filed a motion in state Chancery Court in Jackson County, Mississippi to enforce the March 1996 settlement agreement alleging that Liggett owes Mississippi at least $27,000 in damages (including interest), and $20,000 in punitive damages and attorneys’ fees. In April 2017, the Chancery Court ruled that the settlement agreement should be enforced and referred the matter to a Special Master for further proceedings to determine the amount of damages, if any, to be awarded. In May 2017, Liggett filed a Petition for Interlocutory Appeal to the Mississippi Supreme Court, which was denied. Liggett filed a demand for arbitration regarding two specific issues and moved in Chancery Court to compel arbitration and stay the proceedings pending before the Special Master.  In June 2018, the Chancery Court granted Liggett’s motion to compel arbitration and stayed the proceedings before the Special Master pending completion of the arbitration. On March 21, 2019, the arbitration panel issued its decision as to the two specific issues before it: (i) the panel ruled in favor of Liggett on the first issue, finding that $294,000 of proceeds from Eve Holdings’ 1999 brand sale should not be included in Liggett’s pre-tax income, which would reduce the amount of compensatory damages, if any, that would be due to Mississippi; and (ii) ruled in favor of Mississippi on the second issue, finding that compensatory damages to Mississippi, if any, would be based on 0.5% of Liggett’s annual pre-tax income for the term of the settlement agreement.  The matter will now proceed to the next phase of the proceeding before the designated Special Master to address damages, if any.  Liggett continues to assert that the April 2017 Chancery Court order is in error because the most favored nations provision in the settlement agreement eliminated all of Liggett’s

53



payment obligations to Mississippi, and Liggett intends to appeal that order, as may be necessary, after the Special Master phase of the case concluded.

Critical Accounting Policies

There are no material changes except for the item listed below from the critical accounting policies set forth in Item 7, “Management's Discussion and Analysis of Financial Condition and Results of Operations,” of our Annual Report on Form 10-K, for the year ended December 31, 2018. Please refer to that section and the information below for disclosures regarding the critical accounting policies related to our business.

Leasing Standard. On January 1, 2019, we adopted ASU No. 2016-02- Leases (Topic 842), therefore, our lease accounting policy has been modified as discussed in Note 3 to our condensed consolidated financial statements.


Results of Operations

The following discussion provides an assessment of our results of operations, capital resources and liquidity and should be read in conjunction with our condensed consolidated financial statements included elsewhere in this report. The condensed consolidated financial statements include the accounts of Liggett, Vector Tobacco, Liggett Vector Brands, New Valley and other less significant subsidiaries.

For purposes of this discussion and other consolidated financial reporting, our business segments for the three months ended March 31, 2019 and 2018 were Tobacco and Real Estate. The Tobacco segment consisted of the manufacture and sale of cigarettes. The Real Estate segment included our investment in New Valley, which includes Douglas Elliman, Escena, Sagaponack and investments in real estate ventures.

 
Three Months Ended
 
 
March 31,
 
 
2019
 
2018
 
Revenues:
 
 
 
 
Tobacco
$
256,756

 
$
267,116

 
Real estate
164,168

 
161,850

 
Total revenues
$
420,924

 
$
428,966

 
Operating income (loss):
 
 
 
 
Tobacco
$
60,144

 
$
63,411

(1) 
Real estate
(10,409
)
 
(8,760
)
(2) 
Corporate and Other
(7,145
)
 
(6,567
)
 
Total operating income
$
42,590

 
$
48,084

 
____________________

(1)  
Operating income includes $3,490 of income from a settlement of a long-standing dispute related to the Master Settlement Agreement.
(2)  
Operating income includes $2,469 of litigation settlement and judgment income.


Three Months Ended March 31, 2019 Compared to Three Months Ended March 31, 2018
Revenues. Total revenues were $420,924 for the three months ended March 31, 2019 compared to $428,966 for the three months ended March 31, 2018. The $8,042 (1.9%) decline in revenues was primarily due to a $10,360 decline in Tobacco revenues, which was primarily related to decreased unit sales volume offset by $2,318 increase in Real Estate revenues, which was primarily related to an increase in Douglas Elliman’s brokerage revenues.
Cost of sales. Total cost of sales was $286,020 for the three months ended March 31, 2019 compared to $294,275 for the three months ended March 31, 2018. The $8,255 (2.8%) decline in cost of sales was primarily due to a $7,659 decline in Tobacco cost of sales primarily related to lower sales volume. This was offset by a $596 decline in Real Estate cost of sales, which was primarily related to Douglas Elliman’s agent commissions.

54



Expenses. Operating, selling, general and administrative expenses were $92,314 for the three months ended March 31, 2019 compared to $89,076 for the same period last year. The $3,238 (3.6%) increase was due to a $2,094 increase in Real Estate operating, selling, general and administrative expenses primarily at Douglas Elliman, a $566 increase in Tobacco operating, selling, general and administrative expenses and a $578 increase in Corporate and Other expense.
Operating income. Operating income was $42,590 for the three months ended March 31, 2019 compared to $48,084 for the same period last year, a decline of $5,494 (11.4%). Real Estate operating income declined by $1,649 primarily related to Douglas Elliman’s operations, while Tobacco operating income declined by $3,267 and Corporate and Other operating loss increased by $578.
Other income (expenses). Other expenses were $20,808 and $42,472 for the three months ended March 31, 2019 and 2018, respectively. For the three months ended March 31, 2019, other expenses primarily consisted of interest expense of $37,520, equity in losses from real estate ventures of $2,439. This was offset by income of $10,349 from changes in fair value of derivatives embedded within convertible debt, equity in earnings from investments of $1,362, net gains recognized on investment securities of $4,773, and other income of $2,667. For the three months ended March 31, 2018, other expenses primarily consisted of interest expense of $45,947, net losses recognized on investment securities of $3,340, and equity in losses from real estate ventures of $6,560. This was offset by income of $10,567 from changes in fair value of derivatives embedded within convertible debt, equity in earnings from investments of $1,162, and other income of $1,646.
The value of the embedded derivatives is contingent on changes in interest rates of debt instruments maturing over the duration of the convertible debt, our stock price as well as projections of future cash and stock dividends over the term of the debt. The interest rate component of the value of the embedded derivative is computed by calculating an equivalent non-convertible, unsecured and subordinated borrowing cost. This rate is determined by calculating the implied rate on each of the two series of our Convertible Notes after removing the embedded option value within the convertible security. This rate is based upon market observable inputs and influenced by our stock price, convertible bond trading price, risk-free interest rates and stock volatility. We recognized benefits from reductions in the value of embedded derivatives of $10,349 and $10,567 for the years ended March 31, 2019 and 2018, respectively.
Income before provision for income taxes. Income before income taxes was $21,782 and $5,612 for the three months ended March 31, 2019 and 2018, respectively.
Income tax expense. Income tax expense was $6,749 for the three months ended March 31, 2019 compared to income tax expense of $1,948 for the three months ended March 31, 2018. Our provision for income taxes in interim periods is based on expected income, statutory rates, permanent differences, valuation allowances against deferred tax assets, and any tax planning opportunities available to us. For interim financial reporting, we estimate the annual effective income tax rate based on full year projections and apply the annual effective income tax rate against year-to-date pretax income (loss) to record income tax expense, adjusted for discrete items, if any. We refine annual estimates as new information becomes available. Our effective tax rates for the three months ended March 31, 2019 and 2018 were impacted by non-deductibility of interest expense and non-deductible compensation. Our income tax expense for the three months ended March 31, 2019 is lower than the income tax expense for the three months ended March 31, 2018 due to tax planning opportunities available within the Tax Cuts and Jobs Act (“The Tax Act”). The tax planning opportunities relate to our conclusion from guidance issued in the fourth quarter of 2018 that we will be able to allocate some of our interest expense to our real estate business and the deduction of this interest expense will not be limited. (The Tax Act generally limits a corporation’s interest expense deduction to 30% of taxable income before interest, depreciation and amortization from 2018 to 2021 and then taxable income before interest thereafter for non-excepted trade or businesses. However, one such excepted trade or business is any electing real property trade or business, which portions of our real estate segment may qualify. Interest expense allocable to an excepted trade or business is not subject to limitation.) The Tax Act also permits us to carry forward disallowed interest expense indefinitely. Even after the allocation of some of our interest expense to the real estate segment, we expect a portion of our interest expense in 2019 and future years to be disallowed as a tax deduction and, based on current projections, we do not expect any of this disallowed interest expense to be tax deductible in the future. Consequently, as part of our annual effective tax rate, we have established an interest expense carryforward deferred tax asset and corresponding valuation allowance for any disallowed interest expense in 2019. Additionally, for the three months ended March 31, 2019 our annual effective tax rate includes nondeductible executive compensation due to guidance issued in August 2018. We continue to analyze the impact of the nondeductible items on our operations and capital structure. For the three months ended March 31, 2019, our income tax expense was also lower than our estimated annual effective rate by $114 primarily due to an income tax deduction for stock-based compensation.
Tobacco.
Tobacco revenues. Liggett increased the list price of EAGLE 20’s by $1.10 per carton in February 2019 and $1.00 per carton in September 2018. Liggett also increased the list price of PYRAMID, LIGGETT SELECT, EVE and GRAND PRIX by $1.10 per carton in February 2019, $1.00 per carton in September 2018, and $0.90 per carton in March 2018.

55



All of our Tobacco sales were in the discount category in 2019 and 2018. For the three months ended March 31, 2019, Tobacco revenues were $256,756 compared to $267,116 for the three months ended March 31, 2018. Revenues declined by $10,360 (3.9%) due primarily to a 7.1% (158.6 million units) decline in unit sales volume. We believe our unit volume for the three months ended March 31, 2018 was increased as a result of wholesalers purchasing product in anticipation of the March 2018 price increase. Because the 2019 price increase occurred in February 2019 instead of March 2019, we believe such incremental wholesaler purchasing activity was lower in the three months ended March 31, 2019 compared to the three months ended March 31, 2018. We believe the absence of this incremental buying by wholesalers was a significant contributor to the decline from the 2018 first quarter to the comparable 2019 period.
Tobacco cost of sales. The major components of our Tobacco cost of sales were as follows:
 
 
 
 
Three Months Ended
 
 
 
 
 
March 31,
 
 
 
 
 
2019
 
2018
 
 
 
 
 
 
 
Manufacturing overhead, raw materials and labor
 
$
28,475

 
$
30,552

 
Customer shipping and handling
 
 
1,492

 
1,352

 
Federal Excise Taxes, net
 
 
104,633

 
112,801

 
FDA expense
 
 
6,345

 
5,605

 
MSA expense, net of market share exemption
 
 
36,358

 
34,652

(1) 
 
Total cost of sales
 
 
$
177,303

 
$
184,962

 
(1) Includes $3,490 reduction in expense from a settlement of a long-standing dispute related to the Master Settlement Agreement.

The Tobacco segment’s MSA expense is included in cost of sales. Under the terms of the MSA, we have no payment obligations except to the extent that our tobacco subsidiaries’ market share of the U.S. Cigarette market exceeds 1.92%. The calculation of our benefit from the MSA is an estimate based on U.S. domestic taxable cigarette shipments. As of March 31, 2019, we estimate taxable shipments in the U.S. will decline by 5% in 2019. Our annual MSA liability changes by approximately $1,700 for each percentage change in estimated shipment volumes in the U.S. market. For the three months ended March 31, 2019, the estimated decline in taxable shipments in excess of the annual MSA inflation adjustment resulted in an increase in cost of sales of $1,100 because the value of Liggett’s market share exemption declined compared to the three months ended March 31, 2018.
Tobacco gross profit was $79,453 for the three months ended March 31, 2019 compared to $82,154 for the three months ended March 31, 2018, a decline of $2,701. Tobacco gross profit for the three months ended March 31, 2018 included a $3,490 reduction in cost of sales from a settlement of a long-standing dispute related to the Master Settlement Agreement. This was offset by an increase in gross profit for the three months ended March 31, 2019 of $789, primarily attributable to increased pricing associated with the EAGLE 20’s brand. After careful market analysis and based on our successful results, in September 2018, we began the process of shifting focus from volume to income growth by increasing pricing on EAGLE 20’s and PYRAMID, as well as other brands, in connection with industry-wide price increases. As a percentage of revenue (excluding Federal Excise Taxes), Tobacco gross profit decreased from 53.2% in the 2018 period to 52.2% in the 2019 period. The decrease is the result of the impact of the 2018 MSA settlement offset by increased EAGLE 20’s pricing as discussed above.
The unfavorable sales volume growth was primarily due to a decline in unit volumes of all brands except EAGLE 20’s. Despite the price increases on EAGLE 20’s in September 2018 and March 2019, EAGLE 20’s unit sales volumes increased by 6.8% for the three months ended March 31, 2019 compared to the three months ended March 31, 2018 as a result of momentum from Liggett’s strategy to invest promotional expenses in the brand, which are included as a reduction of revenues. EAGLE 20’s percentage of Liggett’s total unit sales increased from approximately 50% in the three months ended March 31, 2018 to approximately 57% for the three months ended March 31, 2019.
Tobacco expenses. Tobacco operating, selling, general and administrative expenses, excluding settlements and judgments, were $19,309 for the three months ended March 31, 2019 compared to $18,743 for the three months ended March 31, 2018. Tobacco product liability legal expenses, including settlements and judgments, were $1,463 and $1,508 for the three months ended March 31, 2019 and 2018, respectively.

56



Tobacco operating income. Tobacco operating income was $60,144 for the three months ended March 31, 2019 compared to $63,411 for the same period last year. Tobacco operating income for the three months ended March 31, 2018 included a $3,490 reduction in cost of sales from a settlement of a long-standing dispute related to the Master Settlement Agreement. This was offset by an increase in operating income for the three months ended March 31, 2019 of $223 primarily attributable to increased EAGLE 20’s pricing, as discussed above, partially offset by increased operating, selling, general and administrative expenses.
Real Estate.
Real Estate revenues. Real Estate revenues were $164,168 and $161,850 for the three months ended March 31, 2019 and 2018, respectively. Real Estate revenues increased by $2,318 (1.4%), which was primarily related to an increase of $2,197 in Douglas Elliman’s commission and other brokerage income. The increase in commission and other brokerage income was primarily related to increased commission and other brokerage income from Douglas Elliman’s developing marketing and existing-home sales in New York City. This amount was partially offset by declines in existing-home sales in Douglas Elliman’s West market (Los Angeles and Aspen), Northeast market and in its Southeast market, which consists entirely of South Florida.
Real Estate revenues and cost of sales for the three months ended March 31, 2019 and 2018, respectively, were as follows:
 
Three Months Ended
 
March 31,
 
2019
 
2018
Real Estate Revenues:
 
 
 
Commission and other brokerage income
$
152,313

 
$
150,116

Property management revenue
8,351

 
8,338

Title fees
1,233

 
989

Sales on facilities primarily from Escena
2,271

 
2,407

  Total real estate revenues
$
164,168

 
$
161,850

 
 
 
 
Real Estate Cost of Sales:
 
 
 
Real estate agent commissions
$
107,350

 
$
108,026

Cost of sales on facilities primarily from Escena
1,087

 
1,092

Title fees
280

 
195

  Total real estate cost of sales
$
108,717

 
$
109,313

Brokerage cost of sales. Douglas Elliman real estate agent commissions declined by $676 as a result of changes in the sales mix between markets with varying agent commission percentages.
Douglas Elliman’s gross margin on real estate brokerage income increased from 28.0% for the three months ended March 31, 2018 to 29.5% for the three months ended March 31, 2019 primarily as a result of an increase in commission income generated from its development marketing division and existing-home sales in New City market, which traditionally earn higher gross margins.
Real Estate expenses. Real Estate operating, selling, general and administrative expenses, excluding settlements and judgments, were $65,860 and $63,766 for the three months ended March 31, 2019 and 2018, respectively. The increased expenses were associated with increased expenses in Douglas Elliman’s brokerage administrative expenses.
Real Estate operating (loss) income. The Real Estate segment had operating loss of $10,409 for the three months ended March 31, 2019 and operating loss of $8,760 for the three months ended March 31, 2018, an increase of $1,649. Real Estate operating loss for the three months ended March 31, 2018 included $2,469 litigation settlement and judgment income. The remaining difference of $820 was the result of the increase in Douglas Elliman’s gross profit offset by the increase in operating, selling, general and administrative expenses.
Corporate and Other.
Corporate and Other loss. The operating loss at the Corporate and Other segment was $7,145 for the three months ended March 31, 2019 compared to $6,567 for the same period in 2018.

57



Summary of Real Estate Investments
We own and seek to acquire investment interests in various domestic and international real estate projects through debt and equity investments. Our real estate investments primarily include the following projects as of March 31, 2019:
 
(Dollars in Thousands. Area and Unit Information in Ones)
 
Location
Date of Initial Investment
Percentage Owned (1)
Net Cash Invested (Returned)
Cumulative Earnings (Losses)
Carrying Value as of March 31, 2019
Future Capital Commit-
ments from New Valley (2)
Projected Residential and/or Hotel Area
Projected Commercial Space
Projected Number of Residential Lots, Units and/or Hotel Rooms
Actual/Projected Construction Start Date
Projected Construction End Date
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sagaponack
Sagaponack, NY
April 2015
100
%
$
16,691

$

$
16,691

$

TBD

 
N/A

 
1

R
N/A
N/A
Escena, net
Master planned community, golf course, restaurant and shop in Palm Springs, CA
March 2008
100
%
2,450

7,636

10,086


450

Acres

 
667
450

R Lots
H
N/A
N/A
Investments in real estate, net
 
 
 
$
19,141

$
7,636

$
26,777

$

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments in real estate ventures:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10 Madison Square West (1107 Broadway)
Flatiron District/NoMad neighborhood, Manhattan, NY
October 2011
5.0
%
$
(43,671
)
$
43,671

$

$

260,000

SF
20,000

SF
124

R
August 2012
Completed
The Marquand (11 East 68th Street)
Upper East Side, Manhattan, NY
December 2011
18.0
%
(2,355
)
3,007

652


90,000

SF

 
29

R
June 2012
Completed
11 Beach Street
TriBeCa, Manhattan, NY
June 2012
49.5
%
4,790

9,043

13,833


97,000

SF

 
27

R
May 2014
Completed
20 Times Square (701 Seventh Avenue)
Times Square, Manhattan, NY
August 2012
7.9
%
(7,827
)
8,484

657


252,000

SF
80,000

SF
452

H
September 2013
Completed
111 Murray Street
TriBeCa, Manhattan, NY
May 2013
9.5
%
4,448

(701
)
3,747


330,000

SF
1,700

SF
157

R
September 2014
June 2019
160 Leroy Street (3)
West Greenwich Village, Manhattan, NY
March 2013
3.1
%
(626
)
1,602

976


130,000

SF

 
57

R
Fall 2015
Completed
The Dutch (25-19 43rd Avenue)
Long Island City, NY
May 2014
9.9
%
(799
)
1,399

600

 
65,000

SF

 
86

R
September 2014
Completed
87 Park (8701 Collins Avenue)
Miami Beach, FL
December 2013
15.0
%
19,630

4,337

23,967


160,000

SF
TBD

 
70

R
October 2015
December 2019
125 Greenwich Street (3)
Financial District, Manhattan, NY
August 2014
13.4
%
7,992

(7,992
)


306,000

SF
16,000

SF
273

R
March 2015
February 2020
West Hollywood Edition (9040 Sunset Boulevard)
West Hollywood, CA
October 2014
48.5
%
(1,552
)
(197
)
(1,749
)

210,000

SF

 
20
190

R
H
May 2015
June 2019
The XI (76 Eleventh Avenue)
West Chelsea, Manhattan, NY
May 2015
5.1
%
17,000

6,935

23,935


630,000

SF
85,000

SF
236
137

R
H
September 2016
June 2020
Monad Terrace
Miami Beach, FL
May 2015
18.2
%
7,635

2,005

9,640


160,000

SF

 
59

R
May 2016
December 2020
Takanasee (805 Ocean Ave)
Long Branch, NJ
December 2015
22.8
%
5,921

2,109

8,030


63,000

SF

 
13

R
June 2017
TBD
15 East 19th St
Brooklyn, NY
April 2017
9.8
%
402

92

494


24,000

SF

 
33

R
August 2017
July 2019
Dime (209 Havemeyer St)
Brooklyn, NY
November 2017
19.8
%
8,650

1,490

10,140


100,000

SF
150,000

SF
177

R
May 2017
December 2019
352 6th Avenue
Brooklyn, NY
February 2019
37.0
%
500

6

506


5,200

SF

 
4

R
September 2019
September 2020
Condominium and Mixed Use Development
 
 
 
$
20,138

$
75,290

$
95,428

$

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Maryland Portfolio
Primarily Baltimore County, MD
July 2012
7.6
%
$
774

$
(774
)
$

$

N/A

 
N/A

 
5,517

R
N/A
N/A
ST Portfolio

November 2013
16.3
%
(1,669
)
1,669



N/A


N/A


N/A


N/A
N/A
Apartment Buildings
 
 
 
$
(895
)
$
895

$

$

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Park Lane Hotel (36 Central Park South)
Central Park South, Manhattan, NY
November 2013
5.2
%
$
29,470

$
(15,008
)
$
14,462

$

446,000

SF

 
628

H
N/A
N/A
215 Chrystie Street
Lower East Side, Manhattan, NY
December 2012
18.4
%
(4,551
)
4,551



246,000

SF

 
367

H
June 2014
Completed
Coral Beach and Tennis Club
Coral Beach, Bermuda
December 2013
49.0
%
6,048

(4,200
)
1,848


52

Acres

 
101

H
N/A
N/A
Hotels
 
 
 
$
30,967

$
(14,657
)
$
16,310

$

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The Plaza at Harmon Meadow (700 Plaza Drive)
Secaucus, NJ
March 2015
49.0
%
$
4,810

$
(3,071
)
$
1,739

$


219,000

SF

N/A
N /A
Wynn Las Vegas Retail (3131 Las Vegas Blvd South)
Las Vegas, NV
December 2016
1.6
%
5,042

2,303

7,345



160,000

SF

N/A
N/A
Commercial
 
 
 
$
9,852

$
(768
)
$
9,084

$

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Witkoff GP Partners (4)
Multiple
March 2017
15.0
%
$
14,142

$
(784
)
$
13,358

$
5,768

N/A

 
N/A

 
N/A

 
N/A
N/A
1 QPS Tower (23-10 Queens Plaza South)
Long Island City, NY
December 2012
45.4
%
(11,882
)
13,666

1,784


N/A

 
N/A

 
N/A

 
March 2014
Completed
Witkoff EB-5 Capital Partners
Multiple
September 2018
49
%
(387
)
758

371

9,010

N/A

 
N/A

 
N/A

 
N/A
N/A
Diverse Real Estate Portfolio
 
 
 
$
1,873

$
13,640

$
15,513

$
14,778

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments in real estate ventures
 
 
 
$
61,935

$
74,400

$
136,335

$
14,778



 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total Carrying Value
 
 
 
$
81,076

$
82,036

$
163,112

 
 
 
 
 
 
 
 
 
(1) The Percentage Owned reflects our estimated current ownership percentage. Our actual ownership percentage as well as the percentage of earnings and cash distributions may ultimately differ as a result of a number of factors including potential dilution, financing or admission of additional partners.
(2) This column only represents capital commitments required under the various joint venture agreements. However, many of the operating agreements provide for the operating partner to call capital. If a joint venture partner, such as New Valley, declines to fund the capital call, then the partner’s ownership percentage could either be diluted or, in some situations, the character of a funding member’s contribution would be converted from a capital contribution to a member loan.
(3) Carrying value as of March 31, 2019, includes non-controlling interest of $488 and $0 respectively.
(4) The Witkoff GP Partners venture consisted of a $1,859 investment in 500 Broadway, a $7,308 investment in Fontainebleau Las Vegas, $466 investment in 1568 Broadway debt, and a $3,725 investment in 701 7th debt.
N/A - Not applicable
SF - Square feet
H - Hotel rooms
 
 
 
 
 
 
 
 
 
 
 
TBD -To be determined
R - Residential Units
R Lots - Residential lots
 
 
 
 
 
 
 
 
 
 
 
    

58



Other investments in real estate ventures relate to an investment in an insurance consulting company by Douglas Elliman with a carrying value of $2,058 as of March 31, 2019. New Valley capitalizes net interest expense into the carrying value of its ventures whose projects were under development. Net capitalized interest costs included in Carrying Value as of March 31, 2019 were $24,716. This amount is included in the “Cumulative Earnings (Losses)” column in the table above. During the three months ended March 31, 2019, New Valley capitalized $1,315 of interest costs and utilized (reversed) $930 of previously capitalized interest in connection with the recognition of equity in earnings, gains and liquidations from various ventures.

59



Liquidity and Capital Resources

Cash, cash equivalents and restricted cash decreased by $270,918 and $21,634 for the three months ended March 31, 2019 and 2018, respectively.
Cash provided from operations was $19,726 and $40,714 for the three months ended March 31, 2019 and 2018, respectively. The decline primarily related to increases in inventory and accounts receivable balances in the tobacco segment in the 2019 period compared to the 2018 period, lower distributions from real estate ventures in the 2019 period as well as a decline in operating income in the real estate segment in the 2019 period.
Cash used in investing activities was $6,414 for the three months ended March 31, 2019 and cash provided by investing activities was $1,887 for the three months ended March 31, 2018. In the first three months of 2019, cash used in investing activities was for the purchase of investment securities of $20,623, investments in real estate ventures of $871, capital expenditures of $3,825, investments in real estate, net of $641, an increase in cash surrender value of corporate-owned life insurance policies of $238, acquisition of a business of $668, and increase in restricted assets of $7. This was offset by the sale of investment securities of $7,759, pay downs of investment securities of $258, maturities of investment securities of $11,308, and distributions from investments in real estate ventures of $1,134. In the first three months of 2018, cash provided by investing activities was from the sale of investment securities of $2,357, pay downs of investment securities of $446, the maturities of investment securities of $8,112, distributions from investments in real estate ventures of $219, and repayments of notes receivable of $32. This was offset by the purchase of investment securities of $4,364, investments in real estate ventures of $533, capital expenditures of $3,987, investments in real estate, net of $355, an increase in cash surrender value of corporate-owned life insurance policies of $36, and an increase in restricted assets of $4.
Cash used in financing activities was $284,230 and $64,235 for the three months ended March 31, 2019 and 2018, respectively. In the first three months of 2019, cash was used for the dividends and distributions on common stock of $60,459, repayments of debt of $230,466, distributions to non-controlling interest of $285, offset by net borrowings of debt under the revolver of $6,980. In the first three months of 2018, cash was used for the dividends and distributions on common stock of $57,187, repayments of debt of $490, and net repayments of debt under the revolver of $6,558.
For the years ended December 31, 2018, 2017 and 2016, cash payments of dividends and distributions on common stock exceeded cash from operations by $43,533, $79,902 and $101,311, respectively. The terms of our 10.5% Senior Notes due 2026 contain covenants that place significant limitations on our ability to pay dividends and distributions in the future. See “10.5% Senior Notes due 2026” below. For the next twelve months beginning March 31, 2019, we have significant liquidity commitments at the corporate level (not including our tobacco and real estate operations) that require the use of existing cash resources. These include repayment of the $232,000 of principal outstanding on our convertible notes due April 2020 (assuming they do not convert into shares of our common stock) and cash interest expense of approximately $110,400, which includes $34,125 from our 10.5% Senior Notes due 2026 that were issued in November 2018, dividends on our outstanding common shares of approximately $241,100, which is based on a historical quarterly cash dividend of $0.40 per share, and other corporate expenses and taxes.
In order to meet these liquidity requirements as well as other liquidity needs in the normal course of business, we have in the past used cash flows from operations as well as existing cash and cash equivalents, which have, in the past, been generated from operations, monetization of investments and proceeds from debt issuances. Should these resources be insufficient to meet upcoming liquidity needs, we may also liquidate investment securities and other long-term investments, or, if available, draw on Liggett’s credit facility. While there are actions we can take to reduce our liquidity needs, there can be no assurance that such measures will be successful. As of March 31, 2019, we had cash and cash equivalents of $312,638 (including $59,445 of cash at Douglas Elliman and $47,667 of cash at Liggett), investment securities, which were carried at $134,652 (see Note 5 to condensed consolidated financial statements), and long-term investments, which were carried at $66,768 (and, based on market prices as of March 31, 2019, had a fair value of $120,598, including in-transit redemptions (see Note 6 to condensed consolidated financial statements)). As of March 31, 2019, our investments in real estate ventures were carried at $138,393 and our investments in real estate, net were carried at $26,777.

60



Corporate Impact of the Tax Act. The Tax Act limits our interest expense deduction to 30% of taxable income before interest, depreciation and amortization from 2018 to 2021 and then taxable income before interest thereafter for non-excepted trade or businesses. One such excepted trade or business is any electing real property trade or business, which portions of our real estate segment may qualify. Interest expense allocable to an excepted trade or business is not subject to limitation. The Tax Act permits us to carry forward disallowed interest expense indefinitely. Due to our high degree of leverage, a portion of our interest expense in future years may not be deductible, which would increase the after-tax cost of any new debt financings as well as the refinancing of our existing debt. We expect a portion of our interest expense in 2019 and future years to be disallowed as a tax deduction and, based on current projections, we do not expect any of this disallowed interest expense to be tax deductible in the future. Consequently, as part of our annual effective tax rate, we have established an interest expense carryforward deferred tax asset and corresponding valuation allowance for any disallowed interest expense in 2019. We continue to analyze the impact of the nondeductible interest on our operations and capital structure.
Tobacco Litigation. As of March 31, 2019, verdicts have been entered in 16 Engle progeny cases against Liggett. Liggett has paid $39,773, including interest and attorney’s fees, to satisfy the judgments entered against it. It is possible that additional cases could be decided unfavorably.
Notwithstanding the comprehensive nature of the Engle Progeny Settlements, approximately 70 plaintiffs’ claims remain outstanding. Therefore, we and Liggett may still be subject to periodic adverse judgments which could have a material adverse effect on our consolidated financial position, results of operations and cash flows.
Management cannot predict the cash requirements related to any future settlements or judgments, including cash required to bond any appeals, and there is a risk that those requirements will not be able to be met. Management is unable to make a reasonable estimate of the amount or range of loss that could result from an unfavorable outcome of the cases pending against Liggett or the costs of defending such cases. It is possible that our consolidated financial position, results of operations or cash flows could be materially adversely affected by an unfavorable outcome in any such tobacco-related litigation.
Vector.
6.125% Senior Secured Notes due 2025. In January 2017, we issued $850,000 of our 6.125% Senior Secured Notes due 2025 (“6.125% Senior Secured Notes”). The indenture governing our 6.125% Senior Secured Notes (the “2025 Indenture”) contains covenants that restrict the payment of dividends if our consolidated earnings before interest, taxes, depreciation and amortization (“Consolidated EBITDA”), as defined in the 2025 Indenture, for the most recently ended four full quarters is less than $75,000. The 2025 Indenture also restricts the incurrence of debt if our Leverage Ratio and our Secured Leverage Ratio, as defined in the 2025 Indenture, exceed 3.0 and 1.5, respectively. Our Leverage Ratio is defined in the 2025 Indenture as the ratio of our guaranteeing subsidiaries’ total debt less the fair market value of our cash, investment securities and long-term investments to Consolidated EBITDA, as defined in the 2025 Indenture. Our Secured Leverage Ratio is defined in the 2025 Indenture in the same manner as the Leverage Ratio, except that secured indebtedness is substituted for indebtedness. The following table summarizes the requirements of these financial covenants and the results of the calculation, as defined in the 2025 Indenture.
 
 
Indenture
 
March 31,
2019
Covenant
 
Requirement
 
Consolidated EBITDA, as defined
 
$75,000
 
$325,651
Leverage ratio, as defined
 
<3.0 to 1
 
2.72 to 1
Secured leverage ratio, as defined
 
<1.5 to 1
 
1.12 to 1

As of March 31, 2019 and December 31, 2018, we were in compliance with all debt covenants related to the 2025 Indenture.

10.5% Senior Notes due 2026. On November 2, 2018, we issued $325,000 of our 10.5% Senior Notes due 2026. The aggregate net proceeds from the sale of the 10.5% Senior Notes were approximately $315,000 after deducting underwriting discounts, commissions, fees and offering expenses. We used some of the net cash proceeds from the issuance of our 10.5% Senior Notes to retire, the principal amount, plus accrued and unpaid interest on our outstanding 7.5% Variable Interest Senior Convertible Notes in January 2019, and may use the remaining proceeds for general corporate purposes (including to redeem, repurchase, repay or otherwise retire the principal amount, plus accrued and unpaid interest on our outstanding 5.5% Variable Interest Senior Convertible Notes due 2020, at, or prior to, their maturity).
The 10.5% Senior Notes bear interest at a rate of 10.5% per year, payable semi-annually on May 1 and November 1 of each year, beginning on May 1, 2019, and mature on November 1, 2026. Interest will accrue from November 2, 2018. We may redeem some or all of the 10.5% Senior Notes at any time prior to November 1, 2021 at a make-whole redemption price. On or after November 1, 2021, we may redeem some or all of the 10.5% Senior Notes at redemption prices set forth in the indenture, plus accrued and unpaid interest, if any, to the redemption date. In addition, any time prior to November 1, 2021, we may redeem up to 40% of the aggregate outstanding amount of the 10.5% Senior Notes with the net proceeds of certain equity offerings at 110.5%

61



of the aggregate principal amount of the 10.5% Senior Notes, plus accrued and unpaid interest, if any, to the redemption date, if at least 60% of the aggregate principal amount of the 10.5% Senior Notes originally issued remains outstanding after such redemption, and the redemption occurs within 90 days of the closing of such equity offering. In the event of a change of control, as defined in the indenture, each holder of the 10.5% Senior Notes will have the right to require us to make an offer to repurchase some or all of our 10.5% Senior Notes at a repurchase price equal to 101% of the aggregate principal amount of the 10.5% Senior Notes plus accrued and unpaid interest to the date of purchase. If we sell certain assets and does not apply the proceeds as required pursuant to the indenture, we must offer to repurchase the 10.5% Senior Notes at the prices listed in the indenture.
The 10.5% Senior Notes are guaranteed subject to certain customary automatic release provisions on a joint and several basis by all of our wholly-owned domestic subsidiaries that are engaged in the conduct of our cigarette businesses, and by DER Holdings LLC, through which we indirectly own a 100% interest in Douglas Elliman as of December 31, 2018. DER Holdings LLC does not guarantee our 6.125% Senior Secured Notes.
The indenture governing our 10.5% Senior Notes due 2026 (the “2026 Indenture”) restricts our ability to pay dividends and make certain other distributions subject to certain exceptions, including exceptions for (1) dividends and other distributions in an amount up to 50% of our consolidated net income, plus certain specified proceeds received us, if no event of default has occurred, and we are in compliance with a Fixed Charge Coverage Ratio (as defined in the 2026 Indenture) of at least 2.0x, and (2) dividends and other distributions in an unlimited amount, if no event of default has occurred and we are in compliance with a Net Leverage Ratio (as defined in the 2026 Indenture) no greater than 4.0x. As a result, absent an event of default, we can pay dividends if the Net Leverage ratio is below 4.0x, regardless of the value of the Fixed Charge Coverage Ratio at the time. The 2026 Indenture also restricts our ability to incur debt if our Fixed Charge Coverage Ratio is less than 2.0x, and restricts our ability to secure debt other than secured debt incurred pursuant to a Secured Leverage Ratio no greater than 3.75x, unless the 10.5% Senior Notes are secured on an equal and ratable basis. In addition, the 2026 Indenture restricts our ability to spin-off or transfer New Valley and its subsidiaries as a whole, or DER Holdings LLC and its subsidiaries (including Douglas Elliman) as a whole, unless (1) such spin-off or transfer complies with the covenants restricting mergers and asset sales, or (2) our Net Leverage Ratio is no greater than 4.0x. Our Fixed Charge Coverage Ratio is defined in the 2026 Indenture as the ratio of our Consolidated EBITDA to our Fixed Charges (each as defined in the 2026 Indenture). Our Net Leverage Ratio is defined in the 2026 Indenture as the ratio of our and our guaranteeing subsidiaries’ total debt less our cash, cash equivalents, and the fair market value of our investment securities, long-term investments, investments in real estate, net, and investments in real estate ventures, to Consolidated EBITDA, as defined in the 2026 Indenture. Our Secured Leverage Ratio is defined in the 2026 Indenture as the ratio of our and our guaranteeing subsidiaries’ total secured debt, to Consolidated EBITDA, as defined in the 2026 Indenture.
Covenant
 
Indenture Requirement
 
March 31,
2019
Consolidated EBITDA, as defined
 
N/A
 
$249,578
Fixed charge coverage ratio, as defined
 
>2.0 to 1
 
2.56 to 1
Net leverage ratio, as defined
 
<4.0 to 1
 
2.77 to 1
Secured leverage ratio, as defined
 
<3.75 to 1
 
0.56 to 1
As of March 31, 2019 and December 31, 2018, we were in compliance with all of the debt covenants governing our 10.5% Senior Notes.
Liggett Credit Facility and Liggett Term Loan Under Credit Facility. As of March 31, 2019, $37,770 was outstanding under the revolving and term loan portions of the credit facility, all of which was classified as current liabilities. Availability as determined under the Credit Facility was $20,488 based on eligible collateral at March 31, 2019. At March 31, 2019, management believed that Liggett was in compliance with all covenants under the credit facility; Liggett’s EBITDA, as defined, were $247,842 for the last twelve months ended March 31, 2019.
Anticipated Liquidity Obligations. We and our subsidiaries have significant indebtedness and debt service obligations. As of March 31, 2019, we and our subsidiaries had total outstanding indebtedness of $1,475,800, of which $232,000 of our 5.5% variable interest senior convertible notes mature in 2020, $850,000 of our 6.125% Senior Secured Notes mature in 2025, and $325,000 of our 10.5% Senior Notes mature in 2026. There is a risk that we will not be able to generate sufficient funds to repay our debt. If we cannot service our fixed charges, it would have a material adverse effect on our business and results of operations.

62



Our 7.5% convertible notes matured on January 15, 2019 and we used the proceeds of the offering of our 10.5% Senior Notes to pay $230,000 of principal and $8,102 of accrued interest on the maturity date. We may utilize the remaining proceeds from the offering of our 10.5% Senior Notes that were not applied to the repayment of our 7.5% convertible notes to repay, repurchase, retire or redeem our 5.5% variable interest senior convertible notes due April 2020 at or prior to the maturity of these convertible notes or for general corporate purposes, including to pursue business opportunities. We will otherwise need to use our liquidity resources to repay the $232,000 of principal outstanding on these notes when they mature in April 2020, either through use of current liquidity on hand or through external financings.
We believe that our cigarette and real estate operations are positive cash-flow-generating units and will continue to be able to sustain their operations without any significant liquidity concerns.
In order to meet the above liquidity requirements as well as other anticipated liquidity needs in the normal course of business, we had cash and cash equivalents of approximately $312,600, investment securities at fair value of approximately $134,700, long-term investments with an estimated value of approximately $120,600, including $3,984 of in-transit redemptions, and availability under Liggett’s credit facility of approximately $20,500 at March 31, 2019. Management currently anticipates that these amounts, as well as expected cash flows from our operations, proceeds from public and/or private debt and equity financing, management fees and other payments from subsidiaries should be sufficient to meet our liquidity needs over the next 12 months. We may acquire or seek to acquire additional operating businesses through merger, purchase of assets, stock acquisition or other means, or to make other investments, which may limit our liquidity otherwise available.
On a quarterly basis, we evaluate our debt securities available for sale and equity securities without readily determinable fair values that do not qualify for the NAV practical expedient to determine whether an impairment has occurred. If so, we also make a determination if such impairment is considered temporary or other-than-temporary. We believe that the assessment of temporary or other-than-temporary impairment is facts-and-circumstances driven. The impairment indicators that are taken into consideration as part of our analysis include (a) a significant deterioration in the earnings performance, credit rating, asset quality, or business prospects of the investee, (b) a significant adverse change in the regulatory, economic, or technological environment of the investee, (c) a significant adverse change in the general market condition of either the geographical area or the industry in which the investee operates, and (d) factors that raise significant concerns about the investee’s ability to continue as a going concern, such as negative cash flows from operations, working capital deficiencies, or noncompliance with statutory capital requirements or debt covenants.

Market Risk
We are exposed to market risks principally from fluctuations in interest rates, foreign currency exchange rates and equity prices. We seek to minimize these risks through our regular operating and financing activities and our long-term investment strategy. Our market risk management procedures cover all market risk sensitive financial instruments.
As of March 31, 2019, approximately $37,800 of our outstanding debt at face value had variable interest rates determined by various interest rate indices, which increases the risk of fluctuating interest rates. Our exposure to market risk includes interest rate fluctuations in connection with our variable rate borrowings, which could adversely affect our cash flows. As of March 31, 2019, we had no interest rate caps or swaps. Based on a hypothetical 100 basis point increase or decrease in interest rates (1%), our annual interest expense could increase or decrease by approximately $378.
In addition, as of March 31, 2019, $207,700 ($232,000 principal amount) of outstanding debt had a variable interest rate determined by the amount of the dividends on our common stock. The difference between the stated value of the debt and carrying value is due principally to certain embedded derivatives, which were separately valued and recorded upon issuance, and debt issuance costs. Changes to the estimated fair value of these embedded derivatives are reflected within our statements of operations as “Change in fair value of derivatives embedded within convertible debt.” The value of the embedded derivative is contingent on changes in interest rates of debt instruments maturing over the duration of the convertible debt as well as projections of future cash and stock dividends over the term of the debt and changes in the closing stock price at the end of each quarterly period. Based on a hypothetical 100 basis point increase or decrease in interest rates (1%), our annual “Change in fair value of derivatives embedded within convertible debt” could increase or decrease by approximately $103 resulting from the embedded derivative associated with our 5.5% variable interest senior convertible debentures due 2020. An increase in our quarterly dividend rate by $0.10 per share would increase interest expense by approximately $5,000 per year.
We have estimated the fair market value of the embedded derivatives based principally on the results of a valuation model. The value of the embedded derivatives is contingent on changes in interest rates of debt instruments maturing over the duration of the convertible debt, our stock price as well as projections of future cash and stock dividends over the term of the debt. The interest rate component of the value of the embedded derivative is computed by calculating an equivalent non-convertible, unsecured and subordinated borrowing cost. This rate is determined by calculating the implied rate on our 5.5% Convertible Notes when removing the embedded option value within the convertible security. This rate is based upon market observable inputs and influenced by our stock price, convertible bond trading price, risk-free interest rates and stock volatility. The range of estimated fair market values of our embedded derivatives was between $21,125 and $21,022. We recorded the fair market value of our embedded

63



derivatives at the approximate midpoint of the range at $21,075 as of March 31, 2019. The estimated fair market value of our embedded derivatives could change significantly based on future market conditions.
We held debt securities available for sale totaling $88,605 as of March 31, 2019. See Note 5 to our condensed consolidated financial statements. Adverse market conditions could have a significant effect on the value of these investments.

Equity Security Price Risk

As of March 31, 2019, we held various investments in equity securities with a total fair value of $100,249, of which $46,047 represents equity securities at fair value and $54,202 represents equity securities that qualify for the NAV practical expedient. The latter securities represent long-term investments in various investment partnerships. These investments are illiquid and their ultimate realization is subject to the performance of the underlying entities. See Note 5 and 6 to our condensed consolidated financial statements, respectively, for more details on equity securities at fair value and equity securities that qualify for the NAV practical expedient. The impact to our condensed consolidated statement of operations related to equity securities fluctuates based on changes in their fair value.
We record changes in the fair value of equity securities in net income. To the extent that we continue to hold equity securities, our operating results may fluctuate significantly. Based on our equity securities held as of March 31, 2019, a hypothetical decrease of 10% in the price of these equity securities would reduce the fair value of the investments and, accordingly, our net income by approximately $10,025.

New Accounting Pronouncements

Refer to Note 1, Summary of Significant Accounting Policies, to our financial statements for further information on New Accounting Pronouncements.

Legislation and Regulation

There are no material changes from the Legislation and Regulation section set forth in Item 7, “Management's Discussion and Analysis of Financial Condition and Results of Operations,” of our Annual Report on Form 10-K for the year ended December 31, 2018, except as follows.  The following paragraph of “Item. 1.  Business--Legislation and Regulation-Advertising and Warnings on Packaging” from our Annual Report on Form 10-K, which is referenced therein, is amended and restated in its entirety:  

In June 2011, FDA issued a final rule that would have modified the required warnings that appear on cigarette packages and in cigarette advertisements. The rule would have required each cigarette package and advertisement to bear one of nine new textual warning statements accompanied by graphic images. The warnings would have had to appear on at least the top 50% of the front and rear panels of cigarette packages and occupy at least 20% of cigarette advertisements. In August 2011, a number of cigarette manufacturers, including Liggett, filed a federal lawsuit against FDA challenging the constitutionality of these new graphic images on First Amendment and other grounds and seeking an injunction staying implementation of the graphic images, and other related labeling requirements. In February 2012, on First Amendment grounds, the court granted the industry’s motion for summary judgment permanently enjoining implementation of FDA’s graphic warnings regulation. This decision was affirmed on appeal and FDA did not seek United States Supreme Court review. FDA instead decided to undertake research to support a new graphic warnings rule. In October 2016, the American Academy of Pediatrics and other public health groups filed a federal lawsuit claiming that the FDA had unlawfully withheld and unreasonably delayed action on the rule. In September 2018, the District Court for the District of Massachusetts issued an order granting summary judgment to the plaintiffs and ordered FDA to provide an expedited schedule for the issuance of the rule. FDA subsequently proposed a new deadline for the final rule of May 2021. The plaintiffs responded by asking the court to order FDA to publish a final rule by January 31, 2020.  In March 2019, the court ordered FDA to issue a proposed rule by August 15, 2019, and a final rule by March 15, 2020.  Should FDA ultimately issue new graphic warnings that are deemed constitutionally valid, the decision provides that such warnings would go into effect 15 months after they are issued (June 15, 2021 based on the court-ordered timeline). We cannot predict how the inclusion of new warnings, if ultimately required by FDA in new rulemaking, would impact product sales or whether it would have a material adverse effect on us.
 

    

64



SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
In addition to historical information, this report contains “forward-looking statements” within the meaning of the federal securities law. Forward-looking statements include information relating to our intent, belief or current expectations, primarily with respect to, but not limited to:
economic outlook,
capital expenditures,
cost reduction,
legislation and regulations,
cash flows,
operating performance,
litigation, and
related industry developments (including trends affecting our business, financial condition and results of operations).
We identify forward-looking statements in this report by using words or phrases such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may be,” “objective,” “plan,” “seek,” “predict,” “project” and “will be” and similar words or phrases or their negatives.
The forward-looking information involves important risks and uncertainties that could cause our actual results, performance or achievements to differ materially from our anticipated results, performance or achievements expressed or implied by the forward-looking statements. Factors that could cause actual results to differ materially from those suggested by the forward-looking statements include, without limitation, the following:
general economic and market conditions and any changes therein, due to acts of war and terrorism or otherwise,
governmental regulations and policies,
effects of industry competition,
impact of business combinations, including acquisitions and divestitures, both internally for us and externally in the tobacco industry,
impact of legislation on our results of operations and product costs, i.e. the impact of federal legislation providing for regulation of tobacco products by FDA,
impact of substantial increases in federal, state and local excise taxes,
uncertainty related to product liability and other tobacco-related litigations including the Engle progeny cases pending in Florida and other individual and class action cases where certain plaintiffs have alleged compensatory and punitive damage amounts ranging into the hundreds of million and even billions of dollars; and,
potential additional payment obligations for us under the MSA and other settlement agreements with the states.

Further information on the risks and uncertainties to our business include the risk factors discussed above in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and under Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2018 filed with the Securities and Exchange Commission.
Although we believe the expectations reflected in these forward-looking statements are based on reasonable assumptions, there is a risk that these expectations will not be attained and that any deviations will be material. The forward-looking statements speak only as of the date they are made.

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The information under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Market Risk” is incorporated herein by reference.

ITEM 4.    CONTROLS AND PROCEDURES

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we have evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered

65



by this report, and, based on their evaluation, our principal executive officer and principal financial officer have concluded that these controls and procedures are effective.

There have not been any changes in our internal control over financial reporting that occurred during the first quarter of 2019 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. We implemented internal controls to ensure we adequately evaluated our contracts and properly assessed the impact of the new accounting standard related to revenue recognition. There were no significant changes to our internal control over financial reporting due to the adoption of the new standard.

66


PART II

OTHER INFORMATION

Item 1.     Legal Proceedings

Reference is made to Note 9, incorporated herein by reference, to our condensed consolidated financial statements included elsewhere in this report which contains a general description of certain legal proceedings to which our company, or its subsidiaries are a party and certain related matters. Reference is also made to Exhibit 99.1 for additional information regarding the pending smoking-related legal proceedings to which Liggett or us is a party. A copy of Exhibit 99.1 will be furnished without charge upon written request to us at our principal executive offices, 4400 Biscayne Boulevard, 10th Floor, Miami, Florida 33137, Attn. Investor Relations.

Item 1A. Risk Factors

There are no material changes from the risk factors set forth in Item 1A, “Risk Factors,” of our Annual Report on 10-K for the year ended December 31, 2018.
 
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

No equity securities of ours which were not registered under a private offering of the Securities Act have been issued or sold by us during the three months ended March 31, 2019.

Issuer Purchase of Equity Securities

Our purchase of our common stock during the three months ended March 31, 2019 were as follows:

Period
Total Number of Shares Purchased
 
Average Price Paid per Share
 
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
 
Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs
January 1 to January 31, 2019

 
$

 

 

February 1 to February 28, 2019

 

 

 

March 1 to March 31, 2019
15,577

 
11.18

(1) 

 

  Total
15,577

 
$
11.18

 

 


(1) Delivery of shares to us in payment of tax withholding in connection with an employee’s vesting in restricted stock. The shares were immediately canceled.

67



Item 6.    Exhibits:

Certification of Chief Executive Officer, Pursuant to Exchange Act Rule 13a-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
Certification of Chief Financial Officer, Pursuant to Exchange Act Rule 13a-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
Certification of Chief Executive Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
Certification of Chief Financial Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
Material Legal Proceedings
 
 
101.INS
 
 
 
101.SCH
XBRL Taxonomy Extension Schema
 
 
101.CAL
XBRL Taxonomy Extension Calculation Linkbase
 
 
101.DEF
XBRL Taxonomy Extension Definition Linkbase
 
 
101.LAB
XBRL Taxonomy Extension Label Linkbase
 
 
101.PRE
XBRL Taxonomy Extension Presentation Linkbase
* Incorporated by reference


68



SIGNATURE

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.


 
 
VECTOR GROUP LTD.
 
 
(Registrant)
 
 
 
 
 
By: /s/ J. Bryant Kirkland III
 
 
J. Bryant Kirkland III
 
 
Senior Vice President, Treasurer and
 
 
Chief Financial Officer
Date:
May 10, 2019
 

69
Exhibit


EXHIBIT 31.1

RULE 13a-14(a) CERTIFICATION OF CHIEF EXECUTIVE OFFICER


I, Howard M. Lorber, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Vector Group Ltd.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

(a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 10, 2019
 
/s/ Howard M. Lorber
 
Howard M. Lorber
 
President and Chief Executive Officer


Exhibit


EXHIBIT 31.2
RULE 13a-14(a) CERTIFICATION OF CHIEF FINANCIAL OFFICER


I, J. Bryant Kirkland III, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Vector Group Ltd.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

(a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 10, 2019
 
/s/ J. Bryant Kirkland III
 
J. Bryant Kirkland III
 
Senior Vice President, Treasurer and Chief Financial Officer



Exhibit


EXHIBIT 32.1


SECTION 1350 CERTIFICATION OF CHIEF EXECUTIVE OFFICER


In connection with the Quarterly Report of Vector Group Ltd. (the “Company”) on Form 10-Q for the quarter ended March 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Howard M. Lorber, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.




May 10, 2019
 
/s/ Howard M. Lorber
 
Howard M. Lorber
 
President and Chief Executive Officer


Exhibit


EXHIBIT 32.2


SECTION 1350 CERTIFICATION OF CHIEF FINANCIAL OFFICER


In connection with the Quarterly Report of Vector Group Ltd. (the “Company”) on Form 10-Q for the quarter ended March 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, J. Bryant Kirkland III, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.




May 10, 2019
 
/s/ J. Bryant Kirkland III
 
J. Bryant Kirkland III
 
Senior Vice President, Treasurer and Chief Financial Officer


Exhibit


Exhibit 99.1

I. INDIVIDUAL CASES

A. Engle Progeny Cases.

Pursuant to the Florida Supreme Court’s ruling in Engle v. Liggett Group Inc., which decertified the Engle class on a prospective basis, former class members had until January 2008 to file individual lawsuits. Lawsuits by individuals requesting the benefit of the Engle ruling are referred to as the “Engle progeny” cases. Liggett has resolved the claims of all but approximately 70 Engle progeny plaintiffs. For more information on the Engle case and on the settlement, see “Note 9. Contingencies.”

(i)
Engle Progeny Cases with trial dates through March 31, 2020.

Brown v. R. J. Reynolds Tobacco Company, et al., Case No. 2007-CA-003792, Circuit Court of the 5th Judicial Circuit, Marion County (case filed 12/10/07).  The case is set for trial starting 03/09/20.

Marsh v. R.J. Reynolds Tobacco Company, et al., Case No. 12-26323, Circuit Court of the 11th Judicial Circuit, Miami-Dade County (case filed  07/06/12).  One individual suing as personal representative of the estate and survivors of a deceased smoker.  The case is set for trial starting 10/19.


(ii)
Post-Trial Engle Progeny Cases.

Santoro v. R.J. Reynolds, et al., Case No. 08-025807, Circuit Court of the 17th Judicial Circuit, Broward County (case filed 06/05/08). This wrongful death action proceeded to jury trial in March 2017. On March 29, 2017, the jury returned a verdict in favor of the plaintiff and awarded compensatory damages in the amount of $1,605,000. The jury apportioned fault as follows: Decedent - 36%, Philip Morris - 28%, R.J. Reynolds - 26% and Liggett - 10% ($160,500). In April 2017, a joint and several judgment was entered against defendants for $1,027,200 for compensatory damages as well as $15,000 in punitive damages against Liggett. Defendants filed post-trial motions seeking dismissal of all claims. In December 2017, the court granted the motion to set aside the verdict as to all claims other than conspiracy. Defendants moved for rehearing with respect to that claim and plaintiff moved for entry of an amended final judgment to increase plaintiff’s recovery by the percentage of decedent’s fault in light of the Schoeff decision. The court denied defendants’ remaining post trial motions and the motion for rehearing and granted, in part, plaintiff’s motion to amend the final judgment. The parties agreed that the plaintiff is not entitled to punitive damages. A joint and several amended final judgment in the amount of $1,605,000 was entered in May 2018. Defendants appealed. Briefing is underway.

B. Other Individual Cases.

Florida

Baron, et al. v. Philip Morris USA Inc. et al., Case No. 17-CA-023133, Circuit Court of the 17th Judicial Circuit, Broward County (case filed 12/21/17). Two individuals suing.

Bennett, et al. v. Philip Morris USA Inc. et al., Case No. 17-CA-023046, Circuit Court of the 17th Judicial Circuit, Broward County (case filed 12/20/17). Three individuals suing on behalf of the estate.

Broughton v. Liggett Group LLC, et al., Case No. 18-CA-007187, Circuit Court of the 13th Judicial Circuit, Hillsborough County (case filed 07/25/18). One individual suing.

Cole v. R.J. Reynolds Tobacco Company. et al., Case No. 19-000265, Circuit Court of the 6th Judicial Circuit, Pinellas County (case filed 01/11/19). One individual suing.

Cowart v. Liggett Group Inc., et al., Case No. 98-01483-CA, Circuit Court of the 4th Judicial Circuit, Duval County (case filed 03/16/98). One individual suing. Liggett is the only defendant in this case. The case is dormant.

1




Cunningham v. R.J. Reynolds, et al., Case No. 562017-CA-000293, Circuit Court of the 19th Judicial Circuit, St. Lucie County (case filed 02/20/17). One individual suing on behalf of the estate and survivors of a deceased smoker.

Cupp v. Philip Morris USA Inc., et al., Case No. 17-CA-020257, Circuit Court of the 17th Judicial Circuit, Broward County (case filed 11/06/17). One individual suing.

DaSilva, et al. v. Philip Morris USA Inc., et al., Case No. 17-CA-022955, Circuit Court of the 17th Judicial Circuit, Broward County (case filed 12/19/17). Two individuals suing.

Davis v. R.J. Reynolds, et al., Case No. 2019-CA-001182AX, Circuit Court of the 12th Judicial Circuit, Manatee County (case filed 03/19/19). One individual suing.

Feld v. Philip Morris USA Inc., et al., Case No. 17-CA-020119, Circuit Court of the 17th Judicial Circuit, Broward County (case filed 11/03/17). One individual suing. The case is set for trial during the trial period of 10/22/19 - 11/08/19.

Gonzalez v. Philip Morris USA Inc., et al., Case No. 1836558-CA-01, Circuit Court of the 11th Judicial Circuit, Miami-Dade County (case filed 11/03/17). One individual suing.

Harcourt v. Philip Morris USA Inc., et al., Case No. 17-CA-0202979, Circuit Court of the 17th Judicial Circuit, Broward County (case filed 11/07/17). One individual suing.

Lane, et al. v. Philip Morris USA Inc., et al., Case No. 17-011591, Circuit Court of the 17th Judicial Circuit, Broward County (case filed 06/16/17). Two individuals suing.

Mendez v. Philip Morris USA Inc., et al., Case No. 82462185, Circuit Court of the 11th Judicial Circuit, Miami-Dade County (case filed 12/21/18).  One individual suing.

Pagan v. Philip Morris USA Inc., et al., Case No. 17-022217, Circuit Court of the 17th Judicial Circuit, Broward County (case filed 12/08/17).  One individual suing.

Principe v. Philip Morris USA Inc., et al., Case No. 17-CA-025772, Circuit Court of the 11th Judicial Circuit, Miami-Dade County (case filed 11/06/17). One individual suing. The case is set for trial during the trial period of 01/06/20 - 01/24/20.

Rackinac v. Philip Morris USA Inc., et al., Case No. 17-CA-014839, Circuit Court of the 11th Judicial Circuit, Miami-Dade County (case filed 06/16/17). One individual suing. The case is set for trial starting 02/12/20.

Royal v. Philip Morris USA Inc., et al., Case No. 17-CA-020204, Circuit Court of the 17th Judicial Circuit, Broward County (case filed 10/16/17). One individual suing.

Schnitzer, et al., v. Philip Morris USA Inc., et al., Case No. 2018-026537-CA-01, Circuit Court of the 11th Judicial Circuit, Miami-Dade County (case filed 08/06/18). One individual suing.

Smith v. Philip Morris USA Inc., et al., Case No. 17-026268, Circuit Court of the 11th Judicial Circuit, Miami-Dade County (case filed 11/13/17). One individual suing.

Voglio v. R.J. Reynolds Tobacco Co., et al., Case No. 2018-CA-000640-CAAXMX, Circuit Court of the 19th Judicial Circuit, Martin County (case filed 08/29/18). One individual suing on behalf of the estate and survivors of a deceased smoker.

Williams v. Philip Morris USA Inc., et al., Case No. 17-CA-021672, Circuit Court of the 17th Judicial Circuit, Broward County (case filed 11/30/17). One individual suing.



2





Illinois

Clay v. Philip Morris USA Inc., et al., Case No. 1:18-cv-03549, United States District Court, Northern District of Illinois (case filed 04/16/18).  One individual suing.

Dowdle v. Philip Morris USA Inc., et al., Case No. 2018 L 003905, Circuit Court of Cook County, Illinois (case filed 04/17/18).  One individual suing. 

Mitchell v. Philip Morris USA Inc., et al., Case No. 1:18-cv-07739, United States District Court, Northern District of Illinois (case filed 10/22/2018). One individual suing. A motion for remand is pending.

Smith v. Philip Morris USA Inc., et al., Case No. 1:18-cv-06397, United States District Court, Northern District of Illinois (case filed 08/16/18).  One individual suing.  A motion for remand is pending.

Louisiana

Oser v. The American Tobacco Co., et al., Case No. 97-9293, Circuit Court of the Civil District Court, Parish of Orleans (case filed 05/27/97). One individual suing. There has been no recent activity in this case.

Reese, et al. v. R. J. Reynolds, et al., Case No. 2003-12761, Circuit Court of the 22nd Judicial District Court, St. Tammany Parish (case filed 06/10/03). Five individuals suing. There has been no recent activity in this case.

New York

Debobes v. The American Tobacco Company, et al., Case No. 29544/92, Supreme Court of New York, Nassau County (case filed 10/17/97). One individual suing. There has been no recent activity in this case.

Yedwabnick v. The American Tobacco Company, et al., Case No. 20525/97, Supreme Court of New York, Queens County (case filed 09/19/97). One individual suing. There has been no recent activity in this case.

Ohio

Croft, et al. v. Akron Gasket & Packing, et al., Case No. CV04541681, Court of Common Pleas, Cuyahoga County (case filed 08/25/05). Two individuals suing. There has been no recent activity in this case.

West Virginia

Brewer, et al. v. The American Tobacco Company, et al., Case No. 01-C-82, Circuit Court, Ohio County (case filed 03/20/01). Two individuals suing. There has been no recent activity in this case.

Little v. The American Tobacco Company, et al., Case No. 01-C-235, Circuit Court, Ohio County (case filed 06/04/01). One individual suing. There has been no recent activity in this case.


II. CLASS ACTION CASES

In Re: Tobacco Litigation (Personal Injury Cases), Case No. 00-C-5000, Circuit Court, West Virginia, Ohio County (case filed 01/18/00). Although not technically a class action, the court consolidated approximately 750 individual smoker actions that were pending prior to 2001 for trial of certain “common” issues. Liggett was severed from trial of the consolidated action. In May 2013, the jury rejected all but one of the plaintiffs’ claims against the non-Liggett defendants, finding in favor of plaintiffs on the claim that ventilated filter cigarettes between 1964 and July 1, 1969 should have included instructions on how to use them. The court entered judgment in October 2013, dismissing all claims against the non-Liggett defendants except the ventilated filter claim on behalf of 30 plaintiffs. Subsequently, these claims were settled by the non-Liggett defendants. In May 2016, the trial court ruled that the case could

3



proceed against Liggett notwithstanding the outcome of the first phase of the trial against the non-Liggett defendants.  In December 2017, the court ordered plaintiffs’ counsel to confirm all remaining plaintiffs with claims against Liggett. The court further agreed that it would entertain a renewed motion by Liggett regarding the impact of the final judgment in favor of co-defendants on the claims against Liggett and whether those claims are barred by the doctrine of collateral estoppel. In 2017 Liggett moved to dismiss a number of plaintiffs’ claims on various grounds.  The court granted the motions as to approximately 25 plaintiffs and reserved ruling as to other claims until additional discovery is provided by plaintiffs.  The Phase I Common Issues trial is set starting August 12, 2019. It is currently estimated that Liggett could be a defendant in approximately 55 individual cases.

Parsons, et al. v. A C & S Inc., et al., Case No. 00-C-7000, First Judicial Circuit, West Virginia, Ohio County (case filed 02/09/98). This purported class action is brought on behalf of plaintiff and all West Virginia residents who allegedly have claims arising from their exposure to cigarette smoke and asbestos fibers. The operative complaint seeks to recover unspecified compensatory and punitive damages on behalf of the putative class. The case is stayed as a result of the December 2000 bankruptcy petitions filed by three defendants (Nitral Liquidators, Inc., Desseaux Corporation of North America and Armstrong World Industries).

Young, et al. v. American Brands Inc., et al., Case No. 97-19984cv, Civil District Court, Louisiana, Orleans Parish (case filed 11/12/97). This purported personal injury class action is brought on behalf of plaintiff and all similarly situated residents in Louisiana who, though not themselves cigarette smokers, were exposed to secondhand smoke from cigarettes that were manufactured by the defendants, including Liggett, and suffered injury as a result of that exposure. The plaintiffs seek an unspecified amount of compensatory and punitive damages. No class certification hearing has been held. In March 2016 the court entered an order staying the case, including all discovery, pending the completion of the smoking cessation program ordered by the court in Scott v. The American Tobacco Co.

 
III. HEALTH CARE COST RECOVERY ACTIONS

Crow Creek Sioux Tribe v. The American Tobacco Company, et al., Case No. cv-97-09-082, Tribal Court of the Crow Creek Sioux Tribe, South Dakota (case filed 09/26/97). The plaintiff seeks to recover actual and punitive damages, restitution, funding of a clinical cessation program, funding of a corrective public education program and disgorgement of unjust profits from alleged sales to minors. The case is dormant.

4